User login
Hospital‐Based Tobacco Treatment Service
Hospitalization can be considered a teachable moment for smoking cessation13 for the 6.5 million adult smokers who are hospitalized in the United States each year.4 Smokers who receive tobacco treatment during hospitalization and outpatient follow‐up treatment for at least 1 month are more likely to quit than patients who receive no treatment.5, 6
Unless tobacco treatment is explicitly delegated to other providers, physicians shoulder the responsibility of encouraging smokers to quit and prescribing smoking cessation medications. This is problematic in that physicians sometimes fail to counsel their patients about quitting smoking7, 8 or recommend outpatient follow‐up.9 Few hospitals provide comprehensive treatment. In a review of 33 studies on the prevalence of smoking care delivery in hospitals, 3 hospitals reported they provided advice to quit alone, 29 provided advice plus counseling and assistance in quitting, and 8 provided advice or prescription for cessation pharmacotherapy.9 Although post‐discharge support is a key component of effective treatment for hospitalized smokers,6 only 11 reported providing follow‐up treatment, or referral for follow‐up treatment, after discharge. Among these 11 hospitals, respondents reported they provided referral or follow‐up to 1% to 74% of their smokers, with a median percentage of 24%. The 1 study that specified the type of outpatient treatment provided reported the hospital provided the state quitline number to smokers.
Instituting a dedicated smoking cessation program may enhance inpatient treatment, outpatient follow‐up, and treatment outcomes. Two studies have found that institutional smoking cessation programs increased the likelihood that patients would receive treatment and quit compared to hospitals without dedicated programs.10, 11
Although many US hospitals are developing programs to provide systematic treatment for tobacco dependence,9 little is known regarding how programs structure their staff, enroll patients, or provide treatment to patients that smoke. Instituting tobacco treatment services usually requires policy change and system‐wide approaches with quality improvement endpoint goals.8, 1214 In the United States, elements of these services include: 1) developing a cadre of trained tobacco treatment specialists, 2) implementing hospital systems for identifying smokers and referring them to the service, 3) providing inpatient treatment based on current treatment guidelines15 and 4) providing or facilitating follow‐up treatment after discharge, often via fax‐referral to tobacco quitlines. This systematic approach is still lacking in many hospitals.
To date, few evaluations of dedicated hospital‐based smoking cessation programs have been reported in the literature.8, 11 The purpose of this study is to describe patient characteristics and outcomes of a dedicated tobacco treatment service, with paid staff, in a large academic medical center. We describe treatment protocols, profile patients served, treatments provided, and summarization of 6‐month post‐discharge outcomes for smokers referred to the UKanQuit service over a 1‐year period. We close with lessons learned on how to improve the delivery of tobacco treatment to hospitalized patients.
Methods
Design and Setting
This is a descriptive observational study of a tobacco treatment program in a large Midwestern academic medical center between September 1, 2007 and August 31, 2008. The specialty tobacco treatment service (UKanQuit) was established when the hospital campus went smoke free on September 1, 2006. Patients are referred to the service via the hospital electronic medical record (EMR). As nurses complete electronic forms on patients admitted to their units, the EMR prompts nurses to ask patients if they smoke, ask smokers if they would like tobacco treatment medication to prevent withdrawal symptoms while in the hospital, and ask smokers if they would like to talk to a tobacco treatment specialist during their hospital stay. Those who respond yes to the final question are placed on an electronic list for UKanQuit services. Physicians and other health care providers can also order consultation from the UKanQuit service. A description of smokers admitted to the hospital and predictors of referral to UKanQuit within the first year of service is presented elsewhere.16, 17
The UKanQuit staff consists of an interdisciplinary team of counselors with a Ph.D., Masters degrees, and/or substantial experience in case management and substance abuse treatment. All have received intensive training and supervision in treating tobacco dependence. All participate in UKanQuit counseling on a part‐time basis, and spend the remainder of their effort as research assistants and counselors on smoking cessation research projects in the medical center. Hence, staffing consists of 1 full‐time equivalent counselor, 0.15 full‐time equivalent director (Richter), and 0.05 full‐time equivalent medical director (Ellerbeck). The program is funded through a contract with the hospital. We are in the process of hiring a nurse practitioner to create a more sustainable funding stream for the program because nurse practitioners can bill cessation services.
UKanQuit provides hospital counseling from 9 AM to 5 PM on weekdays. UKanQuit staff meets weekly for counseling supervision, strategic planning, continuing education, and troubleshooting difficult cases. In addition to treating smokers, the UKanQuit staff provides training and consultation to hospital personnel via grand rounds and other presentations. The service also provides a platform for medical students and residents to conduct focused research related to quality improvement. To facilitate systematic treatment of tobacco, UKanQuit developed the hospital treatment protocol for nursing staff, developed evidence‐based written self‐help materials that are accessible to hospital staff via the hospital printing system, and developed and instituted a tobacco treatment order set that was recently integrated into the EMR and automatically becomes prioritized as a recommended order set for all patients who report they have smoked in the past 30 days.
Procedures
UKanQuit staff retrieves patient details from the EMR and visits patients at their bedside. All hospital services refer to UKanQuit. UKanQuit provides counseling to Spanish speakers through bilingual/bicultural staff and hospital translators assist UKanQuit staff in counseling patients who speak other languages. The staff conducts a brief assessment at the bedside to inform treatment and contacts patients 6 months following inpatient treatment to assess outcomes and provide additional support and referral. This study evaluating the UKanQuit program was approved by the medical center's Institutional Review Board.
Program Intervention
UKanQuit staff visit patients at the bedside to deliver tobacco treatment. This consists of: (a) assessing withdrawal; (b) working with the health care team to adjust nicotine replacement to keep the patient comfortable; (c) assessing patients' interest in quitting smoking; (d) providing brief motivational intervention to patients not interested in quitting; and (e) providing assistance in quitting (developing a quit plan, arranging for medications on discharge) to patients interested in quitting (Figure 1). UKanQuit staff recommend medications based on the patients' level of dependence, history of cessation, and cessation medication preferences. The recommendation is communicated in person and by chart documentation to the medical team, usually by the nursing staff. The patients' resident or attending physician makes the final determination regarding medication provided. The hospital has nicotine replacement therapy (NRT; patch, gum, and lozenge), bupropion, and varenicline in its formulary. Patients are then offered an option of fax referral to the state tobacco quitline for follow‐up counseling. UKanQuit staff documents the services provided in the EMR via SOAR (Subjective, Objective, Assessment and Referral) notes.
Measures
Baseline Measures
These were collected from the UKanQuit 1‐page program intake form, which UKanQuit designed to collect the minimal information necessary to conduct medication and behavioral counseling, to maximize counseling time, and to fit into the dense schedule of each patient's hospital stay. Demographic measures include age, gender and ethnicity. Smoking behavior measures include number of years smoked, number of cigarettes per day, a single item from the Fagerstrom Test for Nicotine Dependence that assesses time to first cigarette after waking,18, 19 interest in quitting smoking (on a 0‐10 scale, with 10 being very interested in quitting), and a single item from the self report version of the Minnesota Nicotine Withdrawal Scale (MNWS) that asks smokers to rate their desire or craving to smoke over a specified period. The single item craving measure from the MNWS has been found to have high reliability and good construct validity and is neither less sensitive to abstinence nor less reliable than the ten‐item brief questionnaire of smoking urges (QSU‐brief) used in laboratory and clinical trials.20 We asked about craving over the past 24 hours on a scale from 0 (none) to 4 (severe).21
Process Measures
Counselors also document the treatment they provided to smokers including the time spent with patients during counseling, provision of written self‐help materials, whether smokers set goals for quitting, hospital staff had already placed the smoker on a tobacco treatment medication, smokers are interested in increasing or changing their medication, the smoker wants smoking cessation medication on discharge, UKanQuit staff submitted a recommendation to hospital staff to make a medication change and/or provide a prescription for medication on discharge, plans for post‐discharge follow‐up (fax‐referral of patients to the state tobacco quitline or acceptance of UKanQuit counseling after discharge), and the patient agrees to be contacted at 6 months post‐discharge for follow‐up assessment and assistance.
Follow‐Up Measures
Outcome measures were collected by telephone 6 months post‐discharge by study staff who were not involved in the in‐hospital counseling. Call attempts to reach each patient ranged from 1 to 11. Measures included self‐reported 7‐day point prevalence abstinence rates, the number of quit attempts lasting over 24 hours, and cigarettes smoked per day among continuing smokers. Patients are asked if they participated in counseling through the tobacco quitline. Scaled (0‐10) items assess how important it is to the patients to quit smoking or remain quit, how confident they are in being able to quit or remain quit, and how satisfied they were with the assistance provided by UKanQuit. A yes/no item assesses whether patients think the program should be continued. In addition, UKanQuit asked two open‐ended questions to qualitatively assess satisfaction with the program and elicit suggestions for improvements. The questions were: What, if anything, was helpful to you about our services? and How can UKanQuit better help people stop smoking?
Analyses
Categorical variables were summarized by frequencies and percentages; continuous variables were summarized by means and standard deviations (SDs). We compared baseline characteristic differences between respondents and nonrespondents at 6 months follow‐up using chi‐square for categorical variables and t‐test for continuous variables. We also compared cigarettes per day at baseline and 6 months post‐discharge in smokers who were not able to quit using paired t‐test. All analyses were done with SPSS 17.0 statistical package. Open‐ended questions were analyzed using the framework synthesis method.22 Following examination and familiarization with the data, we developed an initial list of themes. We then categorized the responses by these themes using numerical codes. Each thematic code was summarized as a percentage of all responses. Those responses that fit into multiple thematic codes were multiply coded.
Results
Baseline
Within the study period (September 1, 2007 to August 31, 2008), 22,624 patients were admitted to the medical center (Figure 2). A total of 4150 were current smokers (ie, smoked within the past 30 days). UKanQuit staff met with 513 (68%) of 753 patients referred to the service. Some of the reasons why 32% of referred patients were not seen by the UKanQuit staff have been described in our previous paper.17 These include patient was asleep, doctor in the room, out of bed for procedure, and unable to speak. Table 1 displays the characteristics of 513 smokers treated by UKanQuit from September 1, 2007 to August 31, 2008. Patients were predominantly white (74%) with mean age of 50 years. Slightly more than half of smokers were male (57%). They had smoked an average of 18 cigarettes per day for a mean duration of 29 years, and over half (58%) smoked within 5 minutes of waking suggesting a high level of dependence. On a scale of 1 to 10 the mean interest in quitting was 7.9 (SD 2.9) and the mean craving score on a scale of 0 to 4 was 1.2 (SD 1.4) suggesting slight to mild craving.
| Characteristics | Treated (n = 513) |
|---|---|
| |
| Demographics | |
| Mean age (SD), years | 50.2 (13.6) |
| Male, n (%) | 291 (56.7) |
| Ethnicity, n (%) | |
| White | 371 (73.6) |
| AA | 107 (21.2) |
| Latino | 18 (3.6) |
| Other | 8 (1.6) |
| Referral source, n (%) | |
| Nursing profile | 477 (94.1) |
| Physician | 5 (1.0) |
| Other | 25 (4.9) |
| Smoking characteristics | |
| Mean number of years smoked (SD) | 28.9 (14.6) |
| Smokes within 5 minutes of waking n (%) | 270 (58.3) |
| Mean cigarettes smoked per day (SD) | 18.4 (12.6) |
| Mean interest in quitting (SD)* | 7.9 (2.9) |
| Mean craving (SD) | 1.2 (1.4) |
| Tobacco treatment provided | |
| Counseling | |
| Average time spent with patients (SD) | 19.9 (9.1) |
| Received information packet, n (%) | 490 (97.4) |
| Set goals for quitting, n (%) | 352 (73.3) |
| Had quit plan, n (%) | 151 (33.2) |
| Accepted fax referral to quitline, n (%) | 277 (55.8) |
| Opted for UKanQuit counseling, n (%) | 29 (5.9) |
| Medication | |
| On smoking cessation medication, n (%) | 133 (26.2) |
| Interested in receiving or changing smoking cessation medication, n (%) | 132 (26.7) |
| Added or changed smoking cessation medication, n (%) | 195 (40.5) |
| Discharge med, n (%) | 196 (40.2) |
In‐Hospital Treatment
Hospital staff had placed 1 in 4 of the patients on smoking cessation medication prior to the UKanQuit staff visit. Nineteen percent were on NRT (16.2% transdermal patch, 2.5% on lozenge, 0.8% on nicotine gum); 5% on bupropion, 16.5% on varenicline, and 2.5% on clonidine. A total of 1.7% used a combination of Patch and bupropion while 2.5% used a combination of patch and gum. Staff provided 97% of the patients with written materials. Most patients (73%) set a goal for quitting or cutting down, and one‐third developed quit plans. Fifty‐six percent accepted fax referral to their state quitline, and 6% opted for follow‐up counseling with a UKanQuit counselor. Average time spent by UKanQuit with the patient was 20 minutes. Most of the patients treated (n = 426, 86%) agreed that UKanQuit staff can contact them for follow‐up assessment at 6 months.
Outcomes
Staff successfully contacted 196 (46%) of the 426 patients who agreed to 6‐month follow‐up. Responders were older (mean age 53 years, SD 12.6 vs. mean age 48 years, SD 13.8; P < 0.001); were more interested in quitting (mean interest in quitting 8.4, SD 2.5 vs. 7.6, SD 3.1 P = 0.001); and had a lower craving score at baseline (mean craving score 0.99, SD 1.3 vs. 1.29, SD 1.5; P < 0.001) compared to nonresponders. There were no differences between responders and nonresponders by gender, number of cigarettes smoked per day, years of smoking, referral source, inpatient smoking cessation medication used or time spent with UKanQuit hospital staff during the inpatient visit.
Table 2 displays smoking behavior and smoking cessation‐related characteristics of the respondents 6‐month post‐discharge. Over 70% attempted a quit attempt lasting at least 24 hours. The self reported 7‐day point prevalence abstinence rate was 31.8% among respondents. The intent‐to‐treat quit rate was 14.6% among all participants who agreed to follow‐up, counting those who we could not contact as smokers. While 34% used pharmacotherapy, only 5% of those who were fax‐referred to the quitline utilized the service. Most of the patients seen by the UKanQuit counselor considered quitting and staying quit important, mean 8.7, SD 2.3, and their confidence to quit or stay quit was above average, mean 6.6, SD 3.6. They rated the UKanQuit program very high, at 8.3, SD 2.8, on a scale of 0 to 10, and 98% of them wanted the program to continue. Of those who were not able to quit at 6 months, the mean number of cigarettes smoked per day decreased significantly from 17.8, SD 12.0 at baseline to 14.0, SD 9.7 at 6 months follow‐up (P < 0.001).
| Variables | |
|---|---|
| |
| Smoking characteristics | |
| 7 day point prevalence abstinence rate, n (%) | 62 (31.8) |
| Among current smokers at 6 months follow‐up, n = 134 | |
| Proportion of smokers who attempted to quit within 6 months, n (%) | 99 (73.9) |
| Mean CPD for smokers at 6 months (SD) | 14.0 (9.7) |
| Used formal quit smoking program | |
| Quit smoking medication, n (%) | 65 (34.4) |
| Quitline use among those faxed to quitline, n (%)* | 6 (5.0) |
| Importance/ Confidence | |
| How important is it to quit or stay quit, mean (SD) | 8.7 (2.3) |
| How confident are you to quit or stay quit, mean (SD) | 6.6 (3.6) |
| Views about service | |
| Satisfaction with UKanQuit service, mean (SD) | 8.3 (2.8) |
| Wants the UKanQuit program to continue, n (%) | 165 (97.6) |
Satisfaction and Recommendations for Improvement
Most (96%) of participants contacted at follow‐up commented on what was helpful about the services. Table 3 displays the distribution of themes and illustrative comments. Themes included staff encouragement, support and counseling (41.8%); other (27%); information and education materials (20.9%); medication advice and referral (2.6%), and referral to quitline (0.5%)
| n (%) | |
|---|---|
| |
| Staff encouragement, support and counseling | 82 (41.8) |
| You guys did excellent. The friendliness of the people who visited me. | |
| Her outlook and her encouragement | |
| Other | 53 (27.1) |
| I don't remember the visit because I was heavily medicated, | |
| A lot was helpful but I couldn't tell you exactly what part was the most helpful | |
| Information/education material | 41 (20.9) |
| Provided me with a lot of info and the packet was helpful. | |
| The information packet | |
| Program not helpful | 14 (7.1) |
| I really didn't need their information, I was able to quit without it. | |
| Nothing helpful except the companionship | |
| Medication advice/referral | 5 (2.6) |
| They took the time and set up the patches for me | |
| She helped me with questions about medication, especially Chantix | |
| Referral to Quitline | 1 (0.5) |
| Talking on the phone | |
Discussion
Among patients served by this inpatient program, interest in quitting was high but administration of inpatient medications upon admission was low (26%). Nearly all patients were provided with written materials, a majority set some form of goal for quitting or cutting down, and many developed quit plans and received assistance adjusting inpatient and/or discharge medications. After discharge, the majority of study participants made unassisted quit attempts, as utilization of medications and quitline services was suboptimal. Fax‐referral to quitline may not, on its own, fulfill guideline recommendations for post‐discharge follow‐up.
Our intent‐to‐treat quit rate was about half of what was found in Taylor et al.'s11 hospital program dissemination trial. Their program may have had better effects as it was somewhat more intensive. It included at least 1 follow‐up phone call immediately after discharge, as well as an accompanying video and relaxation audiotape or compact disc. However, differences in outcomes may also be due to large differences between the study populations. Hospitals participating in Taylor's study only conducted intervention and outcome assessment among smokers who were ready to quit, willing to enroll in a clinical trial, and willing to complete informed consent. Our intervention and outcome data included patients who agreed to speak with UKanQuit staff, regardless of readiness to quit. Our participants did not have to complete informed consent and enroll in a trial as our analyses were conducted post hoc. Our study outcomes might better reflect quit rates for a program serving all smokers, at all levels of readiness to quit, in actual hospital practices. The mean reduction in cigarette smoking among smokers who continued to smoke at 6 months' follow‐up was statistically significant. However, findings from a lung health study show that 50% or more reduction in smoking was ultimately related to successful quitting.23
Strengths and Limitations
The strengths of the study include the fact that the program attempts to intervene with all smokers, and provides stage‐appropriate intervention based on readiness to quit. It provides a snapshot of how a program is incorporated into clinical practice and describes implementation of protocol components.
This study has a number of limitations. We do not know exactly how many patients received the in‐hospital medication change agreed upon by the counselor and medical team immediately following the patient encounter. Our follow‐up rate was low and abstinence rates were based on self‐report, which limits our ability to draw conclusions about cessation outcomes. Process of care measures are based on counselor self‐report, without verification of services rendered. We are not able to identify the impact of our intervention above and beyond our patients' hospital experience, because we did not have a control group. We collected limited data from study participants so we are not able to better understand causes of nonadherence to quitline or poor pharmacotherapy utilization. Lastly, when the respondents were asked to comment about what was helpful about UKanQuit, 23% of the respondents said they could not remember the UKanQuit visit during their hospital stay. Many hospital medications induce brief amnesia, and patients have numerous consults during their stay and might not be able to separate one from the other. The 6‐month interval between their visit and follow‐up call may also account for their inability to remember the cessation consult.
Our patient population is in fact a subset of all smokers admitted (11% of smokers) because they are motivated enough to agree to talk with a counselor. Our intervention procedures, and results, might be quite different if all smokers were visited by the counselor. Efficacy trials of tobacco treatment in hospitals have focused on smokers who are ready to quit.24 Hence, procedures for working with unmotivated smokers in hospitals are less well established. Policymakers, hospitals, and hospital tobacco treatment programs should examine the most efficient (ie, effective and cost‐effective) approaches for addressing smoking in hospitals and specifically focus on whether all smokers should be treated by dedicated tobacco treatment staff, or only those who agree to a consult.
Lessons Learned
Linking Patients With In‐Hospital Cessation Medications Requires Collaboration With the Entire Health Care Team
Only 1 in 4 UKanQuit participants had been given smoking cessation medication to ameliorate withdrawal before counselors met with the patients. Although we have not systematically collected reasons patients do not receive cessation medication on admission, the 2 most common causes are that patients refuse it or physicians refuse it. Patients refuse medication perhaps because they do not want to quit, they feel they will cope without smoking during their hospital stay, or they are paying out of pocket and want to reduce costs. Physicians do not permit it because they believe it is contraindicated for the patient's health condition, it is contraindicated for the procedure the patient is receiving in the hospital, or they believe it will interfere with wound healing. There is also a considerable delay between ordering and receiving medications; patients who become uncomfortable during their stay sometimes change their minds, but end up being discharged before their medication arrives. Most of these issues pertain to nicotine replacement. Although patients not eligible for NRT may be good candidates for bupropion, varenicline, or even the second line cessation medications of clonidine or nortryptiline, these medications do not provide immediate relief from tobacco withdrawal symptoms and staff are reluctant to start patients on medications they may not receive on an outpatient basis. It is not clear what proportion of hospitalized patients should receive ameliorative medication. Not every hospitalized smoker is a candidate for NRT, due to contraindicated medical conditions, patients' level of dependence, and patients' willingness to accept cessation medication in order to prevent withdrawal. Koplan et al.25 achieved hospital‐wide increases in NRT orders from 1.6% to 2.5% after the introduction of an electronic tobacco treatment order set. These percentages seem low but actually were calculated from all hospital admissions, including smokers and nonsmokers. Moreover, their hospital population had a relatively low smoking rate of 12%. Our in‐hospital and post‐discharge (26.2% and 34.4% respectively) pharmacotherapy utilization rates were based only on smokers who had been seen by our service. Even though 1 in 4 smokers were already on medication when they were seen by counselors, 1 in 4 of patients seen wanted to either add a cessation medication or change their current dose. There is clearly room for improvement in how we offer and administer cessation medications on admission. Also, assessing medication efficacy and adjusting as needed appears to be an important role for in‐hospital counselors.
Facilitating Medications Post‐Discharge Will Require Creativity and Outpatient Follow‐Up
Post‐discharge, only 1 in 3 of our patients reported they used cessation medications. This may, again, be a function of patients' readiness to quit. However, it could also be related to knowledge/attitudes regarding the efficacy of medications or access to low‐cost medications. Some of our patients commented that making medication affordable would be helpful. Although our materials provide information on sources for free or low‐cost medications, this information may not have been salient during the hospital stay. To increase access to medications post‐discharge, programs should consider providing a booster mailer to the home with information on sources for free or reduced medications, providing take‐home starter pharmacotherapy kits lasting 1 to 2 weeks to bridge the gap between hospital discharge and finding another source of medications, and/or a follow‐up call shortly after discharge to verify use of pharmacotherapy and troubleshoot problems with medications or procurement.
Providing Follow‐Up Via Fax Referral to Quitlines Is Not as Simple as It Seems
Although our overall quitline fax‐referral rate was high (over half of all patients seen), rate of enrollment among those referred is much lower than the rates reported elsewhere, which range from 16% to 53%.2628 In our sample of fax‐referred smokers, we do not know how many were not enrolled due to failure to make contact vs. patient refusal once contact was made. One possible factor impacting enrollment rates is whether or not smokers are prescreened for readiness to quit. Nearly half of US quitlines require smokers to be ready to quit in order to receive a full course of treatment,29 but only 20% of smokers are ready to quit at any given time.30 In the cited studies with higher conversion rates, counselors prescreened patients for readiness to quit and only offered fax‐referral to those ready to quit in the next 30 days. Our program offers fax‐referral to all smokers. Our findings suggest that doing so results in high rates of referral but low rates of enrollment among those referred. Future studies should examine the impact of prescreening for readiness versus offering referral to all smokers on net enrollment and cessation.
Linking hospitalized smokers with tobacco quitlines has many potential benefits.31, 32 Proactive tobacco quitlines are effective15 and cost effective33 for smoking cessation; they are available, free, to all US smokers; services are delivered via telephone which minimizes many access barriers; hospitals do not have to bear the costs of the services; and many quitlines are undersubscribed and eager to increase their reach.34 Potential methods for increasing conversion to enrollment include building motivation to accept counseling and preparing patients for the quitline intake procedures. Our program is considering providing a warm handoff to patients by calling the quitline during the bedside consult to permit the quitline to enroll the patient during their hospital stay.
Hospital‐based cessation programs have the potential to deliver tobacco treatment to millions of hospitalized smokers annually. To deliver high‐quality, effective care, hospital cessation programs will have to solve problems inherent in hospital‐based carehow best to integrate into existing hospital systems, how to effectively communicate with other hospital care providers, and how to facilitate transitions in care to ensure patients receive evidence‐based post‐discharge care. We offer this report as the first of hopefully many that address quality improvement for specialized programs dedicated to treating tobacco in hospitals.
Acknowledgements
The authors gratefully acknowledge the contributions of the following UKanQuit Counselors in the planning and development of this manuscript: Brian Hernandez, Alex Perez‐Estrada, Grace Meikenhous, Meredith Benson, Terri Tapp. We also thank Chip Hulen, Albers Bart and Chris Wittkopp of the Organizational Improvement Department of KU Hospital; Marilyn Painter, Joanne McNair and Karisa Deculus of the KU Preventive Medicine and Public Health Department.
- ,.Smokers who are hospitalized: a window of opportunity for cessation interventions.Prev Med.1992;21:262–269.
- ,,.Understanding the potential of teachable moments: the case of smoking cessation.Health Educ Res.2003;18(2):156–170.
- ,.Teachable moments for promoting smoking cessation: the context of cancer care and survivorship.Cancer Control.2003;10(4):325–333.
- ,,.Helping hospitalized smokers quit: new directions for treatment and research.J Consul Clin Psychol.1993;61(5):778–789.
- ,,.Smoking cessation interventions for hospitalized smokers: a systematic review.Arch Intern Med.2008;168(18):1950–1960.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- CDC.Physician and other health‐care professional counseling of smokers to quit‐‐United States, 1991.MMWR Morb Mortal Wkly Rep.1993;42(44):854–857.
- ,,,,,.Implementing tobacco interventions in the real world of managed care.Tob Control.2000;9Suppl 1:I18–I24.
- ,,, et al.Smoking care provision in hospitals: a review of prevalence.Nicotine Tob Res.2008;10(5):757–774.
- ,,,,,.Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success.Arch Intern Med.2008;168(18):1961–1967.
- ,,,,.Dissemination of an effective inpatient tobacco use cessation program.Nicotine Tob Res.2005;7(1):129–137.
- ,,,,.Application of a nurse‐managed inpatient smoking cessation program.Nicotine Tob Res.2002;4(2):211–222.
- ,,,,,.Delivering clinical preventive services is a systems problem.Ann Behav Med.1997;19(3):271–278.
- ,,, et al.Lessons from experienced guideline implementers: attend to many factors and use multiple strategies.Jt Comm J Qual Improv.2000;26(4):171–188.
- U.S. Department of Health and Human Services (USDHHS).Treating Tobacco Use and Dependence: Clinical Practice Guideline 2008 Update.
- ,,,,.Referral and treatment for nicotine dependence among hospitalized patients.Subst Abus.2009;30(1):94–95.
- ,,,,.Prevalence and predictors of tobacco treatment in an academic medical center.Jt Comm J Qual Patient Saf.2009;35(11):551–557.
- ,,,.The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire.Br J Addict.1991;86(9):1119–1127.
- ,,, et al.Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence.Nicotine Tob Res.2007;9 Supp 4:555–570.
- ,.Is the ten‐item Questionnaire of Smoking Urges (QSU‐brief) more sensitive to abstinence than shorter craving measures?Psychopharmacology (Berl).2010;208(3):427–432.
- ,.Signs and symptoms of tobacco withdrawal.Arch Gen Psychiatry.1986;43(3):289–294.
- ,,.Qualitative research in health care. Analysing qualitative data.BMJ.2000;320(7227):114–116.
- ,,,.Smoking reduction in the Lung Health Study.Nicotine Tob Res.2004;6(2):275–280.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- ,,,,.A computerized aid to support smoking cessation treatment for hospital patients.J Gen Intern Med.2008;23(8):1214–1217.
- ,,,,,.The feasibility of connecting physician offices to a state‐level tobacco quit line.Am J Prev Med.2006;30(1):31–37.
- ,,, et al.Clinical faxed referrals to a tobacco quitline: reach, enrollment, and participant characteristics.Am J Prev Med.2009;36(4):337–340.
- ,,, et al.Feasibility of a Spanish/English computerized decision aid to facilitate smoking cessation efforts in underserved communities.J Health Care Poor Underserved.2010;21(2):504–517.
- North American Quitline Consortium. Available at: http://www.naquitline. org. Accessed July2010.
- ,,,,,.Distribution of smokers by stage in three representative samples.Prev Med.1995;24:401–411.
- ,,.Telephone counselling for smoking cessation.Cochrane Database Syst Rev.2006;3:CD002850.
- ,.The potential of quitlines to increase smoking cessation.Drug Alcohol Rev.2006;25(1):73–78.
- ,,, et al.Evidence of real‐world effectiveness of a telephone quitline for smokers.N Engl J Med.2002;347(14):1087–1093.
- Campaign for Tobacco Free Kids Fact Sheets 2008. Quitlines Help Smokers Quit. Available at: http://www.tobaccofreekids.org/research/factsheets/pdf/0326.pdf. Accessed July2010.
Hospitalization can be considered a teachable moment for smoking cessation13 for the 6.5 million adult smokers who are hospitalized in the United States each year.4 Smokers who receive tobacco treatment during hospitalization and outpatient follow‐up treatment for at least 1 month are more likely to quit than patients who receive no treatment.5, 6
Unless tobacco treatment is explicitly delegated to other providers, physicians shoulder the responsibility of encouraging smokers to quit and prescribing smoking cessation medications. This is problematic in that physicians sometimes fail to counsel their patients about quitting smoking7, 8 or recommend outpatient follow‐up.9 Few hospitals provide comprehensive treatment. In a review of 33 studies on the prevalence of smoking care delivery in hospitals, 3 hospitals reported they provided advice to quit alone, 29 provided advice plus counseling and assistance in quitting, and 8 provided advice or prescription for cessation pharmacotherapy.9 Although post‐discharge support is a key component of effective treatment for hospitalized smokers,6 only 11 reported providing follow‐up treatment, or referral for follow‐up treatment, after discharge. Among these 11 hospitals, respondents reported they provided referral or follow‐up to 1% to 74% of their smokers, with a median percentage of 24%. The 1 study that specified the type of outpatient treatment provided reported the hospital provided the state quitline number to smokers.
Instituting a dedicated smoking cessation program may enhance inpatient treatment, outpatient follow‐up, and treatment outcomes. Two studies have found that institutional smoking cessation programs increased the likelihood that patients would receive treatment and quit compared to hospitals without dedicated programs.10, 11
Although many US hospitals are developing programs to provide systematic treatment for tobacco dependence,9 little is known regarding how programs structure their staff, enroll patients, or provide treatment to patients that smoke. Instituting tobacco treatment services usually requires policy change and system‐wide approaches with quality improvement endpoint goals.8, 1214 In the United States, elements of these services include: 1) developing a cadre of trained tobacco treatment specialists, 2) implementing hospital systems for identifying smokers and referring them to the service, 3) providing inpatient treatment based on current treatment guidelines15 and 4) providing or facilitating follow‐up treatment after discharge, often via fax‐referral to tobacco quitlines. This systematic approach is still lacking in many hospitals.
To date, few evaluations of dedicated hospital‐based smoking cessation programs have been reported in the literature.8, 11 The purpose of this study is to describe patient characteristics and outcomes of a dedicated tobacco treatment service, with paid staff, in a large academic medical center. We describe treatment protocols, profile patients served, treatments provided, and summarization of 6‐month post‐discharge outcomes for smokers referred to the UKanQuit service over a 1‐year period. We close with lessons learned on how to improve the delivery of tobacco treatment to hospitalized patients.
Methods
Design and Setting
This is a descriptive observational study of a tobacco treatment program in a large Midwestern academic medical center between September 1, 2007 and August 31, 2008. The specialty tobacco treatment service (UKanQuit) was established when the hospital campus went smoke free on September 1, 2006. Patients are referred to the service via the hospital electronic medical record (EMR). As nurses complete electronic forms on patients admitted to their units, the EMR prompts nurses to ask patients if they smoke, ask smokers if they would like tobacco treatment medication to prevent withdrawal symptoms while in the hospital, and ask smokers if they would like to talk to a tobacco treatment specialist during their hospital stay. Those who respond yes to the final question are placed on an electronic list for UKanQuit services. Physicians and other health care providers can also order consultation from the UKanQuit service. A description of smokers admitted to the hospital and predictors of referral to UKanQuit within the first year of service is presented elsewhere.16, 17
The UKanQuit staff consists of an interdisciplinary team of counselors with a Ph.D., Masters degrees, and/or substantial experience in case management and substance abuse treatment. All have received intensive training and supervision in treating tobacco dependence. All participate in UKanQuit counseling on a part‐time basis, and spend the remainder of their effort as research assistants and counselors on smoking cessation research projects in the medical center. Hence, staffing consists of 1 full‐time equivalent counselor, 0.15 full‐time equivalent director (Richter), and 0.05 full‐time equivalent medical director (Ellerbeck). The program is funded through a contract with the hospital. We are in the process of hiring a nurse practitioner to create a more sustainable funding stream for the program because nurse practitioners can bill cessation services.
UKanQuit provides hospital counseling from 9 AM to 5 PM on weekdays. UKanQuit staff meets weekly for counseling supervision, strategic planning, continuing education, and troubleshooting difficult cases. In addition to treating smokers, the UKanQuit staff provides training and consultation to hospital personnel via grand rounds and other presentations. The service also provides a platform for medical students and residents to conduct focused research related to quality improvement. To facilitate systematic treatment of tobacco, UKanQuit developed the hospital treatment protocol for nursing staff, developed evidence‐based written self‐help materials that are accessible to hospital staff via the hospital printing system, and developed and instituted a tobacco treatment order set that was recently integrated into the EMR and automatically becomes prioritized as a recommended order set for all patients who report they have smoked in the past 30 days.
Procedures
UKanQuit staff retrieves patient details from the EMR and visits patients at their bedside. All hospital services refer to UKanQuit. UKanQuit provides counseling to Spanish speakers through bilingual/bicultural staff and hospital translators assist UKanQuit staff in counseling patients who speak other languages. The staff conducts a brief assessment at the bedside to inform treatment and contacts patients 6 months following inpatient treatment to assess outcomes and provide additional support and referral. This study evaluating the UKanQuit program was approved by the medical center's Institutional Review Board.
Program Intervention
UKanQuit staff visit patients at the bedside to deliver tobacco treatment. This consists of: (a) assessing withdrawal; (b) working with the health care team to adjust nicotine replacement to keep the patient comfortable; (c) assessing patients' interest in quitting smoking; (d) providing brief motivational intervention to patients not interested in quitting; and (e) providing assistance in quitting (developing a quit plan, arranging for medications on discharge) to patients interested in quitting (Figure 1). UKanQuit staff recommend medications based on the patients' level of dependence, history of cessation, and cessation medication preferences. The recommendation is communicated in person and by chart documentation to the medical team, usually by the nursing staff. The patients' resident or attending physician makes the final determination regarding medication provided. The hospital has nicotine replacement therapy (NRT; patch, gum, and lozenge), bupropion, and varenicline in its formulary. Patients are then offered an option of fax referral to the state tobacco quitline for follow‐up counseling. UKanQuit staff documents the services provided in the EMR via SOAR (Subjective, Objective, Assessment and Referral) notes.
Measures
Baseline Measures
These were collected from the UKanQuit 1‐page program intake form, which UKanQuit designed to collect the minimal information necessary to conduct medication and behavioral counseling, to maximize counseling time, and to fit into the dense schedule of each patient's hospital stay. Demographic measures include age, gender and ethnicity. Smoking behavior measures include number of years smoked, number of cigarettes per day, a single item from the Fagerstrom Test for Nicotine Dependence that assesses time to first cigarette after waking,18, 19 interest in quitting smoking (on a 0‐10 scale, with 10 being very interested in quitting), and a single item from the self report version of the Minnesota Nicotine Withdrawal Scale (MNWS) that asks smokers to rate their desire or craving to smoke over a specified period. The single item craving measure from the MNWS has been found to have high reliability and good construct validity and is neither less sensitive to abstinence nor less reliable than the ten‐item brief questionnaire of smoking urges (QSU‐brief) used in laboratory and clinical trials.20 We asked about craving over the past 24 hours on a scale from 0 (none) to 4 (severe).21
Process Measures
Counselors also document the treatment they provided to smokers including the time spent with patients during counseling, provision of written self‐help materials, whether smokers set goals for quitting, hospital staff had already placed the smoker on a tobacco treatment medication, smokers are interested in increasing or changing their medication, the smoker wants smoking cessation medication on discharge, UKanQuit staff submitted a recommendation to hospital staff to make a medication change and/or provide a prescription for medication on discharge, plans for post‐discharge follow‐up (fax‐referral of patients to the state tobacco quitline or acceptance of UKanQuit counseling after discharge), and the patient agrees to be contacted at 6 months post‐discharge for follow‐up assessment and assistance.
Follow‐Up Measures
Outcome measures were collected by telephone 6 months post‐discharge by study staff who were not involved in the in‐hospital counseling. Call attempts to reach each patient ranged from 1 to 11. Measures included self‐reported 7‐day point prevalence abstinence rates, the number of quit attempts lasting over 24 hours, and cigarettes smoked per day among continuing smokers. Patients are asked if they participated in counseling through the tobacco quitline. Scaled (0‐10) items assess how important it is to the patients to quit smoking or remain quit, how confident they are in being able to quit or remain quit, and how satisfied they were with the assistance provided by UKanQuit. A yes/no item assesses whether patients think the program should be continued. In addition, UKanQuit asked two open‐ended questions to qualitatively assess satisfaction with the program and elicit suggestions for improvements. The questions were: What, if anything, was helpful to you about our services? and How can UKanQuit better help people stop smoking?
Analyses
Categorical variables were summarized by frequencies and percentages; continuous variables were summarized by means and standard deviations (SDs). We compared baseline characteristic differences between respondents and nonrespondents at 6 months follow‐up using chi‐square for categorical variables and t‐test for continuous variables. We also compared cigarettes per day at baseline and 6 months post‐discharge in smokers who were not able to quit using paired t‐test. All analyses were done with SPSS 17.0 statistical package. Open‐ended questions were analyzed using the framework synthesis method.22 Following examination and familiarization with the data, we developed an initial list of themes. We then categorized the responses by these themes using numerical codes. Each thematic code was summarized as a percentage of all responses. Those responses that fit into multiple thematic codes were multiply coded.
Results
Baseline
Within the study period (September 1, 2007 to August 31, 2008), 22,624 patients were admitted to the medical center (Figure 2). A total of 4150 were current smokers (ie, smoked within the past 30 days). UKanQuit staff met with 513 (68%) of 753 patients referred to the service. Some of the reasons why 32% of referred patients were not seen by the UKanQuit staff have been described in our previous paper.17 These include patient was asleep, doctor in the room, out of bed for procedure, and unable to speak. Table 1 displays the characteristics of 513 smokers treated by UKanQuit from September 1, 2007 to August 31, 2008. Patients were predominantly white (74%) with mean age of 50 years. Slightly more than half of smokers were male (57%). They had smoked an average of 18 cigarettes per day for a mean duration of 29 years, and over half (58%) smoked within 5 minutes of waking suggesting a high level of dependence. On a scale of 1 to 10 the mean interest in quitting was 7.9 (SD 2.9) and the mean craving score on a scale of 0 to 4 was 1.2 (SD 1.4) suggesting slight to mild craving.
| Characteristics | Treated (n = 513) |
|---|---|
| |
| Demographics | |
| Mean age (SD), years | 50.2 (13.6) |
| Male, n (%) | 291 (56.7) |
| Ethnicity, n (%) | |
| White | 371 (73.6) |
| AA | 107 (21.2) |
| Latino | 18 (3.6) |
| Other | 8 (1.6) |
| Referral source, n (%) | |
| Nursing profile | 477 (94.1) |
| Physician | 5 (1.0) |
| Other | 25 (4.9) |
| Smoking characteristics | |
| Mean number of years smoked (SD) | 28.9 (14.6) |
| Smokes within 5 minutes of waking n (%) | 270 (58.3) |
| Mean cigarettes smoked per day (SD) | 18.4 (12.6) |
| Mean interest in quitting (SD)* | 7.9 (2.9) |
| Mean craving (SD) | 1.2 (1.4) |
| Tobacco treatment provided | |
| Counseling | |
| Average time spent with patients (SD) | 19.9 (9.1) |
| Received information packet, n (%) | 490 (97.4) |
| Set goals for quitting, n (%) | 352 (73.3) |
| Had quit plan, n (%) | 151 (33.2) |
| Accepted fax referral to quitline, n (%) | 277 (55.8) |
| Opted for UKanQuit counseling, n (%) | 29 (5.9) |
| Medication | |
| On smoking cessation medication, n (%) | 133 (26.2) |
| Interested in receiving or changing smoking cessation medication, n (%) | 132 (26.7) |
| Added or changed smoking cessation medication, n (%) | 195 (40.5) |
| Discharge med, n (%) | 196 (40.2) |
In‐Hospital Treatment
Hospital staff had placed 1 in 4 of the patients on smoking cessation medication prior to the UKanQuit staff visit. Nineteen percent were on NRT (16.2% transdermal patch, 2.5% on lozenge, 0.8% on nicotine gum); 5% on bupropion, 16.5% on varenicline, and 2.5% on clonidine. A total of 1.7% used a combination of Patch and bupropion while 2.5% used a combination of patch and gum. Staff provided 97% of the patients with written materials. Most patients (73%) set a goal for quitting or cutting down, and one‐third developed quit plans. Fifty‐six percent accepted fax referral to their state quitline, and 6% opted for follow‐up counseling with a UKanQuit counselor. Average time spent by UKanQuit with the patient was 20 minutes. Most of the patients treated (n = 426, 86%) agreed that UKanQuit staff can contact them for follow‐up assessment at 6 months.
Outcomes
Staff successfully contacted 196 (46%) of the 426 patients who agreed to 6‐month follow‐up. Responders were older (mean age 53 years, SD 12.6 vs. mean age 48 years, SD 13.8; P < 0.001); were more interested in quitting (mean interest in quitting 8.4, SD 2.5 vs. 7.6, SD 3.1 P = 0.001); and had a lower craving score at baseline (mean craving score 0.99, SD 1.3 vs. 1.29, SD 1.5; P < 0.001) compared to nonresponders. There were no differences between responders and nonresponders by gender, number of cigarettes smoked per day, years of smoking, referral source, inpatient smoking cessation medication used or time spent with UKanQuit hospital staff during the inpatient visit.
Table 2 displays smoking behavior and smoking cessation‐related characteristics of the respondents 6‐month post‐discharge. Over 70% attempted a quit attempt lasting at least 24 hours. The self reported 7‐day point prevalence abstinence rate was 31.8% among respondents. The intent‐to‐treat quit rate was 14.6% among all participants who agreed to follow‐up, counting those who we could not contact as smokers. While 34% used pharmacotherapy, only 5% of those who were fax‐referred to the quitline utilized the service. Most of the patients seen by the UKanQuit counselor considered quitting and staying quit important, mean 8.7, SD 2.3, and their confidence to quit or stay quit was above average, mean 6.6, SD 3.6. They rated the UKanQuit program very high, at 8.3, SD 2.8, on a scale of 0 to 10, and 98% of them wanted the program to continue. Of those who were not able to quit at 6 months, the mean number of cigarettes smoked per day decreased significantly from 17.8, SD 12.0 at baseline to 14.0, SD 9.7 at 6 months follow‐up (P < 0.001).
| Variables | |
|---|---|
| |
| Smoking characteristics | |
| 7 day point prevalence abstinence rate, n (%) | 62 (31.8) |
| Among current smokers at 6 months follow‐up, n = 134 | |
| Proportion of smokers who attempted to quit within 6 months, n (%) | 99 (73.9) |
| Mean CPD for smokers at 6 months (SD) | 14.0 (9.7) |
| Used formal quit smoking program | |
| Quit smoking medication, n (%) | 65 (34.4) |
| Quitline use among those faxed to quitline, n (%)* | 6 (5.0) |
| Importance/ Confidence | |
| How important is it to quit or stay quit, mean (SD) | 8.7 (2.3) |
| How confident are you to quit or stay quit, mean (SD) | 6.6 (3.6) |
| Views about service | |
| Satisfaction with UKanQuit service, mean (SD) | 8.3 (2.8) |
| Wants the UKanQuit program to continue, n (%) | 165 (97.6) |
Satisfaction and Recommendations for Improvement
Most (96%) of participants contacted at follow‐up commented on what was helpful about the services. Table 3 displays the distribution of themes and illustrative comments. Themes included staff encouragement, support and counseling (41.8%); other (27%); information and education materials (20.9%); medication advice and referral (2.6%), and referral to quitline (0.5%)
| n (%) | |
|---|---|
| |
| Staff encouragement, support and counseling | 82 (41.8) |
| You guys did excellent. The friendliness of the people who visited me. | |
| Her outlook and her encouragement | |
| Other | 53 (27.1) |
| I don't remember the visit because I was heavily medicated, | |
| A lot was helpful but I couldn't tell you exactly what part was the most helpful | |
| Information/education material | 41 (20.9) |
| Provided me with a lot of info and the packet was helpful. | |
| The information packet | |
| Program not helpful | 14 (7.1) |
| I really didn't need their information, I was able to quit without it. | |
| Nothing helpful except the companionship | |
| Medication advice/referral | 5 (2.6) |
| They took the time and set up the patches for me | |
| She helped me with questions about medication, especially Chantix | |
| Referral to Quitline | 1 (0.5) |
| Talking on the phone | |
Discussion
Among patients served by this inpatient program, interest in quitting was high but administration of inpatient medications upon admission was low (26%). Nearly all patients were provided with written materials, a majority set some form of goal for quitting or cutting down, and many developed quit plans and received assistance adjusting inpatient and/or discharge medications. After discharge, the majority of study participants made unassisted quit attempts, as utilization of medications and quitline services was suboptimal. Fax‐referral to quitline may not, on its own, fulfill guideline recommendations for post‐discharge follow‐up.
Our intent‐to‐treat quit rate was about half of what was found in Taylor et al.'s11 hospital program dissemination trial. Their program may have had better effects as it was somewhat more intensive. It included at least 1 follow‐up phone call immediately after discharge, as well as an accompanying video and relaxation audiotape or compact disc. However, differences in outcomes may also be due to large differences between the study populations. Hospitals participating in Taylor's study only conducted intervention and outcome assessment among smokers who were ready to quit, willing to enroll in a clinical trial, and willing to complete informed consent. Our intervention and outcome data included patients who agreed to speak with UKanQuit staff, regardless of readiness to quit. Our participants did not have to complete informed consent and enroll in a trial as our analyses were conducted post hoc. Our study outcomes might better reflect quit rates for a program serving all smokers, at all levels of readiness to quit, in actual hospital practices. The mean reduction in cigarette smoking among smokers who continued to smoke at 6 months' follow‐up was statistically significant. However, findings from a lung health study show that 50% or more reduction in smoking was ultimately related to successful quitting.23
Strengths and Limitations
The strengths of the study include the fact that the program attempts to intervene with all smokers, and provides stage‐appropriate intervention based on readiness to quit. It provides a snapshot of how a program is incorporated into clinical practice and describes implementation of protocol components.
This study has a number of limitations. We do not know exactly how many patients received the in‐hospital medication change agreed upon by the counselor and medical team immediately following the patient encounter. Our follow‐up rate was low and abstinence rates were based on self‐report, which limits our ability to draw conclusions about cessation outcomes. Process of care measures are based on counselor self‐report, without verification of services rendered. We are not able to identify the impact of our intervention above and beyond our patients' hospital experience, because we did not have a control group. We collected limited data from study participants so we are not able to better understand causes of nonadherence to quitline or poor pharmacotherapy utilization. Lastly, when the respondents were asked to comment about what was helpful about UKanQuit, 23% of the respondents said they could not remember the UKanQuit visit during their hospital stay. Many hospital medications induce brief amnesia, and patients have numerous consults during their stay and might not be able to separate one from the other. The 6‐month interval between their visit and follow‐up call may also account for their inability to remember the cessation consult.
Our patient population is in fact a subset of all smokers admitted (11% of smokers) because they are motivated enough to agree to talk with a counselor. Our intervention procedures, and results, might be quite different if all smokers were visited by the counselor. Efficacy trials of tobacco treatment in hospitals have focused on smokers who are ready to quit.24 Hence, procedures for working with unmotivated smokers in hospitals are less well established. Policymakers, hospitals, and hospital tobacco treatment programs should examine the most efficient (ie, effective and cost‐effective) approaches for addressing smoking in hospitals and specifically focus on whether all smokers should be treated by dedicated tobacco treatment staff, or only those who agree to a consult.
Lessons Learned
Linking Patients With In‐Hospital Cessation Medications Requires Collaboration With the Entire Health Care Team
Only 1 in 4 UKanQuit participants had been given smoking cessation medication to ameliorate withdrawal before counselors met with the patients. Although we have not systematically collected reasons patients do not receive cessation medication on admission, the 2 most common causes are that patients refuse it or physicians refuse it. Patients refuse medication perhaps because they do not want to quit, they feel they will cope without smoking during their hospital stay, or they are paying out of pocket and want to reduce costs. Physicians do not permit it because they believe it is contraindicated for the patient's health condition, it is contraindicated for the procedure the patient is receiving in the hospital, or they believe it will interfere with wound healing. There is also a considerable delay between ordering and receiving medications; patients who become uncomfortable during their stay sometimes change their minds, but end up being discharged before their medication arrives. Most of these issues pertain to nicotine replacement. Although patients not eligible for NRT may be good candidates for bupropion, varenicline, or even the second line cessation medications of clonidine or nortryptiline, these medications do not provide immediate relief from tobacco withdrawal symptoms and staff are reluctant to start patients on medications they may not receive on an outpatient basis. It is not clear what proportion of hospitalized patients should receive ameliorative medication. Not every hospitalized smoker is a candidate for NRT, due to contraindicated medical conditions, patients' level of dependence, and patients' willingness to accept cessation medication in order to prevent withdrawal. Koplan et al.25 achieved hospital‐wide increases in NRT orders from 1.6% to 2.5% after the introduction of an electronic tobacco treatment order set. These percentages seem low but actually were calculated from all hospital admissions, including smokers and nonsmokers. Moreover, their hospital population had a relatively low smoking rate of 12%. Our in‐hospital and post‐discharge (26.2% and 34.4% respectively) pharmacotherapy utilization rates were based only on smokers who had been seen by our service. Even though 1 in 4 smokers were already on medication when they were seen by counselors, 1 in 4 of patients seen wanted to either add a cessation medication or change their current dose. There is clearly room for improvement in how we offer and administer cessation medications on admission. Also, assessing medication efficacy and adjusting as needed appears to be an important role for in‐hospital counselors.
Facilitating Medications Post‐Discharge Will Require Creativity and Outpatient Follow‐Up
Post‐discharge, only 1 in 3 of our patients reported they used cessation medications. This may, again, be a function of patients' readiness to quit. However, it could also be related to knowledge/attitudes regarding the efficacy of medications or access to low‐cost medications. Some of our patients commented that making medication affordable would be helpful. Although our materials provide information on sources for free or low‐cost medications, this information may not have been salient during the hospital stay. To increase access to medications post‐discharge, programs should consider providing a booster mailer to the home with information on sources for free or reduced medications, providing take‐home starter pharmacotherapy kits lasting 1 to 2 weeks to bridge the gap between hospital discharge and finding another source of medications, and/or a follow‐up call shortly after discharge to verify use of pharmacotherapy and troubleshoot problems with medications or procurement.
Providing Follow‐Up Via Fax Referral to Quitlines Is Not as Simple as It Seems
Although our overall quitline fax‐referral rate was high (over half of all patients seen), rate of enrollment among those referred is much lower than the rates reported elsewhere, which range from 16% to 53%.2628 In our sample of fax‐referred smokers, we do not know how many were not enrolled due to failure to make contact vs. patient refusal once contact was made. One possible factor impacting enrollment rates is whether or not smokers are prescreened for readiness to quit. Nearly half of US quitlines require smokers to be ready to quit in order to receive a full course of treatment,29 but only 20% of smokers are ready to quit at any given time.30 In the cited studies with higher conversion rates, counselors prescreened patients for readiness to quit and only offered fax‐referral to those ready to quit in the next 30 days. Our program offers fax‐referral to all smokers. Our findings suggest that doing so results in high rates of referral but low rates of enrollment among those referred. Future studies should examine the impact of prescreening for readiness versus offering referral to all smokers on net enrollment and cessation.
Linking hospitalized smokers with tobacco quitlines has many potential benefits.31, 32 Proactive tobacco quitlines are effective15 and cost effective33 for smoking cessation; they are available, free, to all US smokers; services are delivered via telephone which minimizes many access barriers; hospitals do not have to bear the costs of the services; and many quitlines are undersubscribed and eager to increase their reach.34 Potential methods for increasing conversion to enrollment include building motivation to accept counseling and preparing patients for the quitline intake procedures. Our program is considering providing a warm handoff to patients by calling the quitline during the bedside consult to permit the quitline to enroll the patient during their hospital stay.
Hospital‐based cessation programs have the potential to deliver tobacco treatment to millions of hospitalized smokers annually. To deliver high‐quality, effective care, hospital cessation programs will have to solve problems inherent in hospital‐based carehow best to integrate into existing hospital systems, how to effectively communicate with other hospital care providers, and how to facilitate transitions in care to ensure patients receive evidence‐based post‐discharge care. We offer this report as the first of hopefully many that address quality improvement for specialized programs dedicated to treating tobacco in hospitals.
Acknowledgements
The authors gratefully acknowledge the contributions of the following UKanQuit Counselors in the planning and development of this manuscript: Brian Hernandez, Alex Perez‐Estrada, Grace Meikenhous, Meredith Benson, Terri Tapp. We also thank Chip Hulen, Albers Bart and Chris Wittkopp of the Organizational Improvement Department of KU Hospital; Marilyn Painter, Joanne McNair and Karisa Deculus of the KU Preventive Medicine and Public Health Department.
Hospitalization can be considered a teachable moment for smoking cessation13 for the 6.5 million adult smokers who are hospitalized in the United States each year.4 Smokers who receive tobacco treatment during hospitalization and outpatient follow‐up treatment for at least 1 month are more likely to quit than patients who receive no treatment.5, 6
Unless tobacco treatment is explicitly delegated to other providers, physicians shoulder the responsibility of encouraging smokers to quit and prescribing smoking cessation medications. This is problematic in that physicians sometimes fail to counsel their patients about quitting smoking7, 8 or recommend outpatient follow‐up.9 Few hospitals provide comprehensive treatment. In a review of 33 studies on the prevalence of smoking care delivery in hospitals, 3 hospitals reported they provided advice to quit alone, 29 provided advice plus counseling and assistance in quitting, and 8 provided advice or prescription for cessation pharmacotherapy.9 Although post‐discharge support is a key component of effective treatment for hospitalized smokers,6 only 11 reported providing follow‐up treatment, or referral for follow‐up treatment, after discharge. Among these 11 hospitals, respondents reported they provided referral or follow‐up to 1% to 74% of their smokers, with a median percentage of 24%. The 1 study that specified the type of outpatient treatment provided reported the hospital provided the state quitline number to smokers.
Instituting a dedicated smoking cessation program may enhance inpatient treatment, outpatient follow‐up, and treatment outcomes. Two studies have found that institutional smoking cessation programs increased the likelihood that patients would receive treatment and quit compared to hospitals without dedicated programs.10, 11
Although many US hospitals are developing programs to provide systematic treatment for tobacco dependence,9 little is known regarding how programs structure their staff, enroll patients, or provide treatment to patients that smoke. Instituting tobacco treatment services usually requires policy change and system‐wide approaches with quality improvement endpoint goals.8, 1214 In the United States, elements of these services include: 1) developing a cadre of trained tobacco treatment specialists, 2) implementing hospital systems for identifying smokers and referring them to the service, 3) providing inpatient treatment based on current treatment guidelines15 and 4) providing or facilitating follow‐up treatment after discharge, often via fax‐referral to tobacco quitlines. This systematic approach is still lacking in many hospitals.
To date, few evaluations of dedicated hospital‐based smoking cessation programs have been reported in the literature.8, 11 The purpose of this study is to describe patient characteristics and outcomes of a dedicated tobacco treatment service, with paid staff, in a large academic medical center. We describe treatment protocols, profile patients served, treatments provided, and summarization of 6‐month post‐discharge outcomes for smokers referred to the UKanQuit service over a 1‐year period. We close with lessons learned on how to improve the delivery of tobacco treatment to hospitalized patients.
Methods
Design and Setting
This is a descriptive observational study of a tobacco treatment program in a large Midwestern academic medical center between September 1, 2007 and August 31, 2008. The specialty tobacco treatment service (UKanQuit) was established when the hospital campus went smoke free on September 1, 2006. Patients are referred to the service via the hospital electronic medical record (EMR). As nurses complete electronic forms on patients admitted to their units, the EMR prompts nurses to ask patients if they smoke, ask smokers if they would like tobacco treatment medication to prevent withdrawal symptoms while in the hospital, and ask smokers if they would like to talk to a tobacco treatment specialist during their hospital stay. Those who respond yes to the final question are placed on an electronic list for UKanQuit services. Physicians and other health care providers can also order consultation from the UKanQuit service. A description of smokers admitted to the hospital and predictors of referral to UKanQuit within the first year of service is presented elsewhere.16, 17
The UKanQuit staff consists of an interdisciplinary team of counselors with a Ph.D., Masters degrees, and/or substantial experience in case management and substance abuse treatment. All have received intensive training and supervision in treating tobacco dependence. All participate in UKanQuit counseling on a part‐time basis, and spend the remainder of their effort as research assistants and counselors on smoking cessation research projects in the medical center. Hence, staffing consists of 1 full‐time equivalent counselor, 0.15 full‐time equivalent director (Richter), and 0.05 full‐time equivalent medical director (Ellerbeck). The program is funded through a contract with the hospital. We are in the process of hiring a nurse practitioner to create a more sustainable funding stream for the program because nurse practitioners can bill cessation services.
UKanQuit provides hospital counseling from 9 AM to 5 PM on weekdays. UKanQuit staff meets weekly for counseling supervision, strategic planning, continuing education, and troubleshooting difficult cases. In addition to treating smokers, the UKanQuit staff provides training and consultation to hospital personnel via grand rounds and other presentations. The service also provides a platform for medical students and residents to conduct focused research related to quality improvement. To facilitate systematic treatment of tobacco, UKanQuit developed the hospital treatment protocol for nursing staff, developed evidence‐based written self‐help materials that are accessible to hospital staff via the hospital printing system, and developed and instituted a tobacco treatment order set that was recently integrated into the EMR and automatically becomes prioritized as a recommended order set for all patients who report they have smoked in the past 30 days.
Procedures
UKanQuit staff retrieves patient details from the EMR and visits patients at their bedside. All hospital services refer to UKanQuit. UKanQuit provides counseling to Spanish speakers through bilingual/bicultural staff and hospital translators assist UKanQuit staff in counseling patients who speak other languages. The staff conducts a brief assessment at the bedside to inform treatment and contacts patients 6 months following inpatient treatment to assess outcomes and provide additional support and referral. This study evaluating the UKanQuit program was approved by the medical center's Institutional Review Board.
Program Intervention
UKanQuit staff visit patients at the bedside to deliver tobacco treatment. This consists of: (a) assessing withdrawal; (b) working with the health care team to adjust nicotine replacement to keep the patient comfortable; (c) assessing patients' interest in quitting smoking; (d) providing brief motivational intervention to patients not interested in quitting; and (e) providing assistance in quitting (developing a quit plan, arranging for medications on discharge) to patients interested in quitting (Figure 1). UKanQuit staff recommend medications based on the patients' level of dependence, history of cessation, and cessation medication preferences. The recommendation is communicated in person and by chart documentation to the medical team, usually by the nursing staff. The patients' resident or attending physician makes the final determination regarding medication provided. The hospital has nicotine replacement therapy (NRT; patch, gum, and lozenge), bupropion, and varenicline in its formulary. Patients are then offered an option of fax referral to the state tobacco quitline for follow‐up counseling. UKanQuit staff documents the services provided in the EMR via SOAR (Subjective, Objective, Assessment and Referral) notes.
Measures
Baseline Measures
These were collected from the UKanQuit 1‐page program intake form, which UKanQuit designed to collect the minimal information necessary to conduct medication and behavioral counseling, to maximize counseling time, and to fit into the dense schedule of each patient's hospital stay. Demographic measures include age, gender and ethnicity. Smoking behavior measures include number of years smoked, number of cigarettes per day, a single item from the Fagerstrom Test for Nicotine Dependence that assesses time to first cigarette after waking,18, 19 interest in quitting smoking (on a 0‐10 scale, with 10 being very interested in quitting), and a single item from the self report version of the Minnesota Nicotine Withdrawal Scale (MNWS) that asks smokers to rate their desire or craving to smoke over a specified period. The single item craving measure from the MNWS has been found to have high reliability and good construct validity and is neither less sensitive to abstinence nor less reliable than the ten‐item brief questionnaire of smoking urges (QSU‐brief) used in laboratory and clinical trials.20 We asked about craving over the past 24 hours on a scale from 0 (none) to 4 (severe).21
Process Measures
Counselors also document the treatment they provided to smokers including the time spent with patients during counseling, provision of written self‐help materials, whether smokers set goals for quitting, hospital staff had already placed the smoker on a tobacco treatment medication, smokers are interested in increasing or changing their medication, the smoker wants smoking cessation medication on discharge, UKanQuit staff submitted a recommendation to hospital staff to make a medication change and/or provide a prescription for medication on discharge, plans for post‐discharge follow‐up (fax‐referral of patients to the state tobacco quitline or acceptance of UKanQuit counseling after discharge), and the patient agrees to be contacted at 6 months post‐discharge for follow‐up assessment and assistance.
Follow‐Up Measures
Outcome measures were collected by telephone 6 months post‐discharge by study staff who were not involved in the in‐hospital counseling. Call attempts to reach each patient ranged from 1 to 11. Measures included self‐reported 7‐day point prevalence abstinence rates, the number of quit attempts lasting over 24 hours, and cigarettes smoked per day among continuing smokers. Patients are asked if they participated in counseling through the tobacco quitline. Scaled (0‐10) items assess how important it is to the patients to quit smoking or remain quit, how confident they are in being able to quit or remain quit, and how satisfied they were with the assistance provided by UKanQuit. A yes/no item assesses whether patients think the program should be continued. In addition, UKanQuit asked two open‐ended questions to qualitatively assess satisfaction with the program and elicit suggestions for improvements. The questions were: What, if anything, was helpful to you about our services? and How can UKanQuit better help people stop smoking?
Analyses
Categorical variables were summarized by frequencies and percentages; continuous variables were summarized by means and standard deviations (SDs). We compared baseline characteristic differences between respondents and nonrespondents at 6 months follow‐up using chi‐square for categorical variables and t‐test for continuous variables. We also compared cigarettes per day at baseline and 6 months post‐discharge in smokers who were not able to quit using paired t‐test. All analyses were done with SPSS 17.0 statistical package. Open‐ended questions were analyzed using the framework synthesis method.22 Following examination and familiarization with the data, we developed an initial list of themes. We then categorized the responses by these themes using numerical codes. Each thematic code was summarized as a percentage of all responses. Those responses that fit into multiple thematic codes were multiply coded.
Results
Baseline
Within the study period (September 1, 2007 to August 31, 2008), 22,624 patients were admitted to the medical center (Figure 2). A total of 4150 were current smokers (ie, smoked within the past 30 days). UKanQuit staff met with 513 (68%) of 753 patients referred to the service. Some of the reasons why 32% of referred patients were not seen by the UKanQuit staff have been described in our previous paper.17 These include patient was asleep, doctor in the room, out of bed for procedure, and unable to speak. Table 1 displays the characteristics of 513 smokers treated by UKanQuit from September 1, 2007 to August 31, 2008. Patients were predominantly white (74%) with mean age of 50 years. Slightly more than half of smokers were male (57%). They had smoked an average of 18 cigarettes per day for a mean duration of 29 years, and over half (58%) smoked within 5 minutes of waking suggesting a high level of dependence. On a scale of 1 to 10 the mean interest in quitting was 7.9 (SD 2.9) and the mean craving score on a scale of 0 to 4 was 1.2 (SD 1.4) suggesting slight to mild craving.
| Characteristics | Treated (n = 513) |
|---|---|
| |
| Demographics | |
| Mean age (SD), years | 50.2 (13.6) |
| Male, n (%) | 291 (56.7) |
| Ethnicity, n (%) | |
| White | 371 (73.6) |
| AA | 107 (21.2) |
| Latino | 18 (3.6) |
| Other | 8 (1.6) |
| Referral source, n (%) | |
| Nursing profile | 477 (94.1) |
| Physician | 5 (1.0) |
| Other | 25 (4.9) |
| Smoking characteristics | |
| Mean number of years smoked (SD) | 28.9 (14.6) |
| Smokes within 5 minutes of waking n (%) | 270 (58.3) |
| Mean cigarettes smoked per day (SD) | 18.4 (12.6) |
| Mean interest in quitting (SD)* | 7.9 (2.9) |
| Mean craving (SD) | 1.2 (1.4) |
| Tobacco treatment provided | |
| Counseling | |
| Average time spent with patients (SD) | 19.9 (9.1) |
| Received information packet, n (%) | 490 (97.4) |
| Set goals for quitting, n (%) | 352 (73.3) |
| Had quit plan, n (%) | 151 (33.2) |
| Accepted fax referral to quitline, n (%) | 277 (55.8) |
| Opted for UKanQuit counseling, n (%) | 29 (5.9) |
| Medication | |
| On smoking cessation medication, n (%) | 133 (26.2) |
| Interested in receiving or changing smoking cessation medication, n (%) | 132 (26.7) |
| Added or changed smoking cessation medication, n (%) | 195 (40.5) |
| Discharge med, n (%) | 196 (40.2) |
In‐Hospital Treatment
Hospital staff had placed 1 in 4 of the patients on smoking cessation medication prior to the UKanQuit staff visit. Nineteen percent were on NRT (16.2% transdermal patch, 2.5% on lozenge, 0.8% on nicotine gum); 5% on bupropion, 16.5% on varenicline, and 2.5% on clonidine. A total of 1.7% used a combination of Patch and bupropion while 2.5% used a combination of patch and gum. Staff provided 97% of the patients with written materials. Most patients (73%) set a goal for quitting or cutting down, and one‐third developed quit plans. Fifty‐six percent accepted fax referral to their state quitline, and 6% opted for follow‐up counseling with a UKanQuit counselor. Average time spent by UKanQuit with the patient was 20 minutes. Most of the patients treated (n = 426, 86%) agreed that UKanQuit staff can contact them for follow‐up assessment at 6 months.
Outcomes
Staff successfully contacted 196 (46%) of the 426 patients who agreed to 6‐month follow‐up. Responders were older (mean age 53 years, SD 12.6 vs. mean age 48 years, SD 13.8; P < 0.001); were more interested in quitting (mean interest in quitting 8.4, SD 2.5 vs. 7.6, SD 3.1 P = 0.001); and had a lower craving score at baseline (mean craving score 0.99, SD 1.3 vs. 1.29, SD 1.5; P < 0.001) compared to nonresponders. There were no differences between responders and nonresponders by gender, number of cigarettes smoked per day, years of smoking, referral source, inpatient smoking cessation medication used or time spent with UKanQuit hospital staff during the inpatient visit.
Table 2 displays smoking behavior and smoking cessation‐related characteristics of the respondents 6‐month post‐discharge. Over 70% attempted a quit attempt lasting at least 24 hours. The self reported 7‐day point prevalence abstinence rate was 31.8% among respondents. The intent‐to‐treat quit rate was 14.6% among all participants who agreed to follow‐up, counting those who we could not contact as smokers. While 34% used pharmacotherapy, only 5% of those who were fax‐referred to the quitline utilized the service. Most of the patients seen by the UKanQuit counselor considered quitting and staying quit important, mean 8.7, SD 2.3, and their confidence to quit or stay quit was above average, mean 6.6, SD 3.6. They rated the UKanQuit program very high, at 8.3, SD 2.8, on a scale of 0 to 10, and 98% of them wanted the program to continue. Of those who were not able to quit at 6 months, the mean number of cigarettes smoked per day decreased significantly from 17.8, SD 12.0 at baseline to 14.0, SD 9.7 at 6 months follow‐up (P < 0.001).
| Variables | |
|---|---|
| |
| Smoking characteristics | |
| 7 day point prevalence abstinence rate, n (%) | 62 (31.8) |
| Among current smokers at 6 months follow‐up, n = 134 | |
| Proportion of smokers who attempted to quit within 6 months, n (%) | 99 (73.9) |
| Mean CPD for smokers at 6 months (SD) | 14.0 (9.7) |
| Used formal quit smoking program | |
| Quit smoking medication, n (%) | 65 (34.4) |
| Quitline use among those faxed to quitline, n (%)* | 6 (5.0) |
| Importance/ Confidence | |
| How important is it to quit or stay quit, mean (SD) | 8.7 (2.3) |
| How confident are you to quit or stay quit, mean (SD) | 6.6 (3.6) |
| Views about service | |
| Satisfaction with UKanQuit service, mean (SD) | 8.3 (2.8) |
| Wants the UKanQuit program to continue, n (%) | 165 (97.6) |
Satisfaction and Recommendations for Improvement
Most (96%) of participants contacted at follow‐up commented on what was helpful about the services. Table 3 displays the distribution of themes and illustrative comments. Themes included staff encouragement, support and counseling (41.8%); other (27%); information and education materials (20.9%); medication advice and referral (2.6%), and referral to quitline (0.5%)
| n (%) | |
|---|---|
| |
| Staff encouragement, support and counseling | 82 (41.8) |
| You guys did excellent. The friendliness of the people who visited me. | |
| Her outlook and her encouragement | |
| Other | 53 (27.1) |
| I don't remember the visit because I was heavily medicated, | |
| A lot was helpful but I couldn't tell you exactly what part was the most helpful | |
| Information/education material | 41 (20.9) |
| Provided me with a lot of info and the packet was helpful. | |
| The information packet | |
| Program not helpful | 14 (7.1) |
| I really didn't need their information, I was able to quit without it. | |
| Nothing helpful except the companionship | |
| Medication advice/referral | 5 (2.6) |
| They took the time and set up the patches for me | |
| She helped me with questions about medication, especially Chantix | |
| Referral to Quitline | 1 (0.5) |
| Talking on the phone | |
Discussion
Among patients served by this inpatient program, interest in quitting was high but administration of inpatient medications upon admission was low (26%). Nearly all patients were provided with written materials, a majority set some form of goal for quitting or cutting down, and many developed quit plans and received assistance adjusting inpatient and/or discharge medications. After discharge, the majority of study participants made unassisted quit attempts, as utilization of medications and quitline services was suboptimal. Fax‐referral to quitline may not, on its own, fulfill guideline recommendations for post‐discharge follow‐up.
Our intent‐to‐treat quit rate was about half of what was found in Taylor et al.'s11 hospital program dissemination trial. Their program may have had better effects as it was somewhat more intensive. It included at least 1 follow‐up phone call immediately after discharge, as well as an accompanying video and relaxation audiotape or compact disc. However, differences in outcomes may also be due to large differences between the study populations. Hospitals participating in Taylor's study only conducted intervention and outcome assessment among smokers who were ready to quit, willing to enroll in a clinical trial, and willing to complete informed consent. Our intervention and outcome data included patients who agreed to speak with UKanQuit staff, regardless of readiness to quit. Our participants did not have to complete informed consent and enroll in a trial as our analyses were conducted post hoc. Our study outcomes might better reflect quit rates for a program serving all smokers, at all levels of readiness to quit, in actual hospital practices. The mean reduction in cigarette smoking among smokers who continued to smoke at 6 months' follow‐up was statistically significant. However, findings from a lung health study show that 50% or more reduction in smoking was ultimately related to successful quitting.23
Strengths and Limitations
The strengths of the study include the fact that the program attempts to intervene with all smokers, and provides stage‐appropriate intervention based on readiness to quit. It provides a snapshot of how a program is incorporated into clinical practice and describes implementation of protocol components.
This study has a number of limitations. We do not know exactly how many patients received the in‐hospital medication change agreed upon by the counselor and medical team immediately following the patient encounter. Our follow‐up rate was low and abstinence rates were based on self‐report, which limits our ability to draw conclusions about cessation outcomes. Process of care measures are based on counselor self‐report, without verification of services rendered. We are not able to identify the impact of our intervention above and beyond our patients' hospital experience, because we did not have a control group. We collected limited data from study participants so we are not able to better understand causes of nonadherence to quitline or poor pharmacotherapy utilization. Lastly, when the respondents were asked to comment about what was helpful about UKanQuit, 23% of the respondents said they could not remember the UKanQuit visit during their hospital stay. Many hospital medications induce brief amnesia, and patients have numerous consults during their stay and might not be able to separate one from the other. The 6‐month interval between their visit and follow‐up call may also account for their inability to remember the cessation consult.
Our patient population is in fact a subset of all smokers admitted (11% of smokers) because they are motivated enough to agree to talk with a counselor. Our intervention procedures, and results, might be quite different if all smokers were visited by the counselor. Efficacy trials of tobacco treatment in hospitals have focused on smokers who are ready to quit.24 Hence, procedures for working with unmotivated smokers in hospitals are less well established. Policymakers, hospitals, and hospital tobacco treatment programs should examine the most efficient (ie, effective and cost‐effective) approaches for addressing smoking in hospitals and specifically focus on whether all smokers should be treated by dedicated tobacco treatment staff, or only those who agree to a consult.
Lessons Learned
Linking Patients With In‐Hospital Cessation Medications Requires Collaboration With the Entire Health Care Team
Only 1 in 4 UKanQuit participants had been given smoking cessation medication to ameliorate withdrawal before counselors met with the patients. Although we have not systematically collected reasons patients do not receive cessation medication on admission, the 2 most common causes are that patients refuse it or physicians refuse it. Patients refuse medication perhaps because they do not want to quit, they feel they will cope without smoking during their hospital stay, or they are paying out of pocket and want to reduce costs. Physicians do not permit it because they believe it is contraindicated for the patient's health condition, it is contraindicated for the procedure the patient is receiving in the hospital, or they believe it will interfere with wound healing. There is also a considerable delay between ordering and receiving medications; patients who become uncomfortable during their stay sometimes change their minds, but end up being discharged before their medication arrives. Most of these issues pertain to nicotine replacement. Although patients not eligible for NRT may be good candidates for bupropion, varenicline, or even the second line cessation medications of clonidine or nortryptiline, these medications do not provide immediate relief from tobacco withdrawal symptoms and staff are reluctant to start patients on medications they may not receive on an outpatient basis. It is not clear what proportion of hospitalized patients should receive ameliorative medication. Not every hospitalized smoker is a candidate for NRT, due to contraindicated medical conditions, patients' level of dependence, and patients' willingness to accept cessation medication in order to prevent withdrawal. Koplan et al.25 achieved hospital‐wide increases in NRT orders from 1.6% to 2.5% after the introduction of an electronic tobacco treatment order set. These percentages seem low but actually were calculated from all hospital admissions, including smokers and nonsmokers. Moreover, their hospital population had a relatively low smoking rate of 12%. Our in‐hospital and post‐discharge (26.2% and 34.4% respectively) pharmacotherapy utilization rates were based only on smokers who had been seen by our service. Even though 1 in 4 smokers were already on medication when they were seen by counselors, 1 in 4 of patients seen wanted to either add a cessation medication or change their current dose. There is clearly room for improvement in how we offer and administer cessation medications on admission. Also, assessing medication efficacy and adjusting as needed appears to be an important role for in‐hospital counselors.
Facilitating Medications Post‐Discharge Will Require Creativity and Outpatient Follow‐Up
Post‐discharge, only 1 in 3 of our patients reported they used cessation medications. This may, again, be a function of patients' readiness to quit. However, it could also be related to knowledge/attitudes regarding the efficacy of medications or access to low‐cost medications. Some of our patients commented that making medication affordable would be helpful. Although our materials provide information on sources for free or low‐cost medications, this information may not have been salient during the hospital stay. To increase access to medications post‐discharge, programs should consider providing a booster mailer to the home with information on sources for free or reduced medications, providing take‐home starter pharmacotherapy kits lasting 1 to 2 weeks to bridge the gap between hospital discharge and finding another source of medications, and/or a follow‐up call shortly after discharge to verify use of pharmacotherapy and troubleshoot problems with medications or procurement.
Providing Follow‐Up Via Fax Referral to Quitlines Is Not as Simple as It Seems
Although our overall quitline fax‐referral rate was high (over half of all patients seen), rate of enrollment among those referred is much lower than the rates reported elsewhere, which range from 16% to 53%.2628 In our sample of fax‐referred smokers, we do not know how many were not enrolled due to failure to make contact vs. patient refusal once contact was made. One possible factor impacting enrollment rates is whether or not smokers are prescreened for readiness to quit. Nearly half of US quitlines require smokers to be ready to quit in order to receive a full course of treatment,29 but only 20% of smokers are ready to quit at any given time.30 In the cited studies with higher conversion rates, counselors prescreened patients for readiness to quit and only offered fax‐referral to those ready to quit in the next 30 days. Our program offers fax‐referral to all smokers. Our findings suggest that doing so results in high rates of referral but low rates of enrollment among those referred. Future studies should examine the impact of prescreening for readiness versus offering referral to all smokers on net enrollment and cessation.
Linking hospitalized smokers with tobacco quitlines has many potential benefits.31, 32 Proactive tobacco quitlines are effective15 and cost effective33 for smoking cessation; they are available, free, to all US smokers; services are delivered via telephone which minimizes many access barriers; hospitals do not have to bear the costs of the services; and many quitlines are undersubscribed and eager to increase their reach.34 Potential methods for increasing conversion to enrollment include building motivation to accept counseling and preparing patients for the quitline intake procedures. Our program is considering providing a warm handoff to patients by calling the quitline during the bedside consult to permit the quitline to enroll the patient during their hospital stay.
Hospital‐based cessation programs have the potential to deliver tobacco treatment to millions of hospitalized smokers annually. To deliver high‐quality, effective care, hospital cessation programs will have to solve problems inherent in hospital‐based carehow best to integrate into existing hospital systems, how to effectively communicate with other hospital care providers, and how to facilitate transitions in care to ensure patients receive evidence‐based post‐discharge care. We offer this report as the first of hopefully many that address quality improvement for specialized programs dedicated to treating tobacco in hospitals.
Acknowledgements
The authors gratefully acknowledge the contributions of the following UKanQuit Counselors in the planning and development of this manuscript: Brian Hernandez, Alex Perez‐Estrada, Grace Meikenhous, Meredith Benson, Terri Tapp. We also thank Chip Hulen, Albers Bart and Chris Wittkopp of the Organizational Improvement Department of KU Hospital; Marilyn Painter, Joanne McNair and Karisa Deculus of the KU Preventive Medicine and Public Health Department.
- ,.Smokers who are hospitalized: a window of opportunity for cessation interventions.Prev Med.1992;21:262–269.
- ,,.Understanding the potential of teachable moments: the case of smoking cessation.Health Educ Res.2003;18(2):156–170.
- ,.Teachable moments for promoting smoking cessation: the context of cancer care and survivorship.Cancer Control.2003;10(4):325–333.
- ,,.Helping hospitalized smokers quit: new directions for treatment and research.J Consul Clin Psychol.1993;61(5):778–789.
- ,,.Smoking cessation interventions for hospitalized smokers: a systematic review.Arch Intern Med.2008;168(18):1950–1960.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- CDC.Physician and other health‐care professional counseling of smokers to quit‐‐United States, 1991.MMWR Morb Mortal Wkly Rep.1993;42(44):854–857.
- ,,,,,.Implementing tobacco interventions in the real world of managed care.Tob Control.2000;9Suppl 1:I18–I24.
- ,,, et al.Smoking care provision in hospitals: a review of prevalence.Nicotine Tob Res.2008;10(5):757–774.
- ,,,,,.Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success.Arch Intern Med.2008;168(18):1961–1967.
- ,,,,.Dissemination of an effective inpatient tobacco use cessation program.Nicotine Tob Res.2005;7(1):129–137.
- ,,,,.Application of a nurse‐managed inpatient smoking cessation program.Nicotine Tob Res.2002;4(2):211–222.
- ,,,,,.Delivering clinical preventive services is a systems problem.Ann Behav Med.1997;19(3):271–278.
- ,,, et al.Lessons from experienced guideline implementers: attend to many factors and use multiple strategies.Jt Comm J Qual Improv.2000;26(4):171–188.
- U.S. Department of Health and Human Services (USDHHS).Treating Tobacco Use and Dependence: Clinical Practice Guideline 2008 Update.
- ,,,,.Referral and treatment for nicotine dependence among hospitalized patients.Subst Abus.2009;30(1):94–95.
- ,,,,.Prevalence and predictors of tobacco treatment in an academic medical center.Jt Comm J Qual Patient Saf.2009;35(11):551–557.
- ,,,.The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire.Br J Addict.1991;86(9):1119–1127.
- ,,, et al.Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence.Nicotine Tob Res.2007;9 Supp 4:555–570.
- ,.Is the ten‐item Questionnaire of Smoking Urges (QSU‐brief) more sensitive to abstinence than shorter craving measures?Psychopharmacology (Berl).2010;208(3):427–432.
- ,.Signs and symptoms of tobacco withdrawal.Arch Gen Psychiatry.1986;43(3):289–294.
- ,,.Qualitative research in health care. Analysing qualitative data.BMJ.2000;320(7227):114–116.
- ,,,.Smoking reduction in the Lung Health Study.Nicotine Tob Res.2004;6(2):275–280.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- ,,,,.A computerized aid to support smoking cessation treatment for hospital patients.J Gen Intern Med.2008;23(8):1214–1217.
- ,,,,,.The feasibility of connecting physician offices to a state‐level tobacco quit line.Am J Prev Med.2006;30(1):31–37.
- ,,, et al.Clinical faxed referrals to a tobacco quitline: reach, enrollment, and participant characteristics.Am J Prev Med.2009;36(4):337–340.
- ,,, et al.Feasibility of a Spanish/English computerized decision aid to facilitate smoking cessation efforts in underserved communities.J Health Care Poor Underserved.2010;21(2):504–517.
- North American Quitline Consortium. Available at: http://www.naquitline. org. Accessed July2010.
- ,,,,,.Distribution of smokers by stage in three representative samples.Prev Med.1995;24:401–411.
- ,,.Telephone counselling for smoking cessation.Cochrane Database Syst Rev.2006;3:CD002850.
- ,.The potential of quitlines to increase smoking cessation.Drug Alcohol Rev.2006;25(1):73–78.
- ,,, et al.Evidence of real‐world effectiveness of a telephone quitline for smokers.N Engl J Med.2002;347(14):1087–1093.
- Campaign for Tobacco Free Kids Fact Sheets 2008. Quitlines Help Smokers Quit. Available at: http://www.tobaccofreekids.org/research/factsheets/pdf/0326.pdf. Accessed July2010.
- ,.Smokers who are hospitalized: a window of opportunity for cessation interventions.Prev Med.1992;21:262–269.
- ,,.Understanding the potential of teachable moments: the case of smoking cessation.Health Educ Res.2003;18(2):156–170.
- ,.Teachable moments for promoting smoking cessation: the context of cancer care and survivorship.Cancer Control.2003;10(4):325–333.
- ,,.Helping hospitalized smokers quit: new directions for treatment and research.J Consul Clin Psychol.1993;61(5):778–789.
- ,,.Smoking cessation interventions for hospitalized smokers: a systematic review.Arch Intern Med.2008;168(18):1950–1960.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- CDC.Physician and other health‐care professional counseling of smokers to quit‐‐United States, 1991.MMWR Morb Mortal Wkly Rep.1993;42(44):854–857.
- ,,,,,.Implementing tobacco interventions in the real world of managed care.Tob Control.2000;9Suppl 1:I18–I24.
- ,,, et al.Smoking care provision in hospitals: a review of prevalence.Nicotine Tob Res.2008;10(5):757–774.
- ,,,,,.Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success.Arch Intern Med.2008;168(18):1961–1967.
- ,,,,.Dissemination of an effective inpatient tobacco use cessation program.Nicotine Tob Res.2005;7(1):129–137.
- ,,,,.Application of a nurse‐managed inpatient smoking cessation program.Nicotine Tob Res.2002;4(2):211–222.
- ,,,,,.Delivering clinical preventive services is a systems problem.Ann Behav Med.1997;19(3):271–278.
- ,,, et al.Lessons from experienced guideline implementers: attend to many factors and use multiple strategies.Jt Comm J Qual Improv.2000;26(4):171–188.
- U.S. Department of Health and Human Services (USDHHS).Treating Tobacco Use and Dependence: Clinical Practice Guideline 2008 Update.
- ,,,,.Referral and treatment for nicotine dependence among hospitalized patients.Subst Abus.2009;30(1):94–95.
- ,,,,.Prevalence and predictors of tobacco treatment in an academic medical center.Jt Comm J Qual Patient Saf.2009;35(11):551–557.
- ,,,.The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire.Br J Addict.1991;86(9):1119–1127.
- ,,, et al.Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence.Nicotine Tob Res.2007;9 Supp 4:555–570.
- ,.Is the ten‐item Questionnaire of Smoking Urges (QSU‐brief) more sensitive to abstinence than shorter craving measures?Psychopharmacology (Berl).2010;208(3):427–432.
- ,.Signs and symptoms of tobacco withdrawal.Arch Gen Psychiatry.1986;43(3):289–294.
- ,,.Qualitative research in health care. Analysing qualitative data.BMJ.2000;320(7227):114–116.
- ,,,.Smoking reduction in the Lung Health Study.Nicotine Tob Res.2004;6(2):275–280.
- ,,.Interventions for smoking cessation in hospitalised patients.Cochrane Database Syst Rev.2007(3):CD001837.
- ,,,,.A computerized aid to support smoking cessation treatment for hospital patients.J Gen Intern Med.2008;23(8):1214–1217.
- ,,,,,.The feasibility of connecting physician offices to a state‐level tobacco quit line.Am J Prev Med.2006;30(1):31–37.
- ,,, et al.Clinical faxed referrals to a tobacco quitline: reach, enrollment, and participant characteristics.Am J Prev Med.2009;36(4):337–340.
- ,,, et al.Feasibility of a Spanish/English computerized decision aid to facilitate smoking cessation efforts in underserved communities.J Health Care Poor Underserved.2010;21(2):504–517.
- North American Quitline Consortium. Available at: http://www.naquitline. org. Accessed July2010.
- ,,,,,.Distribution of smokers by stage in three representative samples.Prev Med.1995;24:401–411.
- ,,.Telephone counselling for smoking cessation.Cochrane Database Syst Rev.2006;3:CD002850.
- ,.The potential of quitlines to increase smoking cessation.Drug Alcohol Rev.2006;25(1):73–78.
- ,,, et al.Evidence of real‐world effectiveness of a telephone quitline for smokers.N Engl J Med.2002;347(14):1087–1093.
- Campaign for Tobacco Free Kids Fact Sheets 2008. Quitlines Help Smokers Quit. Available at: http://www.tobaccofreekids.org/research/factsheets/pdf/0326.pdf. Accessed July2010.
Copyright © 2010 Society of Hospital Medicine
Emergency Response at a Children's Hospital
The incidence of sudden pediatric cardiac or respiratory arrest is low.1 Most inpatient pediatric arrests appear to occur as progression of respiratory distress or shock.2 The outcome of inpatient pediatric cardiorespiratory arrests continues to be poor, emphasizing the need for early recognition and intervention. In 2006, as part of its 100,000 Lives Campaign the Institute for Healthcare Improvement recommended the implementation of Rapid Response Teams (RRT) as 1 of the strategies to reduce the number of preventable inpatient deaths.3 We reviewed all emergency response team (ERT) activations for last 13 years at The Children's Hospital in Denver, CO to assist in the development of a new RRT and to identify at risk populations, situations, and system processes the RRT should address.
This is a retrospective review of 13 years of data collection on ERT activations at The Children's Hospital in Denver, CO. We describe demographic and clinical variables, including outcomes of ERT activations at a free‐standing tertiary care children's hospital.
Background/Methods
The Children's Hospital (TCH) is a 270 inpatient bed tertiary care free standing children's hospital associated with University of Colorado at Denver Health Sciences Center. The current distribution of inpatient beds includes: 168 medical/surgical beds, 102 critical care beds (26 pediatric intensive care unit, 16 cardiac intensive care unit, and 60 neonatal intensive care unit). In 2006, nearly 10,000 patients were admitted for care at this hospital with an average inpatient stay of 6 days. TCH is a Level One Regional Trauma Center serving a catchment area of seven states, and a major transplant center for heart, solid organs, and bone marrow.
The history of the TCH Emergency Response Team dates back to 1990 when we first began to follow cardiorespiratory arrests in noncritical care areas of the hospital. In 1992, a Cardiac Or Respiratory event (COR) team including the most senior in‐house specialist was available 24 hours a day, 7 days a week to respond to all arrests within the hospital. The COR committee provided oversight and monitoring of the arrest events, including standardization of crash carts and the development of mock codes to ensure that the responding personnel were qualified in resuscitation practices. The COR team has evolved over the ensuing years, including a name change to the Emergency Response Team (ERT); now a single number activated by any medical staff is used to call the operator who activates the ERT via overhead paging and via code pager system. The 14 member Emergency Response Team consists of PICU/CICU/anesthesia/surgical fellows, ED attending, in‐house residents, PICU/CICU/ED charge nurse, nursing supervisor, resource RN, pharmacist, respiratory therapist, and a messenger.
A database has been maintained by 1 of the authors (DBH) since the inception of the COR/ERT at TCH 16 years ago. This is a retrospective review of this database of ERT activations. An ERT activation could have been triggered by any event that was felt to be emergent, life threatening, and/or needing immediate medical attention. After the event, a debriefing form was filled out about the event. Data collected included date, time, medical record number, location, primary care service, age, sex, primary and secondary diagnoses, and disposition. Data not captured in this database included initial rhythm, need for compressions, cardiac medications, defibrillation or intubation.
Analyses were performed on data collected from January 1993 through April 2007. Medical records of the documented ERT activations were reviewed for missing information and/or clarification of the events. Categories entered in Statistical Package for Social Statistics (SPSS) were similar to information included in the debriefing form: age, sex, admission diagnosis, precipitating event, percentage of admissions, acute vs. chronic diagnosis, winter vs. nonwinter months (October‐March/April‐September), day (6 am‐6 pm) and night (6 pm‐6 am) shifts, survival of ERT activation, survival to discharge, and primary attending service. Data were analyzed using SPSS 16.0 (2007, Chicago, IL). The study was approved by the Colorado Multiple Institutional Review Board.
Results/Conclusion
There were 1537 ERT activations in the database. A total of 203 ERT activations were eliminated from the database: 177 were eliminated from analysis because of missing age, admission diagnosis or time of day of activation, and 26 were ERT activations that had been triggered on adult visitors or adult employees. The remaining 1334 ERT activations were included for analysis.
Table 1 shows the demographics of the patients. The median age was 1.8 years, with a range of 0 to 29 years. A total of 39%(511) of all ERT activations occurred in patients under the age of 1 year with the highest incidence between 1 month and 1 year. Overall, the children at highest risk were males less than 1 year of age with a chronic diagnosis. In addition, time of day and time of year of ERT activations were analyzed as shown. There was no statistical difference between nonwinter (April‐September) and winter (October‐March) months. Statistically, there were significantly more ERT activations during day shifts (6 am‐6 pm) as compared to night shifts (P < 0.001).
| Variable (n = 1334) | n (%) |
|---|---|
| |
| Age | |
| Neonate | 127 (10) |
| <1 year | 384 (29) |
| 1‐3 years | 324 (24) |
| 4‐6 years | 137 (10) |
| 7‐10 years | 120 (9) |
| 11‐13 years | 84 (6) |
| 14‐17 years | 120 (9) |
| >17 years | 38 (3) |
| Gender | |
| Male | 807 (60) |
| Time of day* | |
| Day (06:00‐18:00) | 784 (59) |
| Night (18:00‐06:00) | 550 (41) |
| Time of Year | |
| April‐September | 669 (50) |
| October‐March | 665 (50) |
The most common admission diagnosis (Table 2) and underlying chronic condition was cardiac disease; other common admission diagnoses were infectious disease, trauma, and pulmonary disease. The medical categories of admission diagnosis included congenital/metabolic (39%), gastrointestinal (29%), renal (18%), rheumatology (4%), toxicology (4%), psychiatry (3%), endocrine (2%), and allergy (1%). The surgery category of admission diagnosis included otolaryngology (63%), orthopedics (28%), urology (4%), dental (4%), and ophthalmology (1%).
| Admission Diagnosis (n = 1334) | n (%) |
|---|---|
| |
| Cardiac | 370 (28) |
| Infectious disease | 197 (15) |
| Trauma | 192 (14) |
| Other medical | 137 (10) |
| Pulmonary | 109 (8) |
| Neurology | 79 (6) |
| Other surgery | 76 (6) |
| Neurosurgery | 68 (5) |
| Hematology/oncology | 53 (4) |
| Surgery | 53 (4) |
Finally, the patients' survival rate after an ERT itself was to be 90% (Table 3), with an overall survival rate to discharge of 78% (Table 4). Survival rate to discharge of those patients who survived the ERT event was 87%. Two patients were missing survival event data and 137 patients were missing survival to discharge data.
| Admission Diagnosis | Survival of Event n (%) |
|---|---|
| |
| Cardiac (n = 370) | 315 (85) |
| Infectious disease (n = 197) | 186 (94) |
| Trauma (n = 191) | 168 (88) |
| Other medical (n = 136) | 125 (92) |
| Pulmonary (n = 109) | 97 (89) |
| Neurology (n = 79) | 75 (95) |
| Other surgery (n = 76) | 75 (99) |
| Neurosurgery (n = 68) | 63 (93) |
| Surgery (n = 53) | 50 (94) |
| Hematology/oncology (n = 53) | 46 (87) |
| Total (n = 1332)* | 1200 (90) |
Discussion
We present a retrospective review of 1334 emergency response team activations over 13 years at an academic free‐standing tertiary care children's hospital. In keeping with previous reports, we found that children less than 1 year of age were at the highest risk for activation of the emergency response team.1, 4, 5
The National Registry for CardioPulmonary Resuscitation (NRCPR) database cite respiratory failure (asphyxia) and circulatory shock (ischemia) as the most common causes of in‐hospital cardiac arrests.1 Additionally, more than half of pediatric patients that experience a cardiopulmonary arrest have an underlying chronic illness.1, 2, 4, 5, 6 These are similar to our findings that chronic pulmonary and cardiac diseases were among the most frequent admission diagnosis.
Unlike Peberdy et al.,7we did not find an increase in the number of emergency response team activations at night or on weekends. Instead, we found that an ERT activation was more likely to be requested during the day shifts (6 am‐6 pm) which is a similar to that reported by Jones et al.8 Similarly, Jones et al.8 reported that the hourly rate of their medical emergency team activation was greater during the time between 8 am and 6 pm.
Our overall survival rate (78%) to discharge after an ERT event was much higher than what has been reported by Topjian et al.9 (25%). This likely reflects our inclusion of all emergency response team activations, not just apneic and asystolic arrests. The improved survival rate may also be influenced by the 24/7 presence of pediatric fellows, residents and surgeons in our hospital, which has been associated with improved 24‐hour survival for children receiving in‐hospital cardiopulmonary resuscitation.10
There are several limitations to our data collection and this report. This was a retrospective review and as previously noted some medical details were absent resulting in the exclusion of some cases. We also found that the original debriefing form which was used as the basis for the database did not include some important clinical variable, such as vital signs, more detailed events such as rhythm, medications used, and deficits or changes in baseline function. We suggest including multiple variables in a future multicenter study of pediatric RRT's: facility, admitting service, admission diagnosis, age (chronologic and gestational), sex, how long patient has been in hospital prior to the event, past medical history, vitals signs before and after activation, time/date, location, any precipitating events and actions taken by the RRT (eg, cardiopulmonary resuscitation, defibrillation, emergent intubation, and other emergent interventions), medications, survival of event, survival to discharge, deficits or changes in baseline function after the event and to discharge. In particular, information about history of prematurity would have been helpful in assessing further risk factors. Analysis of survival with or without significant deficits or changes in baseline function would be another useful outcome measure. Figure 1 is an example of a debriefing form a multi‐institutional study or hospitalist led quality improvement project may use to collect this data.
We were able to identify a population of higher‐risk patients (less than 1 year of age with comorbidities and an admission diagnosis of cardiac or respiratory disease) to focus our educational efforts on earlier recognition of patient deterioration for both inpatient ward staff and RRT responders. These findings may assist in future quality assurance issues such as patient placement and early ICU admissions depending on age, chronic conditions, and/or admission diagnosis. Future directions should include multi‐center study of RRT to improve external validity. In addition, a more careful analysis of events surrounding the activation, including incorporating such tools as the Pediatric Early Warning (PEW) Score,11 may further assist hospitals and practitioners identify hospitalized children at risk for deterioration on the inpatient ward.
| Admission Diagnosis | Survival to Discharge n (%) |
|---|---|
| |
| Cardiac (n = 317) | 217 (69) |
| Infectious disease (n = 175) | 139 (79) |
| Trauma (n = 182) | 151 (83) |
| Other medical (n = 125) | 99 (79) |
| Pulmonary (n = 98) | 76 (78) |
| Neurology (n = 71) | 63 (89) |
| Other surgery (n = 74) | 70 (95) |
| Neurosurgery (n = 64) | 53 (83) |
| Surgery (n = 47) | 39 (83) |
| Hematology/oncology (n = 44) | 24 (55) |
| Total (n = 1197)* | 931 (78) |
Acknowledgements
The acknowledge Dr. Genie Roosevelt MD, MPH, and Sara Deakyne MPH for their assistance in data analysis.
- ,,,.In‐hospital pediatric arrest.Pediatr Clin North Am.2008;55(3):589–604.
- ,,, et al.First documented rhythm and clinical outcome from in‐hospital cardiac arrest among children and adults.JAMA.2006;295:50–57.
- 57100K Lives Campaign‐getting started Kit: Rapid response Teams. Available at: http://www.ihi.org/IHI/Programs/Campaign/Campaign.htm?TabId=1 Accessed July2010.
- ,,, et al.Higher survival rates among younger patients after pediatric intensive care unity cardiac arrests.Pediatrics2006;118:2424–2433.
- , et al.A prospective investigation into the epidemiology of in‐hospital pediatric cardiopulmonary resuscitation using the internationalUtseinReporting Style.Pediatrics.2002;109:200–209.
- ,,,,.Results of inpatient pediatric resuscitation.Crit Care Med.1986;14:469–471
- ,,, et al.Survival from in‐hospital cardiac arrest during nights and weekends.JAMA.2008;299:785–792.
- ,,, et al.Circadian pattern of activation of the medical emergency team in a teaching hospital.Crit Care.2005;9:R303–R306.
- ,,.Pediatric cardiopulmonary resuscitation: advances in science, techniques, and outcomes.Pediatrics.2008;122;1086–1098
- ,,, et al.Effect of hospital characteristics on outcomes from pediatric cardiopulmonary resuscitation: a report from the National Registry of Cardiopulmonary Resuscitation.Pediatrics.2006;118:995–1001.
- ,,.The Pediatric Early Warning System score: a severity of illness score to predict urgent medical need in hospitalized children.J Crit Care.2006;21(3):271–278.
The incidence of sudden pediatric cardiac or respiratory arrest is low.1 Most inpatient pediatric arrests appear to occur as progression of respiratory distress or shock.2 The outcome of inpatient pediatric cardiorespiratory arrests continues to be poor, emphasizing the need for early recognition and intervention. In 2006, as part of its 100,000 Lives Campaign the Institute for Healthcare Improvement recommended the implementation of Rapid Response Teams (RRT) as 1 of the strategies to reduce the number of preventable inpatient deaths.3 We reviewed all emergency response team (ERT) activations for last 13 years at The Children's Hospital in Denver, CO to assist in the development of a new RRT and to identify at risk populations, situations, and system processes the RRT should address.
This is a retrospective review of 13 years of data collection on ERT activations at The Children's Hospital in Denver, CO. We describe demographic and clinical variables, including outcomes of ERT activations at a free‐standing tertiary care children's hospital.
Background/Methods
The Children's Hospital (TCH) is a 270 inpatient bed tertiary care free standing children's hospital associated with University of Colorado at Denver Health Sciences Center. The current distribution of inpatient beds includes: 168 medical/surgical beds, 102 critical care beds (26 pediatric intensive care unit, 16 cardiac intensive care unit, and 60 neonatal intensive care unit). In 2006, nearly 10,000 patients were admitted for care at this hospital with an average inpatient stay of 6 days. TCH is a Level One Regional Trauma Center serving a catchment area of seven states, and a major transplant center for heart, solid organs, and bone marrow.
The history of the TCH Emergency Response Team dates back to 1990 when we first began to follow cardiorespiratory arrests in noncritical care areas of the hospital. In 1992, a Cardiac Or Respiratory event (COR) team including the most senior in‐house specialist was available 24 hours a day, 7 days a week to respond to all arrests within the hospital. The COR committee provided oversight and monitoring of the arrest events, including standardization of crash carts and the development of mock codes to ensure that the responding personnel were qualified in resuscitation practices. The COR team has evolved over the ensuing years, including a name change to the Emergency Response Team (ERT); now a single number activated by any medical staff is used to call the operator who activates the ERT via overhead paging and via code pager system. The 14 member Emergency Response Team consists of PICU/CICU/anesthesia/surgical fellows, ED attending, in‐house residents, PICU/CICU/ED charge nurse, nursing supervisor, resource RN, pharmacist, respiratory therapist, and a messenger.
A database has been maintained by 1 of the authors (DBH) since the inception of the COR/ERT at TCH 16 years ago. This is a retrospective review of this database of ERT activations. An ERT activation could have been triggered by any event that was felt to be emergent, life threatening, and/or needing immediate medical attention. After the event, a debriefing form was filled out about the event. Data collected included date, time, medical record number, location, primary care service, age, sex, primary and secondary diagnoses, and disposition. Data not captured in this database included initial rhythm, need for compressions, cardiac medications, defibrillation or intubation.
Analyses were performed on data collected from January 1993 through April 2007. Medical records of the documented ERT activations were reviewed for missing information and/or clarification of the events. Categories entered in Statistical Package for Social Statistics (SPSS) were similar to information included in the debriefing form: age, sex, admission diagnosis, precipitating event, percentage of admissions, acute vs. chronic diagnosis, winter vs. nonwinter months (October‐March/April‐September), day (6 am‐6 pm) and night (6 pm‐6 am) shifts, survival of ERT activation, survival to discharge, and primary attending service. Data were analyzed using SPSS 16.0 (2007, Chicago, IL). The study was approved by the Colorado Multiple Institutional Review Board.
Results/Conclusion
There were 1537 ERT activations in the database. A total of 203 ERT activations were eliminated from the database: 177 were eliminated from analysis because of missing age, admission diagnosis or time of day of activation, and 26 were ERT activations that had been triggered on adult visitors or adult employees. The remaining 1334 ERT activations were included for analysis.
Table 1 shows the demographics of the patients. The median age was 1.8 years, with a range of 0 to 29 years. A total of 39%(511) of all ERT activations occurred in patients under the age of 1 year with the highest incidence between 1 month and 1 year. Overall, the children at highest risk were males less than 1 year of age with a chronic diagnosis. In addition, time of day and time of year of ERT activations were analyzed as shown. There was no statistical difference between nonwinter (April‐September) and winter (October‐March) months. Statistically, there were significantly more ERT activations during day shifts (6 am‐6 pm) as compared to night shifts (P < 0.001).
| Variable (n = 1334) | n (%) |
|---|---|
| |
| Age | |
| Neonate | 127 (10) |
| <1 year | 384 (29) |
| 1‐3 years | 324 (24) |
| 4‐6 years | 137 (10) |
| 7‐10 years | 120 (9) |
| 11‐13 years | 84 (6) |
| 14‐17 years | 120 (9) |
| >17 years | 38 (3) |
| Gender | |
| Male | 807 (60) |
| Time of day* | |
| Day (06:00‐18:00) | 784 (59) |
| Night (18:00‐06:00) | 550 (41) |
| Time of Year | |
| April‐September | 669 (50) |
| October‐March | 665 (50) |
The most common admission diagnosis (Table 2) and underlying chronic condition was cardiac disease; other common admission diagnoses were infectious disease, trauma, and pulmonary disease. The medical categories of admission diagnosis included congenital/metabolic (39%), gastrointestinal (29%), renal (18%), rheumatology (4%), toxicology (4%), psychiatry (3%), endocrine (2%), and allergy (1%). The surgery category of admission diagnosis included otolaryngology (63%), orthopedics (28%), urology (4%), dental (4%), and ophthalmology (1%).
| Admission Diagnosis (n = 1334) | n (%) |
|---|---|
| |
| Cardiac | 370 (28) |
| Infectious disease | 197 (15) |
| Trauma | 192 (14) |
| Other medical | 137 (10) |
| Pulmonary | 109 (8) |
| Neurology | 79 (6) |
| Other surgery | 76 (6) |
| Neurosurgery | 68 (5) |
| Hematology/oncology | 53 (4) |
| Surgery | 53 (4) |
Finally, the patients' survival rate after an ERT itself was to be 90% (Table 3), with an overall survival rate to discharge of 78% (Table 4). Survival rate to discharge of those patients who survived the ERT event was 87%. Two patients were missing survival event data and 137 patients were missing survival to discharge data.
| Admission Diagnosis | Survival of Event n (%) |
|---|---|
| |
| Cardiac (n = 370) | 315 (85) |
| Infectious disease (n = 197) | 186 (94) |
| Trauma (n = 191) | 168 (88) |
| Other medical (n = 136) | 125 (92) |
| Pulmonary (n = 109) | 97 (89) |
| Neurology (n = 79) | 75 (95) |
| Other surgery (n = 76) | 75 (99) |
| Neurosurgery (n = 68) | 63 (93) |
| Surgery (n = 53) | 50 (94) |
| Hematology/oncology (n = 53) | 46 (87) |
| Total (n = 1332)* | 1200 (90) |
Discussion
We present a retrospective review of 1334 emergency response team activations over 13 years at an academic free‐standing tertiary care children's hospital. In keeping with previous reports, we found that children less than 1 year of age were at the highest risk for activation of the emergency response team.1, 4, 5
The National Registry for CardioPulmonary Resuscitation (NRCPR) database cite respiratory failure (asphyxia) and circulatory shock (ischemia) as the most common causes of in‐hospital cardiac arrests.1 Additionally, more than half of pediatric patients that experience a cardiopulmonary arrest have an underlying chronic illness.1, 2, 4, 5, 6 These are similar to our findings that chronic pulmonary and cardiac diseases were among the most frequent admission diagnosis.
Unlike Peberdy et al.,7we did not find an increase in the number of emergency response team activations at night or on weekends. Instead, we found that an ERT activation was more likely to be requested during the day shifts (6 am‐6 pm) which is a similar to that reported by Jones et al.8 Similarly, Jones et al.8 reported that the hourly rate of their medical emergency team activation was greater during the time between 8 am and 6 pm.
Our overall survival rate (78%) to discharge after an ERT event was much higher than what has been reported by Topjian et al.9 (25%). This likely reflects our inclusion of all emergency response team activations, not just apneic and asystolic arrests. The improved survival rate may also be influenced by the 24/7 presence of pediatric fellows, residents and surgeons in our hospital, which has been associated with improved 24‐hour survival for children receiving in‐hospital cardiopulmonary resuscitation.10
There are several limitations to our data collection and this report. This was a retrospective review and as previously noted some medical details were absent resulting in the exclusion of some cases. We also found that the original debriefing form which was used as the basis for the database did not include some important clinical variable, such as vital signs, more detailed events such as rhythm, medications used, and deficits or changes in baseline function. We suggest including multiple variables in a future multicenter study of pediatric RRT's: facility, admitting service, admission diagnosis, age (chronologic and gestational), sex, how long patient has been in hospital prior to the event, past medical history, vitals signs before and after activation, time/date, location, any precipitating events and actions taken by the RRT (eg, cardiopulmonary resuscitation, defibrillation, emergent intubation, and other emergent interventions), medications, survival of event, survival to discharge, deficits or changes in baseline function after the event and to discharge. In particular, information about history of prematurity would have been helpful in assessing further risk factors. Analysis of survival with or without significant deficits or changes in baseline function would be another useful outcome measure. Figure 1 is an example of a debriefing form a multi‐institutional study or hospitalist led quality improvement project may use to collect this data.
We were able to identify a population of higher‐risk patients (less than 1 year of age with comorbidities and an admission diagnosis of cardiac or respiratory disease) to focus our educational efforts on earlier recognition of patient deterioration for both inpatient ward staff and RRT responders. These findings may assist in future quality assurance issues such as patient placement and early ICU admissions depending on age, chronic conditions, and/or admission diagnosis. Future directions should include multi‐center study of RRT to improve external validity. In addition, a more careful analysis of events surrounding the activation, including incorporating such tools as the Pediatric Early Warning (PEW) Score,11 may further assist hospitals and practitioners identify hospitalized children at risk for deterioration on the inpatient ward.
| Admission Diagnosis | Survival to Discharge n (%) |
|---|---|
| |
| Cardiac (n = 317) | 217 (69) |
| Infectious disease (n = 175) | 139 (79) |
| Trauma (n = 182) | 151 (83) |
| Other medical (n = 125) | 99 (79) |
| Pulmonary (n = 98) | 76 (78) |
| Neurology (n = 71) | 63 (89) |
| Other surgery (n = 74) | 70 (95) |
| Neurosurgery (n = 64) | 53 (83) |
| Surgery (n = 47) | 39 (83) |
| Hematology/oncology (n = 44) | 24 (55) |
| Total (n = 1197)* | 931 (78) |
Acknowledgements
The acknowledge Dr. Genie Roosevelt MD, MPH, and Sara Deakyne MPH for their assistance in data analysis.
The incidence of sudden pediatric cardiac or respiratory arrest is low.1 Most inpatient pediatric arrests appear to occur as progression of respiratory distress or shock.2 The outcome of inpatient pediatric cardiorespiratory arrests continues to be poor, emphasizing the need for early recognition and intervention. In 2006, as part of its 100,000 Lives Campaign the Institute for Healthcare Improvement recommended the implementation of Rapid Response Teams (RRT) as 1 of the strategies to reduce the number of preventable inpatient deaths.3 We reviewed all emergency response team (ERT) activations for last 13 years at The Children's Hospital in Denver, CO to assist in the development of a new RRT and to identify at risk populations, situations, and system processes the RRT should address.
This is a retrospective review of 13 years of data collection on ERT activations at The Children's Hospital in Denver, CO. We describe demographic and clinical variables, including outcomes of ERT activations at a free‐standing tertiary care children's hospital.
Background/Methods
The Children's Hospital (TCH) is a 270 inpatient bed tertiary care free standing children's hospital associated with University of Colorado at Denver Health Sciences Center. The current distribution of inpatient beds includes: 168 medical/surgical beds, 102 critical care beds (26 pediatric intensive care unit, 16 cardiac intensive care unit, and 60 neonatal intensive care unit). In 2006, nearly 10,000 patients were admitted for care at this hospital with an average inpatient stay of 6 days. TCH is a Level One Regional Trauma Center serving a catchment area of seven states, and a major transplant center for heart, solid organs, and bone marrow.
The history of the TCH Emergency Response Team dates back to 1990 when we first began to follow cardiorespiratory arrests in noncritical care areas of the hospital. In 1992, a Cardiac Or Respiratory event (COR) team including the most senior in‐house specialist was available 24 hours a day, 7 days a week to respond to all arrests within the hospital. The COR committee provided oversight and monitoring of the arrest events, including standardization of crash carts and the development of mock codes to ensure that the responding personnel were qualified in resuscitation practices. The COR team has evolved over the ensuing years, including a name change to the Emergency Response Team (ERT); now a single number activated by any medical staff is used to call the operator who activates the ERT via overhead paging and via code pager system. The 14 member Emergency Response Team consists of PICU/CICU/anesthesia/surgical fellows, ED attending, in‐house residents, PICU/CICU/ED charge nurse, nursing supervisor, resource RN, pharmacist, respiratory therapist, and a messenger.
A database has been maintained by 1 of the authors (DBH) since the inception of the COR/ERT at TCH 16 years ago. This is a retrospective review of this database of ERT activations. An ERT activation could have been triggered by any event that was felt to be emergent, life threatening, and/or needing immediate medical attention. After the event, a debriefing form was filled out about the event. Data collected included date, time, medical record number, location, primary care service, age, sex, primary and secondary diagnoses, and disposition. Data not captured in this database included initial rhythm, need for compressions, cardiac medications, defibrillation or intubation.
Analyses were performed on data collected from January 1993 through April 2007. Medical records of the documented ERT activations were reviewed for missing information and/or clarification of the events. Categories entered in Statistical Package for Social Statistics (SPSS) were similar to information included in the debriefing form: age, sex, admission diagnosis, precipitating event, percentage of admissions, acute vs. chronic diagnosis, winter vs. nonwinter months (October‐March/April‐September), day (6 am‐6 pm) and night (6 pm‐6 am) shifts, survival of ERT activation, survival to discharge, and primary attending service. Data were analyzed using SPSS 16.0 (2007, Chicago, IL). The study was approved by the Colorado Multiple Institutional Review Board.
Results/Conclusion
There were 1537 ERT activations in the database. A total of 203 ERT activations were eliminated from the database: 177 were eliminated from analysis because of missing age, admission diagnosis or time of day of activation, and 26 were ERT activations that had been triggered on adult visitors or adult employees. The remaining 1334 ERT activations were included for analysis.
Table 1 shows the demographics of the patients. The median age was 1.8 years, with a range of 0 to 29 years. A total of 39%(511) of all ERT activations occurred in patients under the age of 1 year with the highest incidence between 1 month and 1 year. Overall, the children at highest risk were males less than 1 year of age with a chronic diagnosis. In addition, time of day and time of year of ERT activations were analyzed as shown. There was no statistical difference between nonwinter (April‐September) and winter (October‐March) months. Statistically, there were significantly more ERT activations during day shifts (6 am‐6 pm) as compared to night shifts (P < 0.001).
| Variable (n = 1334) | n (%) |
|---|---|
| |
| Age | |
| Neonate | 127 (10) |
| <1 year | 384 (29) |
| 1‐3 years | 324 (24) |
| 4‐6 years | 137 (10) |
| 7‐10 years | 120 (9) |
| 11‐13 years | 84 (6) |
| 14‐17 years | 120 (9) |
| >17 years | 38 (3) |
| Gender | |
| Male | 807 (60) |
| Time of day* | |
| Day (06:00‐18:00) | 784 (59) |
| Night (18:00‐06:00) | 550 (41) |
| Time of Year | |
| April‐September | 669 (50) |
| October‐March | 665 (50) |
The most common admission diagnosis (Table 2) and underlying chronic condition was cardiac disease; other common admission diagnoses were infectious disease, trauma, and pulmonary disease. The medical categories of admission diagnosis included congenital/metabolic (39%), gastrointestinal (29%), renal (18%), rheumatology (4%), toxicology (4%), psychiatry (3%), endocrine (2%), and allergy (1%). The surgery category of admission diagnosis included otolaryngology (63%), orthopedics (28%), urology (4%), dental (4%), and ophthalmology (1%).
| Admission Diagnosis (n = 1334) | n (%) |
|---|---|
| |
| Cardiac | 370 (28) |
| Infectious disease | 197 (15) |
| Trauma | 192 (14) |
| Other medical | 137 (10) |
| Pulmonary | 109 (8) |
| Neurology | 79 (6) |
| Other surgery | 76 (6) |
| Neurosurgery | 68 (5) |
| Hematology/oncology | 53 (4) |
| Surgery | 53 (4) |
Finally, the patients' survival rate after an ERT itself was to be 90% (Table 3), with an overall survival rate to discharge of 78% (Table 4). Survival rate to discharge of those patients who survived the ERT event was 87%. Two patients were missing survival event data and 137 patients were missing survival to discharge data.
| Admission Diagnosis | Survival of Event n (%) |
|---|---|
| |
| Cardiac (n = 370) | 315 (85) |
| Infectious disease (n = 197) | 186 (94) |
| Trauma (n = 191) | 168 (88) |
| Other medical (n = 136) | 125 (92) |
| Pulmonary (n = 109) | 97 (89) |
| Neurology (n = 79) | 75 (95) |
| Other surgery (n = 76) | 75 (99) |
| Neurosurgery (n = 68) | 63 (93) |
| Surgery (n = 53) | 50 (94) |
| Hematology/oncology (n = 53) | 46 (87) |
| Total (n = 1332)* | 1200 (90) |
Discussion
We present a retrospective review of 1334 emergency response team activations over 13 years at an academic free‐standing tertiary care children's hospital. In keeping with previous reports, we found that children less than 1 year of age were at the highest risk for activation of the emergency response team.1, 4, 5
The National Registry for CardioPulmonary Resuscitation (NRCPR) database cite respiratory failure (asphyxia) and circulatory shock (ischemia) as the most common causes of in‐hospital cardiac arrests.1 Additionally, more than half of pediatric patients that experience a cardiopulmonary arrest have an underlying chronic illness.1, 2, 4, 5, 6 These are similar to our findings that chronic pulmonary and cardiac diseases were among the most frequent admission diagnosis.
Unlike Peberdy et al.,7we did not find an increase in the number of emergency response team activations at night or on weekends. Instead, we found that an ERT activation was more likely to be requested during the day shifts (6 am‐6 pm) which is a similar to that reported by Jones et al.8 Similarly, Jones et al.8 reported that the hourly rate of their medical emergency team activation was greater during the time between 8 am and 6 pm.
Our overall survival rate (78%) to discharge after an ERT event was much higher than what has been reported by Topjian et al.9 (25%). This likely reflects our inclusion of all emergency response team activations, not just apneic and asystolic arrests. The improved survival rate may also be influenced by the 24/7 presence of pediatric fellows, residents and surgeons in our hospital, which has been associated with improved 24‐hour survival for children receiving in‐hospital cardiopulmonary resuscitation.10
There are several limitations to our data collection and this report. This was a retrospective review and as previously noted some medical details were absent resulting in the exclusion of some cases. We also found that the original debriefing form which was used as the basis for the database did not include some important clinical variable, such as vital signs, more detailed events such as rhythm, medications used, and deficits or changes in baseline function. We suggest including multiple variables in a future multicenter study of pediatric RRT's: facility, admitting service, admission diagnosis, age (chronologic and gestational), sex, how long patient has been in hospital prior to the event, past medical history, vitals signs before and after activation, time/date, location, any precipitating events and actions taken by the RRT (eg, cardiopulmonary resuscitation, defibrillation, emergent intubation, and other emergent interventions), medications, survival of event, survival to discharge, deficits or changes in baseline function after the event and to discharge. In particular, information about history of prematurity would have been helpful in assessing further risk factors. Analysis of survival with or without significant deficits or changes in baseline function would be another useful outcome measure. Figure 1 is an example of a debriefing form a multi‐institutional study or hospitalist led quality improvement project may use to collect this data.
We were able to identify a population of higher‐risk patients (less than 1 year of age with comorbidities and an admission diagnosis of cardiac or respiratory disease) to focus our educational efforts on earlier recognition of patient deterioration for both inpatient ward staff and RRT responders. These findings may assist in future quality assurance issues such as patient placement and early ICU admissions depending on age, chronic conditions, and/or admission diagnosis. Future directions should include multi‐center study of RRT to improve external validity. In addition, a more careful analysis of events surrounding the activation, including incorporating such tools as the Pediatric Early Warning (PEW) Score,11 may further assist hospitals and practitioners identify hospitalized children at risk for deterioration on the inpatient ward.
| Admission Diagnosis | Survival to Discharge n (%) |
|---|---|
| |
| Cardiac (n = 317) | 217 (69) |
| Infectious disease (n = 175) | 139 (79) |
| Trauma (n = 182) | 151 (83) |
| Other medical (n = 125) | 99 (79) |
| Pulmonary (n = 98) | 76 (78) |
| Neurology (n = 71) | 63 (89) |
| Other surgery (n = 74) | 70 (95) |
| Neurosurgery (n = 64) | 53 (83) |
| Surgery (n = 47) | 39 (83) |
| Hematology/oncology (n = 44) | 24 (55) |
| Total (n = 1197)* | 931 (78) |
Acknowledgements
The acknowledge Dr. Genie Roosevelt MD, MPH, and Sara Deakyne MPH for their assistance in data analysis.
- ,,,.In‐hospital pediatric arrest.Pediatr Clin North Am.2008;55(3):589–604.
- ,,, et al.First documented rhythm and clinical outcome from in‐hospital cardiac arrest among children and adults.JAMA.2006;295:50–57.
- 57100K Lives Campaign‐getting started Kit: Rapid response Teams. Available at: http://www.ihi.org/IHI/Programs/Campaign/Campaign.htm?TabId=1 Accessed July2010.
- ,,, et al.Higher survival rates among younger patients after pediatric intensive care unity cardiac arrests.Pediatrics2006;118:2424–2433.
- , et al.A prospective investigation into the epidemiology of in‐hospital pediatric cardiopulmonary resuscitation using the internationalUtseinReporting Style.Pediatrics.2002;109:200–209.
- ,,,,.Results of inpatient pediatric resuscitation.Crit Care Med.1986;14:469–471
- ,,, et al.Survival from in‐hospital cardiac arrest during nights and weekends.JAMA.2008;299:785–792.
- ,,, et al.Circadian pattern of activation of the medical emergency team in a teaching hospital.Crit Care.2005;9:R303–R306.
- ,,.Pediatric cardiopulmonary resuscitation: advances in science, techniques, and outcomes.Pediatrics.2008;122;1086–1098
- ,,, et al.Effect of hospital characteristics on outcomes from pediatric cardiopulmonary resuscitation: a report from the National Registry of Cardiopulmonary Resuscitation.Pediatrics.2006;118:995–1001.
- ,,.The Pediatric Early Warning System score: a severity of illness score to predict urgent medical need in hospitalized children.J Crit Care.2006;21(3):271–278.
- ,,,.In‐hospital pediatric arrest.Pediatr Clin North Am.2008;55(3):589–604.
- ,,, et al.First documented rhythm and clinical outcome from in‐hospital cardiac arrest among children and adults.JAMA.2006;295:50–57.
- 57100K Lives Campaign‐getting started Kit: Rapid response Teams. Available at: http://www.ihi.org/IHI/Programs/Campaign/Campaign.htm?TabId=1 Accessed July2010.
- ,,, et al.Higher survival rates among younger patients after pediatric intensive care unity cardiac arrests.Pediatrics2006;118:2424–2433.
- , et al.A prospective investigation into the epidemiology of in‐hospital pediatric cardiopulmonary resuscitation using the internationalUtseinReporting Style.Pediatrics.2002;109:200–209.
- ,,,,.Results of inpatient pediatric resuscitation.Crit Care Med.1986;14:469–471
- ,,, et al.Survival from in‐hospital cardiac arrest during nights and weekends.JAMA.2008;299:785–792.
- ,,, et al.Circadian pattern of activation of the medical emergency team in a teaching hospital.Crit Care.2005;9:R303–R306.
- ,,.Pediatric cardiopulmonary resuscitation: advances in science, techniques, and outcomes.Pediatrics.2008;122;1086–1098
- ,,, et al.Effect of hospital characteristics on outcomes from pediatric cardiopulmonary resuscitation: a report from the National Registry of Cardiopulmonary Resuscitation.Pediatrics.2006;118:995–1001.
- ,,.The Pediatric Early Warning System score: a severity of illness score to predict urgent medical need in hospitalized children.J Crit Care.2006;21(3):271–278.
Copyright © 2010 Society of Hospital Medicine
Study Associates Inflammatory Bowel Disease with VTE
Hospitalists should pay attention to a new study that shows patients with inflammatory bowel disease (IBD) are at increased risk of recurrent VTE, according to a veteran hospitalist who studies the topic. Until research advances to the point it can identify weighted risk, however, it’s difficult to emphasize the results too much, he adds.
Still, Alpesh Amin, MD, MBA, SFHM, FACP, professor and chairman of the Department of Medicine and executive director of the HM program at the University of California at Irvine, says the new research solidifies the idea that HM groups should know whether a patient has IBD when doing a risk assessment.
"Now the question is, 'Which risk factors are most significant?'" Dr. Amin says. "More information needs to come to help define that."
The 14-center cohort study found that the probability of recurrence five years after discontinuation of anticoagulation therapy was higher among patients with IBD than patients without IBD (33.4%; 95% confidence interval [CI]: 21.8–45.0 vs. 21.7%; 95% CI: 18.8–24.6; P=0.01) (Gastroenterology. 2010;139(3):779-787). In addition, after adjustment for potential confounders, IBD also rates as an independent risk factor of recurrence (hazard ratio=2.5; 95% CI: 1.4–4.2; P=0.001).
Dr. Amin would like to see data that delineate the risk differential between hospitalized patients with IBD and hospitalized patients admitted for acute flare-ups of their IBD. For example, an IBD patient admitted with bloody diarrhea is usually steered away from anticoagulants for fear of increased bleeding. In some of those cases, hospitalists may instead use an inferior vena cava (IVC) filter. Those devices recently drew attention after an Archives of Internal Medicine report (PDF) and an FDA advisory questioned their long-term safety implications.
"We don't have strong evidence whether having acute flare-ups makes the risk worse or not," Dr. Amin says. "We need to figure out how to deal with that issue."
Hospitalists should pay attention to a new study that shows patients with inflammatory bowel disease (IBD) are at increased risk of recurrent VTE, according to a veteran hospitalist who studies the topic. Until research advances to the point it can identify weighted risk, however, it’s difficult to emphasize the results too much, he adds.
Still, Alpesh Amin, MD, MBA, SFHM, FACP, professor and chairman of the Department of Medicine and executive director of the HM program at the University of California at Irvine, says the new research solidifies the idea that HM groups should know whether a patient has IBD when doing a risk assessment.
"Now the question is, 'Which risk factors are most significant?'" Dr. Amin says. "More information needs to come to help define that."
The 14-center cohort study found that the probability of recurrence five years after discontinuation of anticoagulation therapy was higher among patients with IBD than patients without IBD (33.4%; 95% confidence interval [CI]: 21.8–45.0 vs. 21.7%; 95% CI: 18.8–24.6; P=0.01) (Gastroenterology. 2010;139(3):779-787). In addition, after adjustment for potential confounders, IBD also rates as an independent risk factor of recurrence (hazard ratio=2.5; 95% CI: 1.4–4.2; P=0.001).
Dr. Amin would like to see data that delineate the risk differential between hospitalized patients with IBD and hospitalized patients admitted for acute flare-ups of their IBD. For example, an IBD patient admitted with bloody diarrhea is usually steered away from anticoagulants for fear of increased bleeding. In some of those cases, hospitalists may instead use an inferior vena cava (IVC) filter. Those devices recently drew attention after an Archives of Internal Medicine report (PDF) and an FDA advisory questioned their long-term safety implications.
"We don't have strong evidence whether having acute flare-ups makes the risk worse or not," Dr. Amin says. "We need to figure out how to deal with that issue."
Hospitalists should pay attention to a new study that shows patients with inflammatory bowel disease (IBD) are at increased risk of recurrent VTE, according to a veteran hospitalist who studies the topic. Until research advances to the point it can identify weighted risk, however, it’s difficult to emphasize the results too much, he adds.
Still, Alpesh Amin, MD, MBA, SFHM, FACP, professor and chairman of the Department of Medicine and executive director of the HM program at the University of California at Irvine, says the new research solidifies the idea that HM groups should know whether a patient has IBD when doing a risk assessment.
"Now the question is, 'Which risk factors are most significant?'" Dr. Amin says. "More information needs to come to help define that."
The 14-center cohort study found that the probability of recurrence five years after discontinuation of anticoagulation therapy was higher among patients with IBD than patients without IBD (33.4%; 95% confidence interval [CI]: 21.8–45.0 vs. 21.7%; 95% CI: 18.8–24.6; P=0.01) (Gastroenterology. 2010;139(3):779-787). In addition, after adjustment for potential confounders, IBD also rates as an independent risk factor of recurrence (hazard ratio=2.5; 95% CI: 1.4–4.2; P=0.001).
Dr. Amin would like to see data that delineate the risk differential between hospitalized patients with IBD and hospitalized patients admitted for acute flare-ups of their IBD. For example, an IBD patient admitted with bloody diarrhea is usually steered away from anticoagulants for fear of increased bleeding. In some of those cases, hospitalists may instead use an inferior vena cava (IVC) filter. Those devices recently drew attention after an Archives of Internal Medicine report (PDF) and an FDA advisory questioned their long-term safety implications.
"We don't have strong evidence whether having acute flare-ups makes the risk worse or not," Dr. Amin says. "We need to figure out how to deal with that issue."
In the Literature: Research You Need to Know
Clinical question: Are beta-blockers safe to use in patients with chest pain and recent cocaine use?
Background: Beta-blockers are known to improve outcomes after myocardial infarction, yet are contraindicated in chest pain associated with recent cocaine use. Recommendations against beta-blocker use in the setting of cocaine-induced chest pain are based on case reports, small-scale human experiments, and the theoretical concern that beta-blockers may potentiate cocaine toxicity by creating unopposed alpha-adrenergic stimulation. Clinical outcomes of beta-blocker use in patients with cocaine use and chest pain are unknown.
Study design: Retrospective cohort study.
Setting: San Francisco General Hospital, San Francisco.
Synopsis: Three hundred thirty-one patients with chest pain and positive urine toxicologic screening for cocaine were admitted during the study period. One hundred fifty-one (46%) received a beta-blocker in the ED, per the discretion of the treating physicians. There were no differences in ECG abnormalities, troponin levels, length of stay, intubation, ventricular arrhythmias, use of vasopressors, or death in those patients who did and who did not receive a beta-blocker. Over a median follow-up of 972 days, patients who had been discharged on a beta-blocker did have a significant reduction in cardiovascular death (hazard ratio 0.29, 95% CI, 0.09-0.98, P= 0.047).
Because this was an observational study and post-discharge data were limited only to vital status, definitive conclusions regarding the safety of beta-blockers in cocaine-associated chest pain cannot be made. The authors acknowledge that more rigorous study is indicated given the potential benefit of beta-blockers in this population.
Bottom line: Use of beta-blockers in patients with chest pain and positive urine drug screen for cocaine is not associated with immediate adverse outcomes and might actually reduce cardiovascular mortality over time.
Citation: Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue P, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170(10):874-879.
Reviewed for TH eWire by Kelly Cunningham, MD, Joshua LaBrin, MD, Amanda Salanitro, MD, MSPH, Kelly Sopko, MD, Shelley Ellis, MD, MPH, and Elizabeth Rice, MD, Section of Hospital Medicine, Vanderbilt University, Nashville, Tenn.
For more physician reviews of literature, visit our website.
Clinical question: Are beta-blockers safe to use in patients with chest pain and recent cocaine use?
Background: Beta-blockers are known to improve outcomes after myocardial infarction, yet are contraindicated in chest pain associated with recent cocaine use. Recommendations against beta-blocker use in the setting of cocaine-induced chest pain are based on case reports, small-scale human experiments, and the theoretical concern that beta-blockers may potentiate cocaine toxicity by creating unopposed alpha-adrenergic stimulation. Clinical outcomes of beta-blocker use in patients with cocaine use and chest pain are unknown.
Study design: Retrospective cohort study.
Setting: San Francisco General Hospital, San Francisco.
Synopsis: Three hundred thirty-one patients with chest pain and positive urine toxicologic screening for cocaine were admitted during the study period. One hundred fifty-one (46%) received a beta-blocker in the ED, per the discretion of the treating physicians. There were no differences in ECG abnormalities, troponin levels, length of stay, intubation, ventricular arrhythmias, use of vasopressors, or death in those patients who did and who did not receive a beta-blocker. Over a median follow-up of 972 days, patients who had been discharged on a beta-blocker did have a significant reduction in cardiovascular death (hazard ratio 0.29, 95% CI, 0.09-0.98, P= 0.047).
Because this was an observational study and post-discharge data were limited only to vital status, definitive conclusions regarding the safety of beta-blockers in cocaine-associated chest pain cannot be made. The authors acknowledge that more rigorous study is indicated given the potential benefit of beta-blockers in this population.
Bottom line: Use of beta-blockers in patients with chest pain and positive urine drug screen for cocaine is not associated with immediate adverse outcomes and might actually reduce cardiovascular mortality over time.
Citation: Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue P, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170(10):874-879.
Reviewed for TH eWire by Kelly Cunningham, MD, Joshua LaBrin, MD, Amanda Salanitro, MD, MSPH, Kelly Sopko, MD, Shelley Ellis, MD, MPH, and Elizabeth Rice, MD, Section of Hospital Medicine, Vanderbilt University, Nashville, Tenn.
For more physician reviews of literature, visit our website.
Clinical question: Are beta-blockers safe to use in patients with chest pain and recent cocaine use?
Background: Beta-blockers are known to improve outcomes after myocardial infarction, yet are contraindicated in chest pain associated with recent cocaine use. Recommendations against beta-blocker use in the setting of cocaine-induced chest pain are based on case reports, small-scale human experiments, and the theoretical concern that beta-blockers may potentiate cocaine toxicity by creating unopposed alpha-adrenergic stimulation. Clinical outcomes of beta-blocker use in patients with cocaine use and chest pain are unknown.
Study design: Retrospective cohort study.
Setting: San Francisco General Hospital, San Francisco.
Synopsis: Three hundred thirty-one patients with chest pain and positive urine toxicologic screening for cocaine were admitted during the study period. One hundred fifty-one (46%) received a beta-blocker in the ED, per the discretion of the treating physicians. There were no differences in ECG abnormalities, troponin levels, length of stay, intubation, ventricular arrhythmias, use of vasopressors, or death in those patients who did and who did not receive a beta-blocker. Over a median follow-up of 972 days, patients who had been discharged on a beta-blocker did have a significant reduction in cardiovascular death (hazard ratio 0.29, 95% CI, 0.09-0.98, P= 0.047).
Because this was an observational study and post-discharge data were limited only to vital status, definitive conclusions regarding the safety of beta-blockers in cocaine-associated chest pain cannot be made. The authors acknowledge that more rigorous study is indicated given the potential benefit of beta-blockers in this population.
Bottom line: Use of beta-blockers in patients with chest pain and positive urine drug screen for cocaine is not associated with immediate adverse outcomes and might actually reduce cardiovascular mortality over time.
Citation: Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue P, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170(10):874-879.
Reviewed for TH eWire by Kelly Cunningham, MD, Joshua LaBrin, MD, Amanda Salanitro, MD, MSPH, Kelly Sopko, MD, Shelley Ellis, MD, MPH, and Elizabeth Rice, MD, Section of Hospital Medicine, Vanderbilt University, Nashville, Tenn.
For more physician reviews of literature, visit our website.
Dabigatran: lower hemorrhage risk than warfarin
A recent analysis of previous data found that while warfarin and dabigatran are comparable at preventing stroke in patients with atrial fibrillation who have previously had a stroke or transient ischemic attack, the risk of developing intracranial bleeding is lower with dabigatran.
The study, led by Hans-Christoph Diener, MD, of University Hospital Essen in Germany, aimed to analyze a subgroup of patients from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
The RE-LY trial found that 110 mg dabigatran twice daily was as effective as warfarin in reducing the occurrence of stroke, and that 150 mg dabigatran twice daily was better than warfarin in patients who had atrial fibrillation.
Twenty percent of the participants had previously had a stroke or transient ischemic attack, which increases the risk of having another stroke. Dr Diener and colleagues decided to look at this subgroup because they are more susceptible to adverse events from anticoagulation, especially cerebral hemorrhage.
It is important to note that one of warfarin’s negative side effects is bleeding.
The investigators found that warfarin and both dosages of dabigatran were equally effective in preventing stroke or systemic embolism in patients with a previous transient ischemic attack or stroke.
Compared with warfarin, the relative risk (RR) of stroke or systemic embolism with the 150 mg dose of dabigatran was 0.75 and for the 110 mg dose was 0.84.
The rate of major bleeding was significantly lower in patients on 110 mg dabigatran (RR 0.66) and similar in those on 150 mg dabigatran (RR 1.01) compared with those on warfarin.
The 110 mg dose of dabigatran was also associated with a significant reduction in the rate of vascular death (RR 0.63) and all-cause mortality (0.70).
According to the authors, “The exact mechanism for the lower rate of intracranial bleeding with dabigatran compared with warfarin, beyond a more stable anticoagulation, is not yet known. One possible explanation is that dabigatran does not cross the blood-brain barrier.”
When it comes to choosing a dosage, the authors concluded, “The dose of 150 mg dabigatran twice daily could be preferred to 110 mg twice daily because it significantly reduces the risk of ischemic stroke without increasing the risk of hemorrhagic stroke."
The study was funded by Boehringer Ingelheim and published online first by The Lancet Neurology.
A recent analysis of previous data found that while warfarin and dabigatran are comparable at preventing stroke in patients with atrial fibrillation who have previously had a stroke or transient ischemic attack, the risk of developing intracranial bleeding is lower with dabigatran.
The study, led by Hans-Christoph Diener, MD, of University Hospital Essen in Germany, aimed to analyze a subgroup of patients from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
The RE-LY trial found that 110 mg dabigatran twice daily was as effective as warfarin in reducing the occurrence of stroke, and that 150 mg dabigatran twice daily was better than warfarin in patients who had atrial fibrillation.
Twenty percent of the participants had previously had a stroke or transient ischemic attack, which increases the risk of having another stroke. Dr Diener and colleagues decided to look at this subgroup because they are more susceptible to adverse events from anticoagulation, especially cerebral hemorrhage.
It is important to note that one of warfarin’s negative side effects is bleeding.
The investigators found that warfarin and both dosages of dabigatran were equally effective in preventing stroke or systemic embolism in patients with a previous transient ischemic attack or stroke.
Compared with warfarin, the relative risk (RR) of stroke or systemic embolism with the 150 mg dose of dabigatran was 0.75 and for the 110 mg dose was 0.84.
The rate of major bleeding was significantly lower in patients on 110 mg dabigatran (RR 0.66) and similar in those on 150 mg dabigatran (RR 1.01) compared with those on warfarin.
The 110 mg dose of dabigatran was also associated with a significant reduction in the rate of vascular death (RR 0.63) and all-cause mortality (0.70).
According to the authors, “The exact mechanism for the lower rate of intracranial bleeding with dabigatran compared with warfarin, beyond a more stable anticoagulation, is not yet known. One possible explanation is that dabigatran does not cross the blood-brain barrier.”
When it comes to choosing a dosage, the authors concluded, “The dose of 150 mg dabigatran twice daily could be preferred to 110 mg twice daily because it significantly reduces the risk of ischemic stroke without increasing the risk of hemorrhagic stroke."
The study was funded by Boehringer Ingelheim and published online first by The Lancet Neurology.
A recent analysis of previous data found that while warfarin and dabigatran are comparable at preventing stroke in patients with atrial fibrillation who have previously had a stroke or transient ischemic attack, the risk of developing intracranial bleeding is lower with dabigatran.
The study, led by Hans-Christoph Diener, MD, of University Hospital Essen in Germany, aimed to analyze a subgroup of patients from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
The RE-LY trial found that 110 mg dabigatran twice daily was as effective as warfarin in reducing the occurrence of stroke, and that 150 mg dabigatran twice daily was better than warfarin in patients who had atrial fibrillation.
Twenty percent of the participants had previously had a stroke or transient ischemic attack, which increases the risk of having another stroke. Dr Diener and colleagues decided to look at this subgroup because they are more susceptible to adverse events from anticoagulation, especially cerebral hemorrhage.
It is important to note that one of warfarin’s negative side effects is bleeding.
The investigators found that warfarin and both dosages of dabigatran were equally effective in preventing stroke or systemic embolism in patients with a previous transient ischemic attack or stroke.
Compared with warfarin, the relative risk (RR) of stroke or systemic embolism with the 150 mg dose of dabigatran was 0.75 and for the 110 mg dose was 0.84.
The rate of major bleeding was significantly lower in patients on 110 mg dabigatran (RR 0.66) and similar in those on 150 mg dabigatran (RR 1.01) compared with those on warfarin.
The 110 mg dose of dabigatran was also associated with a significant reduction in the rate of vascular death (RR 0.63) and all-cause mortality (0.70).
According to the authors, “The exact mechanism for the lower rate of intracranial bleeding with dabigatran compared with warfarin, beyond a more stable anticoagulation, is not yet known. One possible explanation is that dabigatran does not cross the blood-brain barrier.”
When it comes to choosing a dosage, the authors concluded, “The dose of 150 mg dabigatran twice daily could be preferred to 110 mg twice daily because it significantly reduces the risk of ischemic stroke without increasing the risk of hemorrhagic stroke."
The study was funded by Boehringer Ingelheim and published online first by The Lancet Neurology.
Joint Commission: U.S. Hospitals Make "Core Measure" Gains
The Joint Commission's annual report on quality initiatives in American hospitals could be more valuable to hospitalist groups if they look at where rankings show room for improvement, one hospitalist says.
Eduard Vasilevskis, MD, assistant professor of medicine in the Section of Hospital Medicine at Vanderbilt University and the Tennessee Valley-Nashville VA Hospital, says substantial gains in core-measure categories are great in aggregate but do little to spur QI in individual hospitals.
"As a group, we're doing pretty well with these core measures," Dr. Vasilevskis says. "But at an institution, it's critical you understand your individual numbers."
"Improving America’s Hospitals” (PDF), released in September, reported composite 2009 care results of 97.7% for heart attacks and 92.9% for pneumonia. Both were the highest measures since the report began tabulating the data in 2002.
Dr. Vasilevskis sees the news as a great sign for patient care but thinks the value of QI is to apply the techniques that have boosted those measures to other issues, such as interdisciplinary and transitional care. Those areas are more difficult to quantify and study, but that makes them ripe for HM group leaders to tackle, he says.
“This is going to take leadership; we need a quarterback on the team,” he adds. “Hospitalists can step up and be that quarterback.”
Dr. Vasilevskis also advocates for stiffer compliance requirements. For example, he says, while the current report lists a 99.4% compliance rate for physicians giving smoking cessation advice, the report includes no data or follow-up to show how that advice pans out. He notes that approach would be costly and time-consuming but could reap a valuable return on the investment.
"The first step is data," he says. "Then it's going to take leadership."
The Joint Commission's annual report on quality initiatives in American hospitals could be more valuable to hospitalist groups if they look at where rankings show room for improvement, one hospitalist says.
Eduard Vasilevskis, MD, assistant professor of medicine in the Section of Hospital Medicine at Vanderbilt University and the Tennessee Valley-Nashville VA Hospital, says substantial gains in core-measure categories are great in aggregate but do little to spur QI in individual hospitals.
"As a group, we're doing pretty well with these core measures," Dr. Vasilevskis says. "But at an institution, it's critical you understand your individual numbers."
"Improving America’s Hospitals” (PDF), released in September, reported composite 2009 care results of 97.7% for heart attacks and 92.9% for pneumonia. Both were the highest measures since the report began tabulating the data in 2002.
Dr. Vasilevskis sees the news as a great sign for patient care but thinks the value of QI is to apply the techniques that have boosted those measures to other issues, such as interdisciplinary and transitional care. Those areas are more difficult to quantify and study, but that makes them ripe for HM group leaders to tackle, he says.
“This is going to take leadership; we need a quarterback on the team,” he adds. “Hospitalists can step up and be that quarterback.”
Dr. Vasilevskis also advocates for stiffer compliance requirements. For example, he says, while the current report lists a 99.4% compliance rate for physicians giving smoking cessation advice, the report includes no data or follow-up to show how that advice pans out. He notes that approach would be costly and time-consuming but could reap a valuable return on the investment.
"The first step is data," he says. "Then it's going to take leadership."
The Joint Commission's annual report on quality initiatives in American hospitals could be more valuable to hospitalist groups if they look at where rankings show room for improvement, one hospitalist says.
Eduard Vasilevskis, MD, assistant professor of medicine in the Section of Hospital Medicine at Vanderbilt University and the Tennessee Valley-Nashville VA Hospital, says substantial gains in core-measure categories are great in aggregate but do little to spur QI in individual hospitals.
"As a group, we're doing pretty well with these core measures," Dr. Vasilevskis says. "But at an institution, it's critical you understand your individual numbers."
"Improving America’s Hospitals” (PDF), released in September, reported composite 2009 care results of 97.7% for heart attacks and 92.9% for pneumonia. Both were the highest measures since the report began tabulating the data in 2002.
Dr. Vasilevskis sees the news as a great sign for patient care but thinks the value of QI is to apply the techniques that have boosted those measures to other issues, such as interdisciplinary and transitional care. Those areas are more difficult to quantify and study, but that makes them ripe for HM group leaders to tackle, he says.
“This is going to take leadership; we need a quarterback on the team,” he adds. “Hospitalists can step up and be that quarterback.”
Dr. Vasilevskis also advocates for stiffer compliance requirements. For example, he says, while the current report lists a 99.4% compliance rate for physicians giving smoking cessation advice, the report includes no data or follow-up to show how that advice pans out. He notes that approach would be costly and time-consuming but could reap a valuable return on the investment.
"The first step is data," he says. "Then it's going to take leadership."
Payment Reform Proposals Take Shape
Medicare’s experiment with bundling episodes of care is finding some encouraging signs of life after fee-for-service (see “A Bundle of Nerves” in the November issue of The Hospitalist). But beyond orthopedics, cardiology, and cardiovascular surgery, what diagnosis-related groups (DRGs) should be bundled, and how should such bundles be fairly divided?
Some healthcare administrators say the system might work best in areas with high device costs, such as spine surgery. SHM supports provisions in the Affordable Care Act establishing a voluntary national pilot program on bundling payments to healthcare providers, and in 2009 backed pilot programs for high-risk medical populations with COPD or congestive heart failure. Cynthia Mason, project manager with the CMS Medicare Demonstrations Group, says the latter is definitely on the list of resource-heavy conditions Medicare will be scrutinizing. “But, obviously, looking at chronic conditions is more challenging because the service is not as standardized as, say, a surgical procedure,” she adds.
That concern, in fact, is driving some of the pessimism from other healthcare experts.
“I think it’s not at all clear that there are very many conditions amenable to bundling,” says Robert Berenson, MD, a senior fellow in the Urban Institute’s Health Policy Center and vice chair of the Medicare Payment Advisory Commission (MedPAC). “Once you get down to the cases that everybody agrees lend themselves to bundling, it may be you're dealing with too small a percentage of spending to really want to go this route."
Emerging efforts to calculate how bundled payments should be fairly divided, however, also might provide more clarity on the best bundling candidates. The experimental PROMETHEUS payment model, developed by the Newton, Conn.-based Health Care Incentives Improvement Institute, is one example. It uses what are called evidence-informed case rates, or ECRs, to assign a budget for an entire episode of care. According to the nonprofit organization, ECRs are adjusted based on the severity and complexity of each patient’s condition, and an algorithm figures out how to divide the check.
There are limits, of course, in dealing with multiple comorbidities right off the bat. Even so, Stuart Guterman, vice president of the Washington, D.C.-based Commonwealth Fund's Program on Payment and System Reform, thinks a big chunk of our healthcare system's costs could be addressed with a limited number of well-defined but high-expense categories.
Click here to listen to Dr. Berenson and Guterman further discuss Medicare payment reform.
Medicare’s experiment with bundling episodes of care is finding some encouraging signs of life after fee-for-service (see “A Bundle of Nerves” in the November issue of The Hospitalist). But beyond orthopedics, cardiology, and cardiovascular surgery, what diagnosis-related groups (DRGs) should be bundled, and how should such bundles be fairly divided?
Some healthcare administrators say the system might work best in areas with high device costs, such as spine surgery. SHM supports provisions in the Affordable Care Act establishing a voluntary national pilot program on bundling payments to healthcare providers, and in 2009 backed pilot programs for high-risk medical populations with COPD or congestive heart failure. Cynthia Mason, project manager with the CMS Medicare Demonstrations Group, says the latter is definitely on the list of resource-heavy conditions Medicare will be scrutinizing. “But, obviously, looking at chronic conditions is more challenging because the service is not as standardized as, say, a surgical procedure,” she adds.
That concern, in fact, is driving some of the pessimism from other healthcare experts.
“I think it’s not at all clear that there are very many conditions amenable to bundling,” says Robert Berenson, MD, a senior fellow in the Urban Institute’s Health Policy Center and vice chair of the Medicare Payment Advisory Commission (MedPAC). “Once you get down to the cases that everybody agrees lend themselves to bundling, it may be you're dealing with too small a percentage of spending to really want to go this route."
Emerging efforts to calculate how bundled payments should be fairly divided, however, also might provide more clarity on the best bundling candidates. The experimental PROMETHEUS payment model, developed by the Newton, Conn.-based Health Care Incentives Improvement Institute, is one example. It uses what are called evidence-informed case rates, or ECRs, to assign a budget for an entire episode of care. According to the nonprofit organization, ECRs are adjusted based on the severity and complexity of each patient’s condition, and an algorithm figures out how to divide the check.
There are limits, of course, in dealing with multiple comorbidities right off the bat. Even so, Stuart Guterman, vice president of the Washington, D.C.-based Commonwealth Fund's Program on Payment and System Reform, thinks a big chunk of our healthcare system's costs could be addressed with a limited number of well-defined but high-expense categories.
Click here to listen to Dr. Berenson and Guterman further discuss Medicare payment reform.
Medicare’s experiment with bundling episodes of care is finding some encouraging signs of life after fee-for-service (see “A Bundle of Nerves” in the November issue of The Hospitalist). But beyond orthopedics, cardiology, and cardiovascular surgery, what diagnosis-related groups (DRGs) should be bundled, and how should such bundles be fairly divided?
Some healthcare administrators say the system might work best in areas with high device costs, such as spine surgery. SHM supports provisions in the Affordable Care Act establishing a voluntary national pilot program on bundling payments to healthcare providers, and in 2009 backed pilot programs for high-risk medical populations with COPD or congestive heart failure. Cynthia Mason, project manager with the CMS Medicare Demonstrations Group, says the latter is definitely on the list of resource-heavy conditions Medicare will be scrutinizing. “But, obviously, looking at chronic conditions is more challenging because the service is not as standardized as, say, a surgical procedure,” she adds.
That concern, in fact, is driving some of the pessimism from other healthcare experts.
“I think it’s not at all clear that there are very many conditions amenable to bundling,” says Robert Berenson, MD, a senior fellow in the Urban Institute’s Health Policy Center and vice chair of the Medicare Payment Advisory Commission (MedPAC). “Once you get down to the cases that everybody agrees lend themselves to bundling, it may be you're dealing with too small a percentage of spending to really want to go this route."
Emerging efforts to calculate how bundled payments should be fairly divided, however, also might provide more clarity on the best bundling candidates. The experimental PROMETHEUS payment model, developed by the Newton, Conn.-based Health Care Incentives Improvement Institute, is one example. It uses what are called evidence-informed case rates, or ECRs, to assign a budget for an entire episode of care. According to the nonprofit organization, ECRs are adjusted based on the severity and complexity of each patient’s condition, and an algorithm figures out how to divide the check.
There are limits, of course, in dealing with multiple comorbidities right off the bat. Even so, Stuart Guterman, vice president of the Washington, D.C.-based Commonwealth Fund's Program on Payment and System Reform, thinks a big chunk of our healthcare system's costs could be addressed with a limited number of well-defined but high-expense categories.
Click here to listen to Dr. Berenson and Guterman further discuss Medicare payment reform.
Treatment of CML continues to progress
NEW YORK—Even with a 10-year overall survival (OS) rate of 84%-90%, researchers continue to carry out trials on emerging drugs to try and find therapies that provide a better outlook for patients.
According to Susan O’Brien, MD, of MD Anderson Cancer Center in Houston, Texas, who presented at the NCCN 5th Annual Congress on Hematologic Malignancies, even if a better treatment is available, it will be tough to demonstrate survival benefits.
Dr O’Brien listed standard-dose imatinib, high-dose imatinib, imatinib-based combinations, second generation tyrosine kinase inhibitors (TKIs) and stem cell transplant as possible frontline therapies, noting that imatinib-based combinations are only used in clinical trials and second-generation TKIs are not available commercially.
At 8 years of follow-up, data on imatinib shows a survival rate of about 84%-90%, compared to about 50% for stem cell transplant, which continues to decrease over time. Dr O’Brien believes transplant is a viable option for some patients down the line, but at this point in time for chronic stage patients, transplant is not a reasonable option when one compares these two survival curves upfront.
Most recommendations for the use of imatinib come from follow-up on the IRIS trial, Hochhaus et al 2009, said Dr O’Brien. The trial compared patients on imatinib vs interferon (IFN-α) and low-dose Ara-C, and led to the approval of imatinib for frontline therapy.
Follow-up of the IRIS trial continues to be crucial because there are not 20- or 30-year data available. Now is the 8-year data will help physicians treat current patients.
Because imatinib is such a targeted therapy, investigators thought that if patients were on imatinib long enough they would develop a mutation or something that leads to resistance, said Dr O’Brien. And as time went on, they expected to see increasingly more episodes of transformation.
“When rate of transformation came out, people were surprised.... What you see is the opposite. If you see transformation, it happens early on,” she said
This finding led to the hypothesis that in some patients there is a very small resistant clone up front. When these patients are administered imatinib , it allows the resistant clone to emerge and form resistant disease. “There are no standard techniques that will pick up this clone, so there is no reason for testing,” she added.
She also pointed out that there has not been enough follow-up to form criteria for suboptimal response. Suboptimal response at 6 months may be more like failure than suboptimal response at 12 months. Dr O’Brien noted that if the response is not technically a failure, the guidelines say imatinib can be continued. But in fact, she said, many people on the NCCN guidelines committee felt that the imatinib dose should be increased in the case of suboptimal response.
Although imatinib has revolutionized the treatment of CML, the search continues for an even better option.
To this end, investigators have conducted 2 trials comparing imatinib head-to-head with nilotinib (Larson et al, 2010 ASCO abstract) or dasatinib (Kantarjian et al, NEJM 2010) in newly diagnosed patients.
At 12 months, nilotinib 300 mg and 400 mg twice a day produced a greater percentage of major molecular responses (MMR) than imatinib 400 mg once a day (44%, 43% vs 22%, respectively). More patients on either dose of nilotinib experienced complete cytogenetic response (CCyR) than with imatinib at 12 months (80%, 78% vs 65%, respectively) and overall response (85%, 82% vs 74%, respectively).
Dasatinib also proved to be more effective than imatinib. More patients randomized to 100mg of dasatinib once a day experienced CCyr by 12 months than patients randomized to 400mg of imatinib once a day (83% vs 72%) as frontline treatment. Percentages of confirmed CCyR were 77% for desatinib and 66% for imatinib. Also, 1.9% of patients receiving dasatinib progressed to accelerated phase or blast phase, compared to 3.5% of patients receiving imatinib.
Dasatinib and nilotonib both result in lower rates of anemia and neutropenia than imatinib. Imatinib therapy still has the lowest occurrence of thrombocytopenia.
With all these new developments and less than 10 years of data to go on, Dr O’Brien brought up some issues physicians should consider when choosing frontline therapy for CML, including the relevance of short-term endpoints, the difficulty of assessing survival differences among developing therapies, the cost of drugs, and the spectrum of toxicities.
NEW YORK—Even with a 10-year overall survival (OS) rate of 84%-90%, researchers continue to carry out trials on emerging drugs to try and find therapies that provide a better outlook for patients.
According to Susan O’Brien, MD, of MD Anderson Cancer Center in Houston, Texas, who presented at the NCCN 5th Annual Congress on Hematologic Malignancies, even if a better treatment is available, it will be tough to demonstrate survival benefits.
Dr O’Brien listed standard-dose imatinib, high-dose imatinib, imatinib-based combinations, second generation tyrosine kinase inhibitors (TKIs) and stem cell transplant as possible frontline therapies, noting that imatinib-based combinations are only used in clinical trials and second-generation TKIs are not available commercially.
At 8 years of follow-up, data on imatinib shows a survival rate of about 84%-90%, compared to about 50% for stem cell transplant, which continues to decrease over time. Dr O’Brien believes transplant is a viable option for some patients down the line, but at this point in time for chronic stage patients, transplant is not a reasonable option when one compares these two survival curves upfront.
Most recommendations for the use of imatinib come from follow-up on the IRIS trial, Hochhaus et al 2009, said Dr O’Brien. The trial compared patients on imatinib vs interferon (IFN-α) and low-dose Ara-C, and led to the approval of imatinib for frontline therapy.
Follow-up of the IRIS trial continues to be crucial because there are not 20- or 30-year data available. Now is the 8-year data will help physicians treat current patients.
Because imatinib is such a targeted therapy, investigators thought that if patients were on imatinib long enough they would develop a mutation or something that leads to resistance, said Dr O’Brien. And as time went on, they expected to see increasingly more episodes of transformation.
“When rate of transformation came out, people were surprised.... What you see is the opposite. If you see transformation, it happens early on,” she said
This finding led to the hypothesis that in some patients there is a very small resistant clone up front. When these patients are administered imatinib , it allows the resistant clone to emerge and form resistant disease. “There are no standard techniques that will pick up this clone, so there is no reason for testing,” she added.
She also pointed out that there has not been enough follow-up to form criteria for suboptimal response. Suboptimal response at 6 months may be more like failure than suboptimal response at 12 months. Dr O’Brien noted that if the response is not technically a failure, the guidelines say imatinib can be continued. But in fact, she said, many people on the NCCN guidelines committee felt that the imatinib dose should be increased in the case of suboptimal response.
Although imatinib has revolutionized the treatment of CML, the search continues for an even better option.
To this end, investigators have conducted 2 trials comparing imatinib head-to-head with nilotinib (Larson et al, 2010 ASCO abstract) or dasatinib (Kantarjian et al, NEJM 2010) in newly diagnosed patients.
At 12 months, nilotinib 300 mg and 400 mg twice a day produced a greater percentage of major molecular responses (MMR) than imatinib 400 mg once a day (44%, 43% vs 22%, respectively). More patients on either dose of nilotinib experienced complete cytogenetic response (CCyR) than with imatinib at 12 months (80%, 78% vs 65%, respectively) and overall response (85%, 82% vs 74%, respectively).
Dasatinib also proved to be more effective than imatinib. More patients randomized to 100mg of dasatinib once a day experienced CCyr by 12 months than patients randomized to 400mg of imatinib once a day (83% vs 72%) as frontline treatment. Percentages of confirmed CCyR were 77% for desatinib and 66% for imatinib. Also, 1.9% of patients receiving dasatinib progressed to accelerated phase or blast phase, compared to 3.5% of patients receiving imatinib.
Dasatinib and nilotonib both result in lower rates of anemia and neutropenia than imatinib. Imatinib therapy still has the lowest occurrence of thrombocytopenia.
With all these new developments and less than 10 years of data to go on, Dr O’Brien brought up some issues physicians should consider when choosing frontline therapy for CML, including the relevance of short-term endpoints, the difficulty of assessing survival differences among developing therapies, the cost of drugs, and the spectrum of toxicities.
NEW YORK—Even with a 10-year overall survival (OS) rate of 84%-90%, researchers continue to carry out trials on emerging drugs to try and find therapies that provide a better outlook for patients.
According to Susan O’Brien, MD, of MD Anderson Cancer Center in Houston, Texas, who presented at the NCCN 5th Annual Congress on Hematologic Malignancies, even if a better treatment is available, it will be tough to demonstrate survival benefits.
Dr O’Brien listed standard-dose imatinib, high-dose imatinib, imatinib-based combinations, second generation tyrosine kinase inhibitors (TKIs) and stem cell transplant as possible frontline therapies, noting that imatinib-based combinations are only used in clinical trials and second-generation TKIs are not available commercially.
At 8 years of follow-up, data on imatinib shows a survival rate of about 84%-90%, compared to about 50% for stem cell transplant, which continues to decrease over time. Dr O’Brien believes transplant is a viable option for some patients down the line, but at this point in time for chronic stage patients, transplant is not a reasonable option when one compares these two survival curves upfront.
Most recommendations for the use of imatinib come from follow-up on the IRIS trial, Hochhaus et al 2009, said Dr O’Brien. The trial compared patients on imatinib vs interferon (IFN-α) and low-dose Ara-C, and led to the approval of imatinib for frontline therapy.
Follow-up of the IRIS trial continues to be crucial because there are not 20- or 30-year data available. Now is the 8-year data will help physicians treat current patients.
Because imatinib is such a targeted therapy, investigators thought that if patients were on imatinib long enough they would develop a mutation or something that leads to resistance, said Dr O’Brien. And as time went on, they expected to see increasingly more episodes of transformation.
“When rate of transformation came out, people were surprised.... What you see is the opposite. If you see transformation, it happens early on,” she said
This finding led to the hypothesis that in some patients there is a very small resistant clone up front. When these patients are administered imatinib , it allows the resistant clone to emerge and form resistant disease. “There are no standard techniques that will pick up this clone, so there is no reason for testing,” she added.
She also pointed out that there has not been enough follow-up to form criteria for suboptimal response. Suboptimal response at 6 months may be more like failure than suboptimal response at 12 months. Dr O’Brien noted that if the response is not technically a failure, the guidelines say imatinib can be continued. But in fact, she said, many people on the NCCN guidelines committee felt that the imatinib dose should be increased in the case of suboptimal response.
Although imatinib has revolutionized the treatment of CML, the search continues for an even better option.
To this end, investigators have conducted 2 trials comparing imatinib head-to-head with nilotinib (Larson et al, 2010 ASCO abstract) or dasatinib (Kantarjian et al, NEJM 2010) in newly diagnosed patients.
At 12 months, nilotinib 300 mg and 400 mg twice a day produced a greater percentage of major molecular responses (MMR) than imatinib 400 mg once a day (44%, 43% vs 22%, respectively). More patients on either dose of nilotinib experienced complete cytogenetic response (CCyR) than with imatinib at 12 months (80%, 78% vs 65%, respectively) and overall response (85%, 82% vs 74%, respectively).
Dasatinib also proved to be more effective than imatinib. More patients randomized to 100mg of dasatinib once a day experienced CCyr by 12 months than patients randomized to 400mg of imatinib once a day (83% vs 72%) as frontline treatment. Percentages of confirmed CCyR were 77% for desatinib and 66% for imatinib. Also, 1.9% of patients receiving dasatinib progressed to accelerated phase or blast phase, compared to 3.5% of patients receiving imatinib.
Dasatinib and nilotonib both result in lower rates of anemia and neutropenia than imatinib. Imatinib therapy still has the lowest occurrence of thrombocytopenia.
With all these new developments and less than 10 years of data to go on, Dr O’Brien brought up some issues physicians should consider when choosing frontline therapy for CML, including the relevance of short-term endpoints, the difficulty of assessing survival differences among developing therapies, the cost of drugs, and the spectrum of toxicities.
Pending Tests at Discharge
The period following discharge is a vulnerable time for patientsthe prevalence of medical errors related to this transition is high and has important patient safety and medico‐legal ramifications.13 Factors contributing to this vulnerability include complexity of hospitalized patients, shorter lengths of stay, and increased discontinuity of care. Hospitalists have recognized this threat to patient safety and have worked toward improving information exchange between inpatient and outpatient providers at hospital discharge.46 Nonetheless, the evidence suggests that more work is necessary. A recent study found that discharge summaries are often incomplete, and do not contain important information requiring follow‐up, such as pending tests.7 Additionally, a review by Kripalani et al. characterizing information deficits at hospital discharge found few interventions which specifically improve communication of pending tests at hospital discharge.8
In a prior study we determined that 41% of patients left the hospital before all laboratory and radiology test results were finalized. Of these results, 9.4% were potentially actionable and could have altered management. Physicians were aware of only 38% of post‐discharge test results.9 This awareness gap is a consequence of several factors including the lack of systems to track and alert providers of test results finalized post discharge. Also, it is unclear who is responsible for pending tests at discharge, since these tests are ordered by the inpatient physicians but often reported in the time period between hospital discharge and the patient's first follow‐up appointment with the primary care physician (PCP). Because responsibility is not explicitly made in the final communication between physicians at discharge, such test results may not be reviewed in a timely manner, potentially resulting in delays in treatment, a need for readmission, or other unfavorable outcomes.
Even in integrated health systems with advanced electronic health records, missed test results which result in treatment delays remain prevalent.10, 11 Test result management applications aid clinicians in reviewing and acting upon results as they become available and such systems may provide solutions to this problem. At Partners Healthcare in Boston, the Results Manager (RM) application was developed to help clinicians in the ambulatory setting safely, reliably, and efficiently review and act upon test results. The application enables clinicians to prioritize test results, utilize guidelines, and generate letters to patients. This system also prompts physicians to set reminders for future testing.12 In a 2.5‐year study evaluating the impact of this intervention, PCPs at 26 adult primary care practices were able to expedite communication of outpatient laboratory and imaging test results to patients with the help of RM. Patients of physicians who participated in the project reported greater satisfaction with test result communication and with information provided about their condition than did a control group of similar patients.13 RM has not yet been studied in the inpatient setting or at care transitions. We describe an attempt at modifying the Partners RM application to help inpatient physicians manage pending tests at hospital discharge.
Methods
Study Setting and Participants
We piloted our application at 2 major academic medical centers (hospitals A and B) associated with Partners Healthcare, an integrated regional health delivery network in eastern Massachusetts, from October 2004 to March 2005. Both centers use the longitudinal medical record (LMR), the electronic medical record (EMR), for nearly all ambulatory practices. The LMR is an internally developed full‐featured EMR, including a repository of laboratory and radiology reports, discharge summaries, ambulatory care notes, medication lists, problem lists, coded allergies, and other patient data. Both centers also have their own inpatient results viewing and order entry systems which provide clinicians caring for patients in the hospital the ability to review results and write orders. Although possible, clinicians caring for patients in the inpatient setting do not routinely access LMR to view test results. Inpatient physician use of the LMR is generally limited to review of the outpatient record, medication lists, and ambulatory notes at admission.
At hospital A, the hospitalist attending physician is typically responsible for all communication to outpatient physicians at discharge, as well as for follow‐up on all test results that return after discharge. Hospital B has 2 types of hospitalist services. One is staffed only by hospitalist and nonhospitalist attending physicians. Nonhospitalist attending physicians were excluded because they care for their own patients in the inpatient and ambulatory setting and typically use RM to manage test results. The other hospitalist service at hospital B is a teaching service consisting of an attending physician, resident, and interns. For this service, the resident is responsible for communication at discharge and follow‐up on all pending tests. For purposes of this study inpatient physicians refers to those physicians responsible for communication with PCPs and follow‐up on pending tests. All inpatient physicians were eligible to participate during the study period.
Test Result Management Application
RM was originally developed by Partners Healthcare to improve timely review and appropriate management of test results in the ambulatory setting. RM was developed for and vetted by primarily ambulatory physicians. The application is browser‐based, provider‐centric, and embedded in the LMR to help ambulatory clinicians review and act upon test results in a safe, reliable, and efficient manner. Although RM has access to all inpatient and outpatient data in the Partners Clinical Data Repository (CDR), given the volume of inpatient tests ordered, hospital‐based results are suppressed by default to limit inundating ambulatory clinicians' queues. Therefore, users of RM only receive results of laboratory and radiology tests ordered in the ambulatory setting. They can track these tests for specific patients for a designated period of time by placing the patient on a watch list. Finally, RM incorporates extensive decision support features to classify the degree of abnormality for each result, presents guidelines to help clinicians manage abnormal results, allows clinicians to generate result letters to patients using predefined, context‐sensitive templates, and prompts physicians to set reminders for future testing. Because RM was developed from the ambulatory perspective, there was limited input from hospitalist physicians with regard to inpatient workflow in the original design of the module.12 See Figure 1 for a screen shot of RM and a description of its features.
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
For purposes of this pilot, we modified RM to allow results of tests ordered in the inpatient setting to be available for viewing (Hospitalist Results Manager, HRM). This feature was turned on only for inpatient physicians as previously defined. Inpatient tests, including pending tests at discharge, continued to be suppressed from PCP's RM queue (however, any physician could access a patient's test result(s) directly from the Partners CDR). Inpatient physicians could track laboratory and radiology results finalized after discharge by keeping discharged patients on their HRM watch list for a designated period of time. The finalized results would become available for review in their HRM queue and abnormal results were displayed prominently at the top of this queue. Inpatient physicians were trained to use HRM in a series of meetings and demonstrations. Although HRM could be accessed from inpatient clinical workstations, it was not part of the inpatient clinical information system.
Surveys
Study surveys were developed and refined through an iterative process and pilot tested among inpatient physicians at both centers for clarity. We surveyed inpatient physicians five months after HRM implementation. Inpatient physicians were asked how often they used HRM, what barriers they faced (respondents asked to quantify agreement to statements on a 5‐point Likert scale), and which elements of an ideal system they would prefer. Finally, we solicited comments regarding perceived obstacles and suggestions for improvement. Because HRM was targeted to inpatient physicians, and because RM has been evaluated from the ambulatory perspective in a prior study,13 PCPs were not surveyed. See Supporting Information Appendix for the survey instrument used in the study.
Results
A total of 35 inpatient physicians participated in the pilot. Among 649 patients discharged during the study period, there were 1075 tests pending of which 555 were subsequently flagged as abnormal in HRM. Study surveys were sent to the 35 inpatient physician participants and 29 were completed, including partial responses (83% survey response rate). The 35 inpatient physician participants had the following characteristics: 22 were male, 13 were female; 21 were trainees and 14 were nontrainees/faculty. All 21 trainees were PGY2s. Nontrainees and faculty varied in experience level (PGY 15: 5, PGY 610: 7, PGY 1120: 1, PGY 21+: 1). Of 29 survey respondents, 7 were from hospital A and 22 were from hospital B; 19 were trainees and 10 were nontrainees/faculty. Of the 6 nonrespondents, 2 were from hospital A and 4 were from hospital B; 2 were trainees and 4 were nontrainees/faculty.
Table 1 shows the results of our survey of inpatient physicians regarding usage of HRM. Of 29 survey respondents, 14 (48%) reported never using HRM. Thirteen (45%) reported using HRM 1 to 2 times per week. None of the respondents used it more than 4 times per week. The frequency of usage was similar for hospitals A and B. Table 2 details barriers to using HRM. Twenty‐three inpatient physicians (79%) reported barriers. Seventeen (59%) thought that results in their HRM queue were not clinically relevant, 16 (55%) felt that HRM did not fit into their daily workflow, 14 (48%) had limited time to use HRM, and 12 (41%) noted that too many results in their HRM queue were on other physician's patients. Seven (24%) reported operational issues and 3 (10%) reported technical issues prohibiting use of HRM. With regard to preferred elements of an ideal results manager system, 21 (72%) inpatient physician respondents wanted to receive notification of abnormal and clinician‐designated pending test results. Four (14%) wanted to receive only abnormal results and 1 (3%) wanted to receive all results. Twenty‐seven (93%) physicians agreed that an ideally designed computerized test result management application would be valuable for managing pending tests at discharge.
| Frequency | Number of Inpatient Physicians Using HRM, n (%) | ||
|---|---|---|---|
| Overall | Hospital A | Hospital B | |
| |||
| Never | 14 (48) | 3 (43) | 11 (50) |
| 12 times per week | 13 (45) | 3 (43) | 10 (45.5) |
| 34 times per week | 2 (7) | 1 (14) | 1 (4.5) |
| 57 times per week | 0 | 0 | 0 |
| >7 times per week | 0 | 0 | 0 |
| Barrier | Overall, n (%) | Hospital A, n (%) | Hospital B, n (%) |
|---|---|---|---|
| |||
| Forgot to use HRM | 23 (79) | 7 (100) | 16 (73) |
| Results not clinically relevant | 17 (59) | 7 (100) | 10 (45) |
| Did not fit daily workflow | 16 (55) | 7 (100) | 9 (41) |
| Too little time to use HRM | 14 (48) | 6 (86) | 8 (46) |
| Results on others' patients | 12 (41) | 6 (86) | 6 (27) |
| HRM was difficult to use | 7 (24) | 2 (29) | 5 (23) |
| Had technical difficulties | 3 (10) | 0 (0) | 3 (14) |
Table 3 provides comments from inpatient physician respondents regarding obstacles prohibiting use of HRM and suggestions for future systems.
|
| Suggestions |
| Would be more useful if accessible from (the inpatient clinical information system). |
| Email notification (would have been useful). |
| At time of discharge, if there is a way to find pending labs at discharge, this would be of great utility. |
| Linking responsibility for follow‐up to test ordering (would have been useful). |
| Smarter system for filtering results so less important results are filtered out (is desirable). |
| Can the system be tied into PCP's email somehow? |
| Obstacles |
| Blood cultures, abnormal films can be difficult and time‐consuming to look up. |
| A big problem is results that automatically trigger even though they're not clinically relevant. |
| Keeping a record of patients that left with tests pending (is often difficult to do). |
| Addressing pending results is very time consuming. |
Discussion
We describe a pilot implementation of a computerized application for the management of pending tests at hospital discharge. From responses to post‐implementation surveys, we were able to identify multiple factors prohibiting successful implementation of the application. These observations may help inform future interventions and evaluations.
Almost half of inpatient physicians reported never using HRM despite training and reminders. The feedback provided by physicians in our study suggested that HRM was not ideally designed from an inpatient physician perspective. We discovered several barriers to its use: (1) HRM overburdened physicians with clinically irrelevant test results, suggesting that more robust filtering of abnormal but low importance test results may be required (eg, a borderline electrolyte abnormality or low but stable hematocrit); (2) HRM did not integrate well into inpatient workflowthe system was not integrated into the inpatient results viewing and computerized physician order entry (CPOE) applications, and therefore required an extra step to access; (3) there was no mechanism of alerting inpatient physicians that finalized test results were available for viewing in their HRM queues (eg, by email or by an alert in the inpatient computer system); (4) because responsibility for these results was unclear, most inpatient physicians had no formal method of managing them, and for many, using HRM represented an additional task; and finally (5) several physicians commented on finding results in their HRM queue that belonged to other physician's patients, implying that the hospital databases were inaccurate in identifying the discharging physician or that rotation schedules, and therefore patient responsibility, had changed in the intervening period. Table 4 summarizes the advantages and respective limitations of features of HRM available to inpatient physicians.
| Advantages | Limitations |
|---|---|
| |
| Creates a physician‐managed queue of pending test results by patient | Does not provide alert or push notification when new results available for patients |
| Filters test results by severity with most critical results appearing at the top of the queue | Severity filter set for outpatients; not restrictive enough for post‐discharge period, resulting in excessive alerting |
| Independent, voluntary acknowledgement of results by user | Active acknowledgment not required; no audit trail, feedback, or escalation if result not acknowledged |
| Embedded within LMR (the ambulatory EMR) | LMR not routinely used by many inpatient physicians |
| Offers patient communication tools (eg, pre‐populated patient results letter) | Tools not optimized for post‐discharge test result communication by inpatient physicians (eg, a tool for PCP result notification and acknowledgment) |
In the literature, there is little information regarding optimal features of a test result management system for transitions from the inpatient to ambulatory care setting. Prior studies outline important functions for results management systems developed for noninpatient sites of care, including the ambulatory and emergency room setting.12, 14, 15 These include a method of prioritizing by degree of abnormality, the ability to reliably and efficiently act upon results, and an automated alerting system for abnormal results. Findings from our study provide insight in defining core functions for result management systems which focus on transitions from the inpatient to ambulatory care setting. These functions include tight integration with applications used by inpatient physicians, clear assignment of responsibility for test results finalized after hospital discharge (as well as a mechanism to reassign responsibility), automated alerts to responsible providers of test results finalized post‐discharge, and ways to automatically filter test results to avoid over‐burdening physicians with clinically irrelevant results.
Almost all surveyed inpatient physicians agreed that an ideally designed electronic post‐discharge results management system would be valuable. For such systems to be successfully adopted, we offer several principles to help guide future work. These include: (1) clarifying responsibility at the time a test is ordered and again at discharge, (2) understanding workflow and communication patterns among inpatient and outpatient clinicians, and (3) integrating technological solutions into existing systems to minimize workflow disruptions. For example, if the primary responsibility for post‐discharge result follow‐up lies with the ordering physician, the system should be integrated within the EMR most often used by inpatient physicians and become part of inpatient physician workflow. If the system depends on administrative databases to identify the responsible providers, these must be accurate. Alternatively, in organizations with computerized provider order entry, responsibility for the result could be assigned when the test is ordered and confirmed at discharge (ie, the results management system would be integrated into the discharge order such that pending tests are reviewed at the time of discharge). The discharging physician should have the ability to assign responsibility for each pending test and select preferred mode(s) of notification once its result is finalized (eg, e‐mail, alphanumeric page, etc.). The system should have the ability to generate an automatic notification to the inpatient and PCP (and perhaps other designated providers involved in the patient's inpatient care), but it should not burden busy clinicians with unnecessary alerts and warnings. Finally, the rules by which results are prioritized must be robust enough to filter out less urgent results, and should be modified to reflect the severity of illness of recently discharged patients. In essence, in consideration of the time constraints of busy clinicians, an ideal results management system should achieve automated notification of test results while minimizing the risk of alert fatigue from the potentially large volume of alerts generated.
Our study has several important limitations. First, although our survey response rate was high, the sample size of actual participants was small. Second, because the study was conducted in 2 similar, tertiary care academic centers, it may not generalize to other settings (we note that hospital B included a nonteaching service similar to those in nonacademic medical centers). This may be particularly true in assessing the importance of specific barriers to use of results management systems, which may vary at different institutions. Third, the representation of survey respondents were skeweda majority of the responses were from trainees (all post‐graduate level [PGY] level 2) and from hospital B. Fourth, we did not actively monitor physician interaction with the test result management application, and therefore, we depended heavily on physician recollection of use of the system when responding to surveys. Finally, we did not convene focus groups of key individuals with regard to the factors facilitating or prohibiting adoption of the system. Use of semi‐structured, key informant interviews (ie, focus groups) before and after implementation of an electronic results management application, have been shown to be effective in evaluating potential barriers and facilitators of adoption.16 Focus groups of and/or interviews with inpatient and PCPs, physician extenders, and housestaff could have been useful to better characterize the potential barriers and facilitators of adoption noted by survey respondents in our study.
In summary, we offer several lessons from our attempt to implement a system to manage pending tests at hospital discharge. The success of implementing future systems to address this patient safety concern will rely on accurately assigning responsibility for these test results, integrating the system within clinical information systems commonly used by the inpatient physician, addressing workflow issues and time constraints, maximizing appropriateness of alerting, and minimizing alert fatigue.
- ,,,,.The incidence and severity of adverse events affecting patients after discharge from the hospital.Ann Intern Med.2003;138(3):161–167.
- ,,,.Medical errors related to discontinuity of care from an inpatient to an outpatient setting.J Gen Intern Med.2003;18(8):646–651.
- .Key legal principles for hospitalists.Am J Med.2001;111(9B):5S–9S.
- ,,.Passing the clinical baton: 6 principles to guide the hospitalist.Am J Med.2001;111(9B):36S–39S.
- ,.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141(7):533–536.
- ,,,.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2(5):314–323.
- ,,, et al.Adequacy of hospital discharge summaries in documenting tests with pending results and outpatient follow‐up providers.J Gen Intern Med.2009;24(9):1002–1006.
- ,,,,,.Deficits in communication and information transfer between hospital‐based and primary care physicians: Implications for patient safety and continuity of care.JAMA.2007;297(8):831–841.
- ,,, et al.Patient safety concerns arising from test results that return after hospital discharge.Ann Intern Med.2005;143(2):121–128.
- ,,.The continuing problem of missed test results in an integrated health system with an advanced electronic medical record.Jt Comm J Qual Patient Saf.2007;33(8):485–492.
- ,.The frequency of missed test results and associated treatment delays in a highly computerized health system.BMC Fam Pract.2007;8:32.
- ,,,,.Design and implementation of a comprehensive outpatient results manager.J Biomed Inform.2003;36(1–2):80–91.
- ,,, et al.Impact of an automated test results management system on patients' satisfaction about test result communication.Arch Intern Med.2007;167(20):2233–2239.
- ,,,,,.“I wish I had seen this test result earlier!”: dissatisfaction with test result management systems in primary care.Arch Intern Med.2004;164(20):2223–2228.
- ,,.Potential impact of a computerized system to report late‐arriving laboratory results in the emergency department.Pediatr Emerg Care.2000;16(5):313–315.
- ,,, et al.Electronic results management in pediatric ambulatory care: Qualitative assessment.Pediatrics.2009;123Suppl 2:S85–S91.
The period following discharge is a vulnerable time for patientsthe prevalence of medical errors related to this transition is high and has important patient safety and medico‐legal ramifications.13 Factors contributing to this vulnerability include complexity of hospitalized patients, shorter lengths of stay, and increased discontinuity of care. Hospitalists have recognized this threat to patient safety and have worked toward improving information exchange between inpatient and outpatient providers at hospital discharge.46 Nonetheless, the evidence suggests that more work is necessary. A recent study found that discharge summaries are often incomplete, and do not contain important information requiring follow‐up, such as pending tests.7 Additionally, a review by Kripalani et al. characterizing information deficits at hospital discharge found few interventions which specifically improve communication of pending tests at hospital discharge.8
In a prior study we determined that 41% of patients left the hospital before all laboratory and radiology test results were finalized. Of these results, 9.4% were potentially actionable and could have altered management. Physicians were aware of only 38% of post‐discharge test results.9 This awareness gap is a consequence of several factors including the lack of systems to track and alert providers of test results finalized post discharge. Also, it is unclear who is responsible for pending tests at discharge, since these tests are ordered by the inpatient physicians but often reported in the time period between hospital discharge and the patient's first follow‐up appointment with the primary care physician (PCP). Because responsibility is not explicitly made in the final communication between physicians at discharge, such test results may not be reviewed in a timely manner, potentially resulting in delays in treatment, a need for readmission, or other unfavorable outcomes.
Even in integrated health systems with advanced electronic health records, missed test results which result in treatment delays remain prevalent.10, 11 Test result management applications aid clinicians in reviewing and acting upon results as they become available and such systems may provide solutions to this problem. At Partners Healthcare in Boston, the Results Manager (RM) application was developed to help clinicians in the ambulatory setting safely, reliably, and efficiently review and act upon test results. The application enables clinicians to prioritize test results, utilize guidelines, and generate letters to patients. This system also prompts physicians to set reminders for future testing.12 In a 2.5‐year study evaluating the impact of this intervention, PCPs at 26 adult primary care practices were able to expedite communication of outpatient laboratory and imaging test results to patients with the help of RM. Patients of physicians who participated in the project reported greater satisfaction with test result communication and with information provided about their condition than did a control group of similar patients.13 RM has not yet been studied in the inpatient setting or at care transitions. We describe an attempt at modifying the Partners RM application to help inpatient physicians manage pending tests at hospital discharge.
Methods
Study Setting and Participants
We piloted our application at 2 major academic medical centers (hospitals A and B) associated with Partners Healthcare, an integrated regional health delivery network in eastern Massachusetts, from October 2004 to March 2005. Both centers use the longitudinal medical record (LMR), the electronic medical record (EMR), for nearly all ambulatory practices. The LMR is an internally developed full‐featured EMR, including a repository of laboratory and radiology reports, discharge summaries, ambulatory care notes, medication lists, problem lists, coded allergies, and other patient data. Both centers also have their own inpatient results viewing and order entry systems which provide clinicians caring for patients in the hospital the ability to review results and write orders. Although possible, clinicians caring for patients in the inpatient setting do not routinely access LMR to view test results. Inpatient physician use of the LMR is generally limited to review of the outpatient record, medication lists, and ambulatory notes at admission.
At hospital A, the hospitalist attending physician is typically responsible for all communication to outpatient physicians at discharge, as well as for follow‐up on all test results that return after discharge. Hospital B has 2 types of hospitalist services. One is staffed only by hospitalist and nonhospitalist attending physicians. Nonhospitalist attending physicians were excluded because they care for their own patients in the inpatient and ambulatory setting and typically use RM to manage test results. The other hospitalist service at hospital B is a teaching service consisting of an attending physician, resident, and interns. For this service, the resident is responsible for communication at discharge and follow‐up on all pending tests. For purposes of this study inpatient physicians refers to those physicians responsible for communication with PCPs and follow‐up on pending tests. All inpatient physicians were eligible to participate during the study period.
Test Result Management Application
RM was originally developed by Partners Healthcare to improve timely review and appropriate management of test results in the ambulatory setting. RM was developed for and vetted by primarily ambulatory physicians. The application is browser‐based, provider‐centric, and embedded in the LMR to help ambulatory clinicians review and act upon test results in a safe, reliable, and efficient manner. Although RM has access to all inpatient and outpatient data in the Partners Clinical Data Repository (CDR), given the volume of inpatient tests ordered, hospital‐based results are suppressed by default to limit inundating ambulatory clinicians' queues. Therefore, users of RM only receive results of laboratory and radiology tests ordered in the ambulatory setting. They can track these tests for specific patients for a designated period of time by placing the patient on a watch list. Finally, RM incorporates extensive decision support features to classify the degree of abnormality for each result, presents guidelines to help clinicians manage abnormal results, allows clinicians to generate result letters to patients using predefined, context‐sensitive templates, and prompts physicians to set reminders for future testing. Because RM was developed from the ambulatory perspective, there was limited input from hospitalist physicians with regard to inpatient workflow in the original design of the module.12 See Figure 1 for a screen shot of RM and a description of its features.
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
For purposes of this pilot, we modified RM to allow results of tests ordered in the inpatient setting to be available for viewing (Hospitalist Results Manager, HRM). This feature was turned on only for inpatient physicians as previously defined. Inpatient tests, including pending tests at discharge, continued to be suppressed from PCP's RM queue (however, any physician could access a patient's test result(s) directly from the Partners CDR). Inpatient physicians could track laboratory and radiology results finalized after discharge by keeping discharged patients on their HRM watch list for a designated period of time. The finalized results would become available for review in their HRM queue and abnormal results were displayed prominently at the top of this queue. Inpatient physicians were trained to use HRM in a series of meetings and demonstrations. Although HRM could be accessed from inpatient clinical workstations, it was not part of the inpatient clinical information system.
Surveys
Study surveys were developed and refined through an iterative process and pilot tested among inpatient physicians at both centers for clarity. We surveyed inpatient physicians five months after HRM implementation. Inpatient physicians were asked how often they used HRM, what barriers they faced (respondents asked to quantify agreement to statements on a 5‐point Likert scale), and which elements of an ideal system they would prefer. Finally, we solicited comments regarding perceived obstacles and suggestions for improvement. Because HRM was targeted to inpatient physicians, and because RM has been evaluated from the ambulatory perspective in a prior study,13 PCPs were not surveyed. See Supporting Information Appendix for the survey instrument used in the study.
Results
A total of 35 inpatient physicians participated in the pilot. Among 649 patients discharged during the study period, there were 1075 tests pending of which 555 were subsequently flagged as abnormal in HRM. Study surveys were sent to the 35 inpatient physician participants and 29 were completed, including partial responses (83% survey response rate). The 35 inpatient physician participants had the following characteristics: 22 were male, 13 were female; 21 were trainees and 14 were nontrainees/faculty. All 21 trainees were PGY2s. Nontrainees and faculty varied in experience level (PGY 15: 5, PGY 610: 7, PGY 1120: 1, PGY 21+: 1). Of 29 survey respondents, 7 were from hospital A and 22 were from hospital B; 19 were trainees and 10 were nontrainees/faculty. Of the 6 nonrespondents, 2 were from hospital A and 4 were from hospital B; 2 were trainees and 4 were nontrainees/faculty.
Table 1 shows the results of our survey of inpatient physicians regarding usage of HRM. Of 29 survey respondents, 14 (48%) reported never using HRM. Thirteen (45%) reported using HRM 1 to 2 times per week. None of the respondents used it more than 4 times per week. The frequency of usage was similar for hospitals A and B. Table 2 details barriers to using HRM. Twenty‐three inpatient physicians (79%) reported barriers. Seventeen (59%) thought that results in their HRM queue were not clinically relevant, 16 (55%) felt that HRM did not fit into their daily workflow, 14 (48%) had limited time to use HRM, and 12 (41%) noted that too many results in their HRM queue were on other physician's patients. Seven (24%) reported operational issues and 3 (10%) reported technical issues prohibiting use of HRM. With regard to preferred elements of an ideal results manager system, 21 (72%) inpatient physician respondents wanted to receive notification of abnormal and clinician‐designated pending test results. Four (14%) wanted to receive only abnormal results and 1 (3%) wanted to receive all results. Twenty‐seven (93%) physicians agreed that an ideally designed computerized test result management application would be valuable for managing pending tests at discharge.
| Frequency | Number of Inpatient Physicians Using HRM, n (%) | ||
|---|---|---|---|
| Overall | Hospital A | Hospital B | |
| |||
| Never | 14 (48) | 3 (43) | 11 (50) |
| 12 times per week | 13 (45) | 3 (43) | 10 (45.5) |
| 34 times per week | 2 (7) | 1 (14) | 1 (4.5) |
| 57 times per week | 0 | 0 | 0 |
| >7 times per week | 0 | 0 | 0 |
| Barrier | Overall, n (%) | Hospital A, n (%) | Hospital B, n (%) |
|---|---|---|---|
| |||
| Forgot to use HRM | 23 (79) | 7 (100) | 16 (73) |
| Results not clinically relevant | 17 (59) | 7 (100) | 10 (45) |
| Did not fit daily workflow | 16 (55) | 7 (100) | 9 (41) |
| Too little time to use HRM | 14 (48) | 6 (86) | 8 (46) |
| Results on others' patients | 12 (41) | 6 (86) | 6 (27) |
| HRM was difficult to use | 7 (24) | 2 (29) | 5 (23) |
| Had technical difficulties | 3 (10) | 0 (0) | 3 (14) |
Table 3 provides comments from inpatient physician respondents regarding obstacles prohibiting use of HRM and suggestions for future systems.
|
| Suggestions |
| Would be more useful if accessible from (the inpatient clinical information system). |
| Email notification (would have been useful). |
| At time of discharge, if there is a way to find pending labs at discharge, this would be of great utility. |
| Linking responsibility for follow‐up to test ordering (would have been useful). |
| Smarter system for filtering results so less important results are filtered out (is desirable). |
| Can the system be tied into PCP's email somehow? |
| Obstacles |
| Blood cultures, abnormal films can be difficult and time‐consuming to look up. |
| A big problem is results that automatically trigger even though they're not clinically relevant. |
| Keeping a record of patients that left with tests pending (is often difficult to do). |
| Addressing pending results is very time consuming. |
Discussion
We describe a pilot implementation of a computerized application for the management of pending tests at hospital discharge. From responses to post‐implementation surveys, we were able to identify multiple factors prohibiting successful implementation of the application. These observations may help inform future interventions and evaluations.
Almost half of inpatient physicians reported never using HRM despite training and reminders. The feedback provided by physicians in our study suggested that HRM was not ideally designed from an inpatient physician perspective. We discovered several barriers to its use: (1) HRM overburdened physicians with clinically irrelevant test results, suggesting that more robust filtering of abnormal but low importance test results may be required (eg, a borderline electrolyte abnormality or low but stable hematocrit); (2) HRM did not integrate well into inpatient workflowthe system was not integrated into the inpatient results viewing and computerized physician order entry (CPOE) applications, and therefore required an extra step to access; (3) there was no mechanism of alerting inpatient physicians that finalized test results were available for viewing in their HRM queues (eg, by email or by an alert in the inpatient computer system); (4) because responsibility for these results was unclear, most inpatient physicians had no formal method of managing them, and for many, using HRM represented an additional task; and finally (5) several physicians commented on finding results in their HRM queue that belonged to other physician's patients, implying that the hospital databases were inaccurate in identifying the discharging physician or that rotation schedules, and therefore patient responsibility, had changed in the intervening period. Table 4 summarizes the advantages and respective limitations of features of HRM available to inpatient physicians.
| Advantages | Limitations |
|---|---|
| |
| Creates a physician‐managed queue of pending test results by patient | Does not provide alert or push notification when new results available for patients |
| Filters test results by severity with most critical results appearing at the top of the queue | Severity filter set for outpatients; not restrictive enough for post‐discharge period, resulting in excessive alerting |
| Independent, voluntary acknowledgement of results by user | Active acknowledgment not required; no audit trail, feedback, or escalation if result not acknowledged |
| Embedded within LMR (the ambulatory EMR) | LMR not routinely used by many inpatient physicians |
| Offers patient communication tools (eg, pre‐populated patient results letter) | Tools not optimized for post‐discharge test result communication by inpatient physicians (eg, a tool for PCP result notification and acknowledgment) |
In the literature, there is little information regarding optimal features of a test result management system for transitions from the inpatient to ambulatory care setting. Prior studies outline important functions for results management systems developed for noninpatient sites of care, including the ambulatory and emergency room setting.12, 14, 15 These include a method of prioritizing by degree of abnormality, the ability to reliably and efficiently act upon results, and an automated alerting system for abnormal results. Findings from our study provide insight in defining core functions for result management systems which focus on transitions from the inpatient to ambulatory care setting. These functions include tight integration with applications used by inpatient physicians, clear assignment of responsibility for test results finalized after hospital discharge (as well as a mechanism to reassign responsibility), automated alerts to responsible providers of test results finalized post‐discharge, and ways to automatically filter test results to avoid over‐burdening physicians with clinically irrelevant results.
Almost all surveyed inpatient physicians agreed that an ideally designed electronic post‐discharge results management system would be valuable. For such systems to be successfully adopted, we offer several principles to help guide future work. These include: (1) clarifying responsibility at the time a test is ordered and again at discharge, (2) understanding workflow and communication patterns among inpatient and outpatient clinicians, and (3) integrating technological solutions into existing systems to minimize workflow disruptions. For example, if the primary responsibility for post‐discharge result follow‐up lies with the ordering physician, the system should be integrated within the EMR most often used by inpatient physicians and become part of inpatient physician workflow. If the system depends on administrative databases to identify the responsible providers, these must be accurate. Alternatively, in organizations with computerized provider order entry, responsibility for the result could be assigned when the test is ordered and confirmed at discharge (ie, the results management system would be integrated into the discharge order such that pending tests are reviewed at the time of discharge). The discharging physician should have the ability to assign responsibility for each pending test and select preferred mode(s) of notification once its result is finalized (eg, e‐mail, alphanumeric page, etc.). The system should have the ability to generate an automatic notification to the inpatient and PCP (and perhaps other designated providers involved in the patient's inpatient care), but it should not burden busy clinicians with unnecessary alerts and warnings. Finally, the rules by which results are prioritized must be robust enough to filter out less urgent results, and should be modified to reflect the severity of illness of recently discharged patients. In essence, in consideration of the time constraints of busy clinicians, an ideal results management system should achieve automated notification of test results while minimizing the risk of alert fatigue from the potentially large volume of alerts generated.
Our study has several important limitations. First, although our survey response rate was high, the sample size of actual participants was small. Second, because the study was conducted in 2 similar, tertiary care academic centers, it may not generalize to other settings (we note that hospital B included a nonteaching service similar to those in nonacademic medical centers). This may be particularly true in assessing the importance of specific barriers to use of results management systems, which may vary at different institutions. Third, the representation of survey respondents were skeweda majority of the responses were from trainees (all post‐graduate level [PGY] level 2) and from hospital B. Fourth, we did not actively monitor physician interaction with the test result management application, and therefore, we depended heavily on physician recollection of use of the system when responding to surveys. Finally, we did not convene focus groups of key individuals with regard to the factors facilitating or prohibiting adoption of the system. Use of semi‐structured, key informant interviews (ie, focus groups) before and after implementation of an electronic results management application, have been shown to be effective in evaluating potential barriers and facilitators of adoption.16 Focus groups of and/or interviews with inpatient and PCPs, physician extenders, and housestaff could have been useful to better characterize the potential barriers and facilitators of adoption noted by survey respondents in our study.
In summary, we offer several lessons from our attempt to implement a system to manage pending tests at hospital discharge. The success of implementing future systems to address this patient safety concern will rely on accurately assigning responsibility for these test results, integrating the system within clinical information systems commonly used by the inpatient physician, addressing workflow issues and time constraints, maximizing appropriateness of alerting, and minimizing alert fatigue.
The period following discharge is a vulnerable time for patientsthe prevalence of medical errors related to this transition is high and has important patient safety and medico‐legal ramifications.13 Factors contributing to this vulnerability include complexity of hospitalized patients, shorter lengths of stay, and increased discontinuity of care. Hospitalists have recognized this threat to patient safety and have worked toward improving information exchange between inpatient and outpatient providers at hospital discharge.46 Nonetheless, the evidence suggests that more work is necessary. A recent study found that discharge summaries are often incomplete, and do not contain important information requiring follow‐up, such as pending tests.7 Additionally, a review by Kripalani et al. characterizing information deficits at hospital discharge found few interventions which specifically improve communication of pending tests at hospital discharge.8
In a prior study we determined that 41% of patients left the hospital before all laboratory and radiology test results were finalized. Of these results, 9.4% were potentially actionable and could have altered management. Physicians were aware of only 38% of post‐discharge test results.9 This awareness gap is a consequence of several factors including the lack of systems to track and alert providers of test results finalized post discharge. Also, it is unclear who is responsible for pending tests at discharge, since these tests are ordered by the inpatient physicians but often reported in the time period between hospital discharge and the patient's first follow‐up appointment with the primary care physician (PCP). Because responsibility is not explicitly made in the final communication between physicians at discharge, such test results may not be reviewed in a timely manner, potentially resulting in delays in treatment, a need for readmission, or other unfavorable outcomes.
Even in integrated health systems with advanced electronic health records, missed test results which result in treatment delays remain prevalent.10, 11 Test result management applications aid clinicians in reviewing and acting upon results as they become available and such systems may provide solutions to this problem. At Partners Healthcare in Boston, the Results Manager (RM) application was developed to help clinicians in the ambulatory setting safely, reliably, and efficiently review and act upon test results. The application enables clinicians to prioritize test results, utilize guidelines, and generate letters to patients. This system also prompts physicians to set reminders for future testing.12 In a 2.5‐year study evaluating the impact of this intervention, PCPs at 26 adult primary care practices were able to expedite communication of outpatient laboratory and imaging test results to patients with the help of RM. Patients of physicians who participated in the project reported greater satisfaction with test result communication and with information provided about their condition than did a control group of similar patients.13 RM has not yet been studied in the inpatient setting or at care transitions. We describe an attempt at modifying the Partners RM application to help inpatient physicians manage pending tests at hospital discharge.
Methods
Study Setting and Participants
We piloted our application at 2 major academic medical centers (hospitals A and B) associated with Partners Healthcare, an integrated regional health delivery network in eastern Massachusetts, from October 2004 to March 2005. Both centers use the longitudinal medical record (LMR), the electronic medical record (EMR), for nearly all ambulatory practices. The LMR is an internally developed full‐featured EMR, including a repository of laboratory and radiology reports, discharge summaries, ambulatory care notes, medication lists, problem lists, coded allergies, and other patient data. Both centers also have their own inpatient results viewing and order entry systems which provide clinicians caring for patients in the hospital the ability to review results and write orders. Although possible, clinicians caring for patients in the inpatient setting do not routinely access LMR to view test results. Inpatient physician use of the LMR is generally limited to review of the outpatient record, medication lists, and ambulatory notes at admission.
At hospital A, the hospitalist attending physician is typically responsible for all communication to outpatient physicians at discharge, as well as for follow‐up on all test results that return after discharge. Hospital B has 2 types of hospitalist services. One is staffed only by hospitalist and nonhospitalist attending physicians. Nonhospitalist attending physicians were excluded because they care for their own patients in the inpatient and ambulatory setting and typically use RM to manage test results. The other hospitalist service at hospital B is a teaching service consisting of an attending physician, resident, and interns. For this service, the resident is responsible for communication at discharge and follow‐up on all pending tests. For purposes of this study inpatient physicians refers to those physicians responsible for communication with PCPs and follow‐up on pending tests. All inpatient physicians were eligible to participate during the study period.
Test Result Management Application
RM was originally developed by Partners Healthcare to improve timely review and appropriate management of test results in the ambulatory setting. RM was developed for and vetted by primarily ambulatory physicians. The application is browser‐based, provider‐centric, and embedded in the LMR to help ambulatory clinicians review and act upon test results in a safe, reliable, and efficient manner. Although RM has access to all inpatient and outpatient data in the Partners Clinical Data Repository (CDR), given the volume of inpatient tests ordered, hospital‐based results are suppressed by default to limit inundating ambulatory clinicians' queues. Therefore, users of RM only receive results of laboratory and radiology tests ordered in the ambulatory setting. They can track these tests for specific patients for a designated period of time by placing the patient on a watch list. Finally, RM incorporates extensive decision support features to classify the degree of abnormality for each result, presents guidelines to help clinicians manage abnormal results, allows clinicians to generate result letters to patients using predefined, context‐sensitive templates, and prompts physicians to set reminders for future testing. Because RM was developed from the ambulatory perspective, there was limited input from hospitalist physicians with regard to inpatient workflow in the original design of the module.12 See Figure 1 for a screen shot of RM and a description of its features.
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
For purposes of this pilot, we modified RM to allow results of tests ordered in the inpatient setting to be available for viewing (Hospitalist Results Manager, HRM). This feature was turned on only for inpatient physicians as previously defined. Inpatient tests, including pending tests at discharge, continued to be suppressed from PCP's RM queue (however, any physician could access a patient's test result(s) directly from the Partners CDR). Inpatient physicians could track laboratory and radiology results finalized after discharge by keeping discharged patients on their HRM watch list for a designated period of time. The finalized results would become available for review in their HRM queue and abnormal results were displayed prominently at the top of this queue. Inpatient physicians were trained to use HRM in a series of meetings and demonstrations. Although HRM could be accessed from inpatient clinical workstations, it was not part of the inpatient clinical information system.
Surveys
Study surveys were developed and refined through an iterative process and pilot tested among inpatient physicians at both centers for clarity. We surveyed inpatient physicians five months after HRM implementation. Inpatient physicians were asked how often they used HRM, what barriers they faced (respondents asked to quantify agreement to statements on a 5‐point Likert scale), and which elements of an ideal system they would prefer. Finally, we solicited comments regarding perceived obstacles and suggestions for improvement. Because HRM was targeted to inpatient physicians, and because RM has been evaluated from the ambulatory perspective in a prior study,13 PCPs were not surveyed. See Supporting Information Appendix for the survey instrument used in the study.
Results
A total of 35 inpatient physicians participated in the pilot. Among 649 patients discharged during the study period, there were 1075 tests pending of which 555 were subsequently flagged as abnormal in HRM. Study surveys were sent to the 35 inpatient physician participants and 29 were completed, including partial responses (83% survey response rate). The 35 inpatient physician participants had the following characteristics: 22 were male, 13 were female; 21 were trainees and 14 were nontrainees/faculty. All 21 trainees were PGY2s. Nontrainees and faculty varied in experience level (PGY 15: 5, PGY 610: 7, PGY 1120: 1, PGY 21+: 1). Of 29 survey respondents, 7 were from hospital A and 22 were from hospital B; 19 were trainees and 10 were nontrainees/faculty. Of the 6 nonrespondents, 2 were from hospital A and 4 were from hospital B; 2 were trainees and 4 were nontrainees/faculty.
Table 1 shows the results of our survey of inpatient physicians regarding usage of HRM. Of 29 survey respondents, 14 (48%) reported never using HRM. Thirteen (45%) reported using HRM 1 to 2 times per week. None of the respondents used it more than 4 times per week. The frequency of usage was similar for hospitals A and B. Table 2 details barriers to using HRM. Twenty‐three inpatient physicians (79%) reported barriers. Seventeen (59%) thought that results in their HRM queue were not clinically relevant, 16 (55%) felt that HRM did not fit into their daily workflow, 14 (48%) had limited time to use HRM, and 12 (41%) noted that too many results in their HRM queue were on other physician's patients. Seven (24%) reported operational issues and 3 (10%) reported technical issues prohibiting use of HRM. With regard to preferred elements of an ideal results manager system, 21 (72%) inpatient physician respondents wanted to receive notification of abnormal and clinician‐designated pending test results. Four (14%) wanted to receive only abnormal results and 1 (3%) wanted to receive all results. Twenty‐seven (93%) physicians agreed that an ideally designed computerized test result management application would be valuable for managing pending tests at discharge.
| Frequency | Number of Inpatient Physicians Using HRM, n (%) | ||
|---|---|---|---|
| Overall | Hospital A | Hospital B | |
| |||
| Never | 14 (48) | 3 (43) | 11 (50) |
| 12 times per week | 13 (45) | 3 (43) | 10 (45.5) |
| 34 times per week | 2 (7) | 1 (14) | 1 (4.5) |
| 57 times per week | 0 | 0 | 0 |
| >7 times per week | 0 | 0 | 0 |
| Barrier | Overall, n (%) | Hospital A, n (%) | Hospital B, n (%) |
|---|---|---|---|
| |||
| Forgot to use HRM | 23 (79) | 7 (100) | 16 (73) |
| Results not clinically relevant | 17 (59) | 7 (100) | 10 (45) |
| Did not fit daily workflow | 16 (55) | 7 (100) | 9 (41) |
| Too little time to use HRM | 14 (48) | 6 (86) | 8 (46) |
| Results on others' patients | 12 (41) | 6 (86) | 6 (27) |
| HRM was difficult to use | 7 (24) | 2 (29) | 5 (23) |
| Had technical difficulties | 3 (10) | 0 (0) | 3 (14) |
Table 3 provides comments from inpatient physician respondents regarding obstacles prohibiting use of HRM and suggestions for future systems.
|
| Suggestions |
| Would be more useful if accessible from (the inpatient clinical information system). |
| Email notification (would have been useful). |
| At time of discharge, if there is a way to find pending labs at discharge, this would be of great utility. |
| Linking responsibility for follow‐up to test ordering (would have been useful). |
| Smarter system for filtering results so less important results are filtered out (is desirable). |
| Can the system be tied into PCP's email somehow? |
| Obstacles |
| Blood cultures, abnormal films can be difficult and time‐consuming to look up. |
| A big problem is results that automatically trigger even though they're not clinically relevant. |
| Keeping a record of patients that left with tests pending (is often difficult to do). |
| Addressing pending results is very time consuming. |
Discussion
We describe a pilot implementation of a computerized application for the management of pending tests at hospital discharge. From responses to post‐implementation surveys, we were able to identify multiple factors prohibiting successful implementation of the application. These observations may help inform future interventions and evaluations.
Almost half of inpatient physicians reported never using HRM despite training and reminders. The feedback provided by physicians in our study suggested that HRM was not ideally designed from an inpatient physician perspective. We discovered several barriers to its use: (1) HRM overburdened physicians with clinically irrelevant test results, suggesting that more robust filtering of abnormal but low importance test results may be required (eg, a borderline electrolyte abnormality or low but stable hematocrit); (2) HRM did not integrate well into inpatient workflowthe system was not integrated into the inpatient results viewing and computerized physician order entry (CPOE) applications, and therefore required an extra step to access; (3) there was no mechanism of alerting inpatient physicians that finalized test results were available for viewing in their HRM queues (eg, by email or by an alert in the inpatient computer system); (4) because responsibility for these results was unclear, most inpatient physicians had no formal method of managing them, and for many, using HRM represented an additional task; and finally (5) several physicians commented on finding results in their HRM queue that belonged to other physician's patients, implying that the hospital databases were inaccurate in identifying the discharging physician or that rotation schedules, and therefore patient responsibility, had changed in the intervening period. Table 4 summarizes the advantages and respective limitations of features of HRM available to inpatient physicians.
| Advantages | Limitations |
|---|---|
| |
| Creates a physician‐managed queue of pending test results by patient | Does not provide alert or push notification when new results available for patients |
| Filters test results by severity with most critical results appearing at the top of the queue | Severity filter set for outpatients; not restrictive enough for post‐discharge period, resulting in excessive alerting |
| Independent, voluntary acknowledgement of results by user | Active acknowledgment not required; no audit trail, feedback, or escalation if result not acknowledged |
| Embedded within LMR (the ambulatory EMR) | LMR not routinely used by many inpatient physicians |
| Offers patient communication tools (eg, pre‐populated patient results letter) | Tools not optimized for post‐discharge test result communication by inpatient physicians (eg, a tool for PCP result notification and acknowledgment) |
In the literature, there is little information regarding optimal features of a test result management system for transitions from the inpatient to ambulatory care setting. Prior studies outline important functions for results management systems developed for noninpatient sites of care, including the ambulatory and emergency room setting.12, 14, 15 These include a method of prioritizing by degree of abnormality, the ability to reliably and efficiently act upon results, and an automated alerting system for abnormal results. Findings from our study provide insight in defining core functions for result management systems which focus on transitions from the inpatient to ambulatory care setting. These functions include tight integration with applications used by inpatient physicians, clear assignment of responsibility for test results finalized after hospital discharge (as well as a mechanism to reassign responsibility), automated alerts to responsible providers of test results finalized post‐discharge, and ways to automatically filter test results to avoid over‐burdening physicians with clinically irrelevant results.
Almost all surveyed inpatient physicians agreed that an ideally designed electronic post‐discharge results management system would be valuable. For such systems to be successfully adopted, we offer several principles to help guide future work. These include: (1) clarifying responsibility at the time a test is ordered and again at discharge, (2) understanding workflow and communication patterns among inpatient and outpatient clinicians, and (3) integrating technological solutions into existing systems to minimize workflow disruptions. For example, if the primary responsibility for post‐discharge result follow‐up lies with the ordering physician, the system should be integrated within the EMR most often used by inpatient physicians and become part of inpatient physician workflow. If the system depends on administrative databases to identify the responsible providers, these must be accurate. Alternatively, in organizations with computerized provider order entry, responsibility for the result could be assigned when the test is ordered and confirmed at discharge (ie, the results management system would be integrated into the discharge order such that pending tests are reviewed at the time of discharge). The discharging physician should have the ability to assign responsibility for each pending test and select preferred mode(s) of notification once its result is finalized (eg, e‐mail, alphanumeric page, etc.). The system should have the ability to generate an automatic notification to the inpatient and PCP (and perhaps other designated providers involved in the patient's inpatient care), but it should not burden busy clinicians with unnecessary alerts and warnings. Finally, the rules by which results are prioritized must be robust enough to filter out less urgent results, and should be modified to reflect the severity of illness of recently discharged patients. In essence, in consideration of the time constraints of busy clinicians, an ideal results management system should achieve automated notification of test results while minimizing the risk of alert fatigue from the potentially large volume of alerts generated.
Our study has several important limitations. First, although our survey response rate was high, the sample size of actual participants was small. Second, because the study was conducted in 2 similar, tertiary care academic centers, it may not generalize to other settings (we note that hospital B included a nonteaching service similar to those in nonacademic medical centers). This may be particularly true in assessing the importance of specific barriers to use of results management systems, which may vary at different institutions. Third, the representation of survey respondents were skeweda majority of the responses were from trainees (all post‐graduate level [PGY] level 2) and from hospital B. Fourth, we did not actively monitor physician interaction with the test result management application, and therefore, we depended heavily on physician recollection of use of the system when responding to surveys. Finally, we did not convene focus groups of key individuals with regard to the factors facilitating or prohibiting adoption of the system. Use of semi‐structured, key informant interviews (ie, focus groups) before and after implementation of an electronic results management application, have been shown to be effective in evaluating potential barriers and facilitators of adoption.16 Focus groups of and/or interviews with inpatient and PCPs, physician extenders, and housestaff could have been useful to better characterize the potential barriers and facilitators of adoption noted by survey respondents in our study.
In summary, we offer several lessons from our attempt to implement a system to manage pending tests at hospital discharge. The success of implementing future systems to address this patient safety concern will rely on accurately assigning responsibility for these test results, integrating the system within clinical information systems commonly used by the inpatient physician, addressing workflow issues and time constraints, maximizing appropriateness of alerting, and minimizing alert fatigue.
- ,,,,.The incidence and severity of adverse events affecting patients after discharge from the hospital.Ann Intern Med.2003;138(3):161–167.
- ,,,.Medical errors related to discontinuity of care from an inpatient to an outpatient setting.J Gen Intern Med.2003;18(8):646–651.
- .Key legal principles for hospitalists.Am J Med.2001;111(9B):5S–9S.
- ,,.Passing the clinical baton: 6 principles to guide the hospitalist.Am J Med.2001;111(9B):36S–39S.
- ,.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141(7):533–536.
- ,,,.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2(5):314–323.
- ,,, et al.Adequacy of hospital discharge summaries in documenting tests with pending results and outpatient follow‐up providers.J Gen Intern Med.2009;24(9):1002–1006.
- ,,,,,.Deficits in communication and information transfer between hospital‐based and primary care physicians: Implications for patient safety and continuity of care.JAMA.2007;297(8):831–841.
- ,,, et al.Patient safety concerns arising from test results that return after hospital discharge.Ann Intern Med.2005;143(2):121–128.
- ,,.The continuing problem of missed test results in an integrated health system with an advanced electronic medical record.Jt Comm J Qual Patient Saf.2007;33(8):485–492.
- ,.The frequency of missed test results and associated treatment delays in a highly computerized health system.BMC Fam Pract.2007;8:32.
- ,,,,.Design and implementation of a comprehensive outpatient results manager.J Biomed Inform.2003;36(1–2):80–91.
- ,,, et al.Impact of an automated test results management system on patients' satisfaction about test result communication.Arch Intern Med.2007;167(20):2233–2239.
- ,,,,,.“I wish I had seen this test result earlier!”: dissatisfaction with test result management systems in primary care.Arch Intern Med.2004;164(20):2223–2228.
- ,,.Potential impact of a computerized system to report late‐arriving laboratory results in the emergency department.Pediatr Emerg Care.2000;16(5):313–315.
- ,,, et al.Electronic results management in pediatric ambulatory care: Qualitative assessment.Pediatrics.2009;123Suppl 2:S85–S91.
- ,,,,.The incidence and severity of adverse events affecting patients after discharge from the hospital.Ann Intern Med.2003;138(3):161–167.
- ,,,.Medical errors related to discontinuity of care from an inpatient to an outpatient setting.J Gen Intern Med.2003;18(8):646–651.
- .Key legal principles for hospitalists.Am J Med.2001;111(9B):5S–9S.
- ,,.Passing the clinical baton: 6 principles to guide the hospitalist.Am J Med.2001;111(9B):36S–39S.
- ,.Lost in transition: challenges and opportunities for improving the quality of transitional care.Ann Intern Med.2004;141(7):533–536.
- ,,,.Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists.J Hosp Med.2007;2(5):314–323.
- ,,, et al.Adequacy of hospital discharge summaries in documenting tests with pending results and outpatient follow‐up providers.J Gen Intern Med.2009;24(9):1002–1006.
- ,,,,,.Deficits in communication and information transfer between hospital‐based and primary care physicians: Implications for patient safety and continuity of care.JAMA.2007;297(8):831–841.
- ,,, et al.Patient safety concerns arising from test results that return after hospital discharge.Ann Intern Med.2005;143(2):121–128.
- ,,.The continuing problem of missed test results in an integrated health system with an advanced electronic medical record.Jt Comm J Qual Patient Saf.2007;33(8):485–492.
- ,.The frequency of missed test results and associated treatment delays in a highly computerized health system.BMC Fam Pract.2007;8:32.
- ,,,,.Design and implementation of a comprehensive outpatient results manager.J Biomed Inform.2003;36(1–2):80–91.
- ,,, et al.Impact of an automated test results management system on patients' satisfaction about test result communication.Arch Intern Med.2007;167(20):2233–2239.
- ,,,,,.“I wish I had seen this test result earlier!”: dissatisfaction with test result management systems in primary care.Arch Intern Med.2004;164(20):2223–2228.
- ,,.Potential impact of a computerized system to report late‐arriving laboratory results in the emergency department.Pediatr Emerg Care.2000;16(5):313–315.
- ,,, et al.Electronic results management in pediatric ambulatory care: Qualitative assessment.Pediatrics.2009;123Suppl 2:S85–S91.
Copyright © 2010 Society of Hospital Medicine
BEST PRACTICES IN: Managing Eczema With Natural Ingredients
A supplement to Skin & Allergy News. This supplement was sponsored by Johnson & Johnson Consumer Products Company.
- What Role Should Colloidal Oatmeal Play?
- What Other Naturally Derived Ingredients May Benefit Patients With AD?
- The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and The University of California, San Diego School of Medicine
Professor of Clinical
Pediatrics and Medicine
(Dermatology)
The University of California
San Diego, CA
Dr. Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children’s Hospital
San Diego, CA
Dr. Reyes Merin has nothing to disclose.
Copyright (c) 2010 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was sponsored by Johnson & Johnson Consumer Products Company.
- What Role Should Colloidal Oatmeal Play?
- What Other Naturally Derived Ingredients May Benefit Patients With AD?
- The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and The University of California, San Diego School of Medicine
Professor of Clinical
Pediatrics and Medicine
(Dermatology)
The University of California
San Diego, CA
Dr. Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children’s Hospital
San Diego, CA
Dr. Reyes Merin has nothing to disclose.
Copyright (c) 2010 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was sponsored by Johnson & Johnson Consumer Products Company.
- What Role Should Colloidal Oatmeal Play?
- What Other Naturally Derived Ingredients May Benefit Patients With AD?
- The Value of 510(k) Products in Eczema
Faculty/Faculty Disclosure
Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and The University of California, San Diego School of Medicine
Professor of Clinical
Pediatrics and Medicine
(Dermatology)
The University of California
San Diego, CA
Dr. Eichenfield was a consultant to Johnson and Johnson.
Melissa Reyes Merin, MD
Clinical Fellow
Rady Children’s Hospital
San Diego, CA
Dr. Reyes Merin has nothing to disclose.
Copyright (c) 2010 Elsevier Inc.